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Chapter 1
Introduction
“Biology is a science like all other sciences, following 
the same laws, the same rules, and the same 
evolution; the same methods are applicable. As for 
other sciences, it should be successively descriptive, 
analytical, and synthetic. [...] How can an attempt 
to make a cell be less acceptable than an attempt to 
make a molecule?” 
Stéphane Leduc in La biologie synthétique [1]
In the early 20th century, Stéphane Leduc introduced the concept of 
synthetic biology. According to Leduc, analytical biology would al-
ways be limited by the intricate connections between phenomena in-
side a biological system. No phenomenon could be isolated from the 
others, as this phenomenon would cease or the living organism would 
die. Leduc proposed the idea that a cell could be reconstructed from 
basic building blocks generating biological phenomena of increasing 
complexity. For Leduc, a synthetic method was applicable to biology, 
meaning that life could be explained using a bottom-up approach.
Synthetic biology emerged as a concrete productive field about a 
century later. Definition of synthetic biology shifted from the funda-
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mental concept of Leduc to a broader and more inclusive perspective. 
A definition of synthetic biology can be found on the website of the 
synthetic biology research community (http://syntheticbiology.org): 
“Synthetic Biology is: 
A) The design and construction of new biological parts, 
devices, and systems, and 
B) the re-design of existing, natural biological systems 
for useful purposes.”
Synthetic biology is not only useful for fundamental research, but can 
also be used for productive purposes. It is broadly accepted that synthetic 
biology uses forward-engineering approaches in order to rationally de-
sign new cellular behaviours from recombinant genetic circuits [2]. In 
less than 20 years, synthetic biology allowed the design and implementa-
tion of complex genetic circuits in order to produce valuable therapeutic 
molecules or change cells into biological sensors (See section 1.1 and 1.3 
of this chapter). Synthetic biology essentially focusses on:
• Designing and implementing complex genetic circuits, such as 
oscillators, toggle switches, logic gates, memory devices and 
quorum sensing devices
• Creating new biological devices with increased orthogonality 
with both cellular regulation system and other synthetic reg-
ulation systems. This consisted in engineering new (pre/post) 
transcriptional regulation, translational and post-translational 
synthetic regulation systems, as well as new functional ribo-
somes or genetic code.
• translating new cellular functions into industrial and medical 
applications, such as industrial synthesis of complex mole-
cules, or rapid generation of biotic and abiotic biosensors
• Defining life from a functional perspective. That is minimising 
the genome of existing organisms (top-down approach) or 
building up a protocell, function by function (bottom up ap-
proach, corresponding to the definition of Leduc).
11
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Brief glossary
activator: protein capable of triggering the tran-
scription of a gene or increasing its transcription 
rate.
entrainment: process leading multiple coupled 
oscillators to display the same period. such oscil-
lators can display different periods when they are 
observed independently. entrainment can be illus-
trated by Huygens’s coupled pendula experiment.
Logic gate: genetic circuit whose activity is condi-
tioned by logic operations similar to those found in 
electronic circuits. logic operations, also described 
as Boolean operations, can be for instance, TrUe, 
false, aND, or, etc..
Orthogonality: absence of interference between 
multiple systems.
oscillator: a system displaying a periodic be-
haviour.  an oscillating gene is alternatively active 
or repressed due to the generation of a delayed 
negative feedback. 
repressor: protein capable of preventing the tran-
scription of a gene by occupying a DNa region, the 
operator, in vicinity of the promoter.
robustness: in a context of oscillatory behaviour, 
robustness characterises the ability of a system 
to oscillate over a broad range of parameters, i.e. 
gene concentration, activator and repressor con-
centration, inducer concentration, degradation 
rates, etc...
Tuneability: describes the possibility to control the 
behaviour of a network by changing primary in-
puts, such as inducer concentration.
12
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The increasing complexity of the new circuits and their negative im-
pact on cell viability has become a serious issue which limits further 
development of the field and their applications [3] (See section 1.2 of 
this chapter). New genetic designs are prone to impact the endogenous 
gene regulation of the cell or saturate the essential expression and deg-
radation machineries. This phenomenon, known as resource burden is 
at the origin of major host-circuit incompatibility. The mobilisation of 
metabolic flows acts as a drain, which compromises cell homeostasis. 
Furthermore, adaptation mechanisms used by the cell, such as genetic 
mutations, tend to decrease the efficiency of foreign circuits.
In contrast with cellular systems, cell-free protein synthesis platforms 
are very versatile and rapidly tuneable systems that can be used when 
cell-based synthetic biology is often limited (see section 1.3 of this 
chapter). Cell-free synthetic biology, which consists in the reproduc-
tion of the cellular behaviour in vitro, offers a promising approach to 
address issues related to host-circuit incompatibility. recent devel-
opments, including the diversification of transcription factors used 
for cell-free gene expression reactions, and miniaturisation of the re-
action in open reactors, now make it possible to rapidly test new ge-
netic circuits in order to ensure their compatibility with a target host 
organism. Furthermore, cell-free synthetic biology offers new appli-
cations outside the lab, in contrast to many in vivo systems, which 
are restricted to a safe and controlled environment. Cell-free proteins 
synthesis platforms can be used for:
• rapid testing and characterisation of synthetic modules and 
circuits. As such testing can be performed in a cell-like envi-
ronment, further resource burden and compatibility issues can 
be addressed.
• production of problematic molecules, often toxic for living 
cells, and diagnosis devices outside the lab
• Development of artificial or minimal cells
In this chapter, I will give a brief overview of the milestone achievements 
that contributed to the expansion of the field. I will also describe ap-
13
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plications that could be uniquely developed using a synthetic biology 
(SB) approach. Further, I will discuss the major issues limiting the de-
velopment of more complex and productive gene networks in cell-based 
synthetic biology. In a last part, I will show, through a series of examples, 
how cell-free synthetic biology constitutes a unique approach to help 
further developments in cell-based circuits, contribute to more funda-
mental aspects of research in biology and create new SB applications.
1.1. The development of cell-based 
synthetic biology
1.1.1. Before synthetic biology
The first use of a microorganism for industrial production of a med-
ical drug took place in the mid-1940s, with the natural production 
of penicillin by Penicillium chrysogenum. At that time, knowledge of 
genetics was extremely limited, as the central hypothesis of molecular 
biology - one gene instructing the production of one protein - had 
yet to be formulated [4]. In 1946, Lederbergh and tatum suggested 
the existence of bacterial conjugation, which is the possibility for a 
competent bacterium to acquire new phenotypic traits from another 
bacterium after transfer of a plasmid DNA molecule [5]. 
Another major discovery by Monod and Jacob, the discovery of the 
lac operon[6], also played a fundamental role in the emergence of 
synthetic biology. Their work suggested the existence of gene net-
works regulating the cellular response to changes in external resourc-
es. This gave rise to the idea that bacteria could be modified in order 
to accomplish new productive and regulatory functions by designing 
and assembling new DNA molecules [7]. 
In the 1970s, the first protocols allowing transformation of E. coli af-
ter a calcium chloride treatment were published [8, 9]. The rise of 
14
CHApter 1
recombinant protein production occurred in the 1970-80s, after the 
development of molecular biology techniques, such as polymerase 
chain reaction (pCr) and cloning procedures. New circuits were de-
signed to induce simple and linear functions in the host cell. With the 
leading concept of system biology, the 1990s approached the cellular 
complexity as a system integrating hierarchical sub-systems and reg-
ulation modules [10]. The top-down approach, consisting in studying 
the impact of a gene knock-out on the function of sub-systems, along 
with improvements in DNA sequencing techniques and bioinformat-
ics analysis, led to a better understanding of the structure of cellular 
networks [11-13].  
1.1.2. Early years (2000-2007)
In 2000, two publications described for the first time the design and 
the implementation of synthetic gene networks in E. coli. The first 
work, published by Gardner et al. introduced the implementation of 
a synthetic toggle switch [14]. A toggle switch, or bistable switch, is 
a system capable of switching between two exclusive states. For in-
stance, the toggle switch described by Gardner and co-workers could 
switch from a regime producing a protein 1, to another regime pro-
ducing protein 2. This switch was based on the production of two 
repressor proteins, configured such as they would mutually repress 
each other (Fig. 1.1a). two versions of the toggle switch were pro-
posed. The first one involved two modules, ptrc-2-cI (LacI repressed) 
and pLs1con-lacI (CI repressed). Addition of isopropylthiogalacto-
side (IptG) would suppress the repressive effect of LacI proteins on 
the expression of the ptrc-2-cI module. The expression of cI protein 
was also coupled with the expression of the GFp readout. The reverse 
path involved the expression of the ptrc-2-cI to be switched off. This 
was achieved by deactivating the cI proteins, which are heat-sensi-
tive. An increase in temperature would allow the expression of LacI 
proteins and a return to the initial state (Fig. 1.1b). The second switch 
was constructed following a similar design. It also involved the use 
of LacI repressor protein, this time coupled to the expression of the 
tetracycline repressor protein tetr. The two modules, pLteto-1-la-
15
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cI (tetr repressed) and ptrc-2-tetr (LacI repressed), were therefore 
sensitive to the addition of IptG and to the addition of anhydrotetra-
cycline (Atc) (Fig. 1.1c).
At the same time elowitz and Leibler described the implementation 
of the first synthetic oscillator [15]. The oscillator topology consisted 
of three negative-feedback modules, λpr-tetr, pLteto1-lacI and pLla-
co1-cI (Fig. 1.1d). Such a system, involving an odd number of Not 
gates, is also described as a ring oscillator in electronic engineering. 
The expression of the first module led to the repression of the sec-
ond module. This allowed the expression of the third module, which 
led to the repression of the first module. All three repressor proteins 
were also tagged for specific degradation by ClpXp protease complex. 
This topology generated a delayed negative feedback loop, allowing 
the emergence of an oscillatory behaviour, monitored by the produc-
tion of the GFp readout from a pLteto1-gfp module. The expression 
of GFp was concomitant with the expression of the second module. 
Bacteria transformed with this system, called repressilator, exhibit an 
oscillatory behaviour. This behaviour was observed over a few cell 
generations (Fig. 1.1e). The system however suffered from a high vari-
ability in period and amplitude between individual cells. For this rea-
son, the determination of the period was performed by fluorescence 
measurements at a single-cell level (Fig. 1.1e-f).   Moreover, the oscil-
lations rapidly dampened as cells were entering the stationary phase. 
This could be explained by a decrease in abundance of rNA poly-
merase-σ70 transcription factor complex. As the concentration of oth-
er transcription factors, such as σ28, usually increases while entering 
the stationary phase, competition between transcription factors for 
forming a complex with the core rNA-polymerase increases. It was 
hypothesised by purcell et al. that a promoter allowing transcription 
from both σ70 and σ28 might improve the duration of the oscillations 
[16]. It was also later demonstrated that the coupling of a positive 
feedback loop to the repressilator enhanced the robustness of the os-
cillations [17]. 
reports from Gardner et al. and elowitz and Leibler had a funda-
mental relevance for the development of synthetic biology. First they 
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demonstrated the possibility to use a rationally designed gene net-
work in order to trigger a new, complex behaviour in cells. Second, 
they validated the crucial role of quantitative analysis and modelling 
of cellular flows (i.e. rates of gene expression, rate of protein degrada-
tion, kinetics of repressor-operator binding, etc...) for successful im-
plementation of such networks. Further research to improve the com-
patibility between a synthetic network and a host organism would 
systematically involve the implementation of models from in numero 
molecular biology [18-20].  
Successive developments in synthetic biology involved a better un-
derstanding of autoregulation through positive and negative feed-
backs [21-23]. A combinatorial approach was also used to generate 
sets of genetic modules that would induce logic gate behaviour in E. 
coli [24]. The idea that synthetic biology could be used not only for 
productive purposes but also for understanding cellular mechanisms 
emerged, with the study of noise and stochasticity in gene expression. 
Synthetic constructs were used to study variability in gene expres-
sion, from one cell to another and from one gene to another inside 
the same cell [25-27]. Noticeably, the first synthetic circuit allowing 
intercellular communication was built at that time [28], highlighting 
the strong potential of synthetic approaches for the development of 
quorum sensing bacterial devices. 
In the following years, as the field of synthetic biology received a grow-
ing interest from the scientific community, more efforts were made 
to gather common knowledge and develop engineering standards to 
facilitate exchange between groups. For instance, a common compu-
tational language, the Synthetic Biology open Language (SBoL), was 
developed to describe new modules and their interactions [29]. The 
registry for Standard Biological parts (rSBp) was created. It consist-
ed of an online public repository storing sequences of new synthetic 
constructs, along with a physical library gathering those constructs. 
Also, the openWetWare was developed as a wiki platform to make 
detailed protocols available to the whole community.
orthogonality, which represents the low degree of interference be-
tween a regulated synthetic circuit and the host regulation, is one 
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crucial parameter for a successful implementation. orthogonality is 
usually achieved by using circuit regulation mechanisms that are ex-
ogenous to the host. In order to extend the library of orthogonal reg-
ulation strategies available for synthetic circuits, post-transcriptional 
regulation mechanisms were developed by engineering so-called ri-
boregulators [30, 31]. 
The first synthetic riboregulators could be divided into two main 
groups. one was based on riboregulation by a ligand. Briefly, this li-
gand binds a small antiswitch rNA sequence, which induces a con-
formation change in the antiswitch. This new conformation allows 
the antiswitch to bind the ribosome binding site (rBS) sequence of 
an mrNA and prevent further translation. Bayer and Smolke used 
the couple theophylline-theophylline aptamer to regulate the trans-
lation of a GFp readout (Fig.  1.2a) [31]. Cells transcribing the an-
tiswitch rNA in absence of theophylline, along with the switchable 
GFp mrNA produce GFp (Fig. 1.2b). upon addition of theophylline, 
production of GFp rapidly decreases. 
The second group of orthogonal riboswitches was based on the in-
trinsic property of an mrNA to prevent its own translation. As de-
scribed by Isaacs et al., a small sequence at the 5’-untranslated region, 
complementary to the ribosome binding sequence, hybridises with 
the rBS, generating a cis-repression event [30]. In order to allow the 
translation of the mrNA, the transcription of a second rNA, termed 
as trans-activator rNA, was required. The trans-activator rNA was 
complementary to the cis-repressor sequence. In presence of the 
trans-activator sequence, the rBS is therefore available for initiating 
translation (Fig. 1.2c). Although providing an oN/oFF ratio over 10 
(green curve/red curve in Fig. 1.2d), this regulation module allows 
little diversification, as the sequence and structure constraints had to 
be conserved [32]. Such constraints consisted of a sequence comple-
mentary to the rBS followed by a u-turn motif, which was generated 
by a YuNr sequence (pyrimidine-uracyl-nucleotide-purine).
The first AND-logic gate was also developed [33]. An output t7-gfp 
module was used. The expression of GFp required the presence of t7 
rNA polymerase (t7rNAp) for transcription. The transcription of 
18
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Figure 1.1: First synthetic circuits driving complex bacterial behaviour. Toggle switch: The first 
synthetic toggle switch was based on two repressor modules, arranged in a mutually repressing 
topology (a). Such topology allowed bistability upon addition of IPTG or rise in temperature 
when the repressor proteins used were LacI and CI (b). In a similar way, bistable behaviour was 
observed upon addition of IPTG or aTc when the repressor proteins used were LacI and TetR 
(c). Repressilator: The first synthetic oscillator was based on a ring topology (d). It allowed the 
implementation of genetic oscillations in E. coli cells (e). fluorescence signal measured over 
time at a single-cell level (f). Toggle switch figures from [14]. Repressilator figures from [15]
19
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the gene coding for the t7 rNAp from the pBAD promoter was condi-
tioned by the addition of arabinose. The t7rnap mrNA was translated 
only in presence of a newly engineered suppressor trNA. The tran-
scription of this suppressor trNA was conditioned by the addition of 
salicylate. The production of GFp was therefore conditioned to the 
presence of both arabinose and salicylate in the growth medium.
Finally, a major driving force for the field of synthetic biology came 
from the perspectives of medical and industrial applications. In 
2003, Keasling and co-workers presented an engineered strain of E. 
coli. This new strain could produce isoprenoids, which are essential 
precursors for the synthesis of larger molecules used in medicine, 
such as steroids [34]. In 2006, ro et al announced the production of 
small amounts of biosynthetic artemisinic acid by engineered S. cer-
evisiae [35]. This product, involved in treatments against the malar-
ial parasite, is naturally synthesised by Artemisia annua, the sweet 
wormwood plant. The possibility of synthesising the artemisinic 
acid in a fermentor instead of relying on unstable field production, 
with fluctuating prices and risks of shortage, was a serious argument 
in favour of synthetic biology approach (SB approach). The case for 
SB artemisinin inspired considerable efforts in the field of metabolic 
engineering and complex product biosynthesis. For a review sum-
marising the advances of metabolic engineering and drug synthesis 
at that time, see [36].
Summarising the first period of synthetic biology, seminal achieve-
ments led to a growing interest of the scientific community for this 
new field of biology. By the end of 2007, the synthetic biology com-
munity was well organised and efforts were converging in a few direc-
tions, such as implementation of complex gene networks, metabolic 
engineering or expansion of regulation libraries. The field could how-
ever be seen as a collection of singular achievements, i.e. few logic 
gates, few rNA circuits, few dedicated gene oscillators, which would 
seed and expand during the following years. From a technical point 
of view, a major limitation laid in the inability to rapidly construct 
large genetic assemblies. This limited the number of genes that could 
be introduced in one plasmid, and therefore the complexity of be-
20
CHApter 1
Figure 1.2: First riboregulators. Ligand-controlled riboregulator: An antiswitch RNA containing 
an aptamer sequence folds upon binding with a chemical ligand and prevents translation 
of a GFP mRNA (a). Illustration of a theophylline-controlled riboregulator integrated in 
S. cerevisiae. Upon addition of theophylline, cells stop translating the gfp mRNA (b). Cis-
repressed riboregulator: The 5’-UTR region of an mRNA folds and sequesters the RBS. A trans-
activating RNA binds the cis-repressing sequence, allowing translation (c). The cis-repressed 
riboregulator is integrated into E. coli and fluorescence is measured using FACS. Black curve 
indicates autofluorescence, blue curve indicates the fluorescence signal in absence of cis-
repressing sequence. signal from cis-repressed circuit in absence (red) or in presence (green) 
of the trans-activating element. (d) Ligand-controlled riboregulator figures from [31]. Cis-
repressed/ trans-activated riboregulator from [30].
21
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haviours that could be generated. Moreover, the functionality of new 
genetic modules could not be reliably characterised. The integration 
of new genetic modules into circuits required tremendous efforts in 
tuning individual building block activities, which strongly limited the 
transposition of genetic circuits to new strains or organisms [37-39]. 
Some of the issues, related to the lack of characterisation of individ-
ual building blocks and the burden they generate, will be further dis-
cussed in this chapter.
1.1.3. Expansion and diversification  
(2008-2016)
In 2008, Hasty and co-workers introduced a robust and tuneable syn-
thetic gene oscillator which would become a standard in the field of 
system engineering [40]. The development of the oscillator combined 
thorough efforts in topology design, strain selection and simulation 
studies. The oscillator was constituted of two primary modules gen-
erating dual feedbacks, and a reporter module. The key component 
of the network, the promoter plac/ara, allowed repression by LacI pro-
teins and activation by AraC proteins in presence of arabinose [41]. 
The negative-feedback module, plac/ara-lacI-ssrA, was capable of gen-
erating a delayed self-negative feedback and repress the expression of 
the second module (Fig. 1.3a). LacI tetramers generate a strong arrest 
in transcription and the delay was generated by the time elapsed be-
tween transcription and multimerisation of LacI proteins. In order to 
limit the influence of the host metabolism on the circuit, Hasty and 
co-workers used an E. coli strain engineered to not produce endoge-
nous LacI. The second module, plac/ara-araC-ssrA, amplified its expres-
sion in presence of arabinose, as the AraC protein dimers display a 
high affinity for the rNA polymerase, which increased the transcrip-
tion rates for both the positive and the negative feedback modules. 
Consequently, the system alternatively switched from an active phase, 
characterised by an increase in AraC and LacI protein concentrations, 
and a repressed phase driven by the presence of LacI tetramers. 
22
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Most of the cells transformed with these modules displayed oscillat-
ing behaviour, monitored by measuring the production of GFp at a 
single-cell level (Fig. 1.3b). In contrast to previous oscillator studies, 
a microfluidic system providing a laminar flow of medium kept cells 
far from the stationary phase. This allowed authors to observe that the 
phase of the oscillations was transmitted through many generations. 
oscillations were observed over a broad range of IptG (Fig.  1.3c) 
and arabinose (Fig.  1.3d) concentrations. These two ligands were 
used to tune the period from 13 to 60 minutes. Interestingly, the sim-
ple mathematical model used for the development of the network 
failed to describe the robustness of the oscillator. A second model, 
including individual steps of transcription, translation, as well as pro-
tein multimerisation and protein-DNA interactions, displayed a be-
haviour that was in closer agreement with the robustness observed 
experimentally. This second model also suggested the existence of a 
secondary oscillating space only due to the presence of the delayed 
negative feedback. The delayed negative feedback module was studied 
without the positive feedback module. Such topology is known as a 
Godwin oscillator [42].  oscillations were also observable, but their 
robustness was greatly decreased, as the oscillator displayed a more 
chaotic behaviour. These observations demonstrated the importance 
of the positive feedback for both the robustness and the tunability of 
the system.
The work of Hasty and co-workers was of crucial importance for the 
field of circuitry design. Firstly, their approach for rationally design-
ing the circuit allowed long-term, robust, and tuneable oscillations, 
observable on large population of individual cells. Secondly, the 
precise understanding of molecular mechanisms along with a good 
kinetic description of the system allowed the implementation of an 
efficient model. Such a model could help in the characterisation of 
individual modules and predict a behaviour that was not observed in 
the initial experiments. Thirdly, this work highlighted the importance 
of strain selection for the host-circuit compatibility and the use of 
microfluidic devices for the observation of single bacteria growing far 
from the stationary phase.
23
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In parallel, the use of recombinases enabled the development of so-
called digital circuits that are capable of classical digital operations, 
such as counting, logics and memory. recombinases are enzymes in-
ducing a site-specific, irreversible, recombination of DNA sequences. 
They therefore allow transcriptional control with a high signal-to-
noise ratio. 
DNA recombinations first allowed implementation of synthetic bac-
terial memory. upon discrete induction of their expression, Fried-
land et al. were able to determine how many times a readout sequence 
had been modified in the life of the bacterial colony [43]. 
Figure 1.3: Dual-feedback genetic oscillator. Topology of the dual-feedback 
oscillator (a). Fluorescence signal of cells transformed with the circuit. The 
top trace represents the signal obtained from the red curve (b). as the 
operator is regulated by LacI and AraC concentrations, period can be tuned 
by changing IPTG (c) or arabinose (d) concentrations. From [40].
24
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2-bit logic gates had been entirely implemented by Voigt and co-work-
ers in E. coli, but such implementation involved the difficult layering 
of multiple repressor-based circuits [44]. By using two inducible re-
combinase modules coupled to a series of target sequences, Siuti et al. 
developed a complete set of 2-bit logic gates, including a transmission 
of the gate state to next bacterial generations [45]. The implementation 
of the gates was based on the orthogonal expression of two recombi-
nases, Bxb1 and phiC31, which were able to irreversibly invert or ex-
cise DNA fragments at specific sites [46]. orthogonal expression was 
Figure 1.4: all 2-bit logic gates implemented in E. coli. Using Gibson assembly, 16 logic gates were 
implemented via orthogonal, cis-repressed, expression of recombinases Bxb1 and phiC31 (a). A 
NIMPLY B logic gate: the expression of enzyme A excludes the expression of enzyme B (b). XOR 
logic gate: expression of one enzyme excludes the expression of the other enzyme (c). From [45].
25
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achieved by using riboswitches with no apparent mutual influence. 
Authors used the relative position and orientation of each computa-
tional part as a toolbox to implement the complete set of logic gates. 
Such parts were, for instance, the promoters, the output gene, and the 
terminators (Fig 4a).  The irreversible recombinations were carried on 
to the next bacterial generations, also allowing memory implemen-
tation in the colony, in contrast with the system used by Voigt and 
co-workers, which was interestingly transient. I describe here two ex-
amples of the logic gates, which had been previously implemented, 
but such implementation had required considerable efforts. 
Example 1: A NIMPLY B (Fig. 1.4b)
The output gene is in antisense orientation. If none of the enzymes are 
expressed, no signal is formed. expression of Bxb1 alone brings the 
promoter and the output gene in the same direction, with the output 
gene in the correct orientation, which generates a signal. expression 
of phiC31 reverses the promoter orientation. For this reason, the ex-
pression of Bxb1 is required for the signal formation, but it implies no 
expression of phiC31
Example 2: XOR (Fig, 4c)
The promoter is in antisense orientation and flanked by the two re-
combinase sequences. expression of one of the enzymes, either Bxb1 
or phiC31, allows the formation of signal. However, the expression 
of the second enzyme cancels the reorientation triggered by the first 
enzyme. expression of the recombinases is therefore alternative but 
exclusive.
post-transcriptional regulator libraries were also expanded. First, in 
an attempt to diversify the repertoire of riboregulators with con-
served structural patterns, Jaramillo and co-workers proposed a 
method to automate the design of de novo cis-repressed mrNAs and 
their transactivating sequence [47, 48]. They hypothesised that the 
efficiency of cis-repression/trans-activation designs could be pre-
26
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Figure 1.5: Diversification of riboregulators. Automated design of de novo riboregulators: new 
riboregulators are automatically designed following iterative optimisation towards folding 
constraints of the cis-repressed and the trans-activating rNas and their hybrid (a). The best 
6 candidates were tested in E. coli, in absence (blue column) or in presence (red column) of 
activator RNA (b).  Toehold switch: the cis-repressed RNA sequesters the RBS in the loop of 
a hairpin structure. Addition of Trigger RNA opens the stem, which frees the RBS and allows 
translation (c). A series of toehold switches were tested in E. coli, displaying a very high apparent 
activation ratio (d). automatised design of de novo riboregulators figures from [47]. Toehold 
switch figures from [32].
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dicted by a limited number of thermodynamic parameters. Several 
predefined structures, such as the YuNr loop previously described, 
are known for efficient riboregulation. The conservation of these 
structures is also compatible with variations in the global sequence. 
The authors therefore used a model to screen up to 1040 sequence 
variations, with imposed structures for both the cis-repressed and 
the trans-activating rNAs. Candidates were selected according to 
their score, predicted for their ability to rapidly form a stable hy-
brid activated for translation (Fig.  1.5a). Authors also tested the 
six best solutions by implementing them in E. coli cells (Fig. 1.5b). 
After experimental evaluation, the best two candidates, which also 
showed very limited signs of crosstalk activation, were used to build 
an AND-logic gate. 
Although this method established the potential of using modelling for 
screening massive amounts of sequences, it also revealed the limited 
possibilities for diversifying the libraries of riboregulators imposed 
by both the structure and the sequence. The possibility to generate se-
quence-constraint-free riboregulators, namely toehold switches, was 
presented two years later by Green et al. [32]. The design of toehold 
switches relied on the sequestration of the rBS in the loop of an inter-
nal hairpin structure disrupted upon transcription of a trigger rNA. 
Because the rBS no longer participates in the stem formation of the 
cis-regulator, the trans-activating rNA does not require the presence 
of an rBS sequence (Fig. 1.5c). The design of toehold switches there-
fore allows much wider sequence diversity than the previous ribo-
regulators, for an unpreceded cis-repression/ trans-activation ratio 
(Fig. 1.5d). 
Improvements in bacterial communication allowed the coordina-
tion of cellular response at a population level. A circuit was devel-
oped to allow light-sensitive bacteria to signal edge-detection [49]. 
Another striking example of bacterial communication was present-
ed by Danino et al., who successfully implemented a genetic oscil-
lator including a positive feedback loop based on the production 
of acyl-homoserine lactone (AHL) [50]. The complex Luxr-AHL, 
which generates the positive feedback, also triggers the expression 
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of the AIIA enzyme. This enzyme degrades the AHL, therefore gen-
erating a negative feedback. The crucial feature of this design is the 
intrinsic property of AHL molecules to diffuse inside and outside 
the cell (Fig. 1.6a). This allows cells to communicate their state to 
their neighbours and generate a phenomenon termed as quorum 
sensing.  When the cell culture reaches the required minimal den-
sity, the bacterial population is able to generate large variations in 
AHL concentration. Authors had also previously demonstrated the 
importance of maintaining the cell population in an exponential 
growth phase using a microfluidic device [40]. For this reason, au-
thors designed a microfluidic device including a trapping chamber 
allowing control over the cell density and the replacement rate of 
nutrients and AHL (Fig.  1.6b).  This allows the synthetic circuits 
to synchronise oscillations. Furthermore, it provided unprecedent-
ed levels of robustness (Fig. 1.6c) and decreased variability at the 
population level (Fig. 1.6d). The synchronisation would however be 
maintained to a short range (<mm) due to the limited diffusion of 
the AHL molecules and to the presence of the medium flow. 
In continuity of this work, Mondragon-palomino et al. used a syn-
thetic approach to understand how different oscillators could in-
teract and couple, via a phenomenon called entrainment [51]. 
entrainment is a very common feature of natural gene oscillators, 
such as circadian clocks. Many subsystems are coupled together via 
entrainment, which renders them difficult to study in an isolated 
way. For this reason, understanding the mechanisms participating 
to the generation of entrainment is particularly relevant in biolo-
gy, but also challenging. Authors therefore used a synthetic circuit 
displaying a low entrainment level with the E. coli host organism 
(See Fig. 1.3)[40, 51]. In order to mimic the influence of external 
variations displaying a locked period, such as daylight, authors used 
sinusoidal variations of arabinose or IptG concentration, the two 
chemicals that had been previously used to tune the period of oscil-
lations. They then studied the coupling with the oscillations of the 
LacI-AraC circuit (Fig. 1.6e), by monitoring the influence of peri-
odic variations of arabinose or IptG ligands on the oscillations of 
the synthetic circuit (Fig. 1.6f). using a deterministic model, they 
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further identified the entrainment regions, which correspond to a 
set of parameters (amplitude in ligand concentration and forced pe-
riod) capable of entraining the synthetic circuit (Fig. 1.6g). 
The synchronisation of oscillating circuits was later expanded to 
millimetre scale [52]. The circuit was based on the LuxI-AIIA cir-
cuit previously described, coupled to the expression of an addition-
al NADH dehydrogenase II protein (NDH-II) (Fig.  1.g). NDH-II 
generates H2o2, which is a natural activator of the lux operator via 
inactivation of the ArcAB repressor protein [53, 54]. As H2o2 is ca-
pable of rapidly diffusing through polydimethylsyloxylane (pDMS) 
membrane of the microfluidic device (Fig. 1.6h), it provides a sec-
ond signalling wave for long-scale quorum sensing additional to 
the short-scale AHL synchronisation (Fig.  1.6i). This allowed the 
entrainment of consistent oscillations generated by over 2.5 million 
cells in a 5mm-scale device for over 10 hours (Fig. 1.6j). The circuit 
was also coupled to a secondary circuit under influence of arsenite 
concentration. presence of arsenite in the medium generates an in-
crease in both the period and the amplitude of the oscillations. The 
microfluidic device could therefore be used as a macroscopic bio-
sensor for arsenite detection.
In a more recent work, Hasty and co-workers also generated two new 
genetic circuits suitable for quorum sensing with different degrees of 
inter-circuit orthogonality [55]. In future work, Hasty and co-workers 
envision to expand the quorum sensing to interspecies communica-
tion, allowing the engineering of synthetic ecosystems for improved 
resource management and design of more complex sensors.
progress in large-sequence cloning techniques, namely the gold-
en-gate assembly [56] and the Gibson assembly [57], allowed the 
reliable construction of large genetic modules. one milestone ap-
plication of the Gibson assembly was the construction of a whole 
genome, entirely chemically synthesised. This genome allowed the 
generation of a viable synthetic form of Mycoplasma mycoides [58]. 
In the continuity of genome engineering, new techniques allowing 
the edition of genome emerged. First the multiplex automated ge-
nome engineering (MAGe) method demonstrates the possibility to 
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Figure 1.6: long-scale synchronisation of genetic oscillations via quorum sensing and 
entrainment. synchronisation via quorum sensing: topology of the quorum sensing oscillator 
network (a). Microfluidic chamber used for maintaining cells at a constant density in exponential 
growth phase (b). E. coli cells displayed high synchronicity and robust oscillations (c). entrainment: 
the LacI/AraC genetic oscillator was used to mimic the entrainment observed in circadian clocks 
(d). oscillations of arabinose concentration led to the entrainment of the genetic oscillator (e). 
Using a mathematical model, authors investigated the relationship between forced oscillations 
and natural oscillations in order to deduce entrainment regions (f), long-range synchronisation: 
topology of the quorum sensing oscillator coupled to the production of H2o2 (g). The microfluidic 
setup used was an expansion of the device described in b. H2O2 rapidly diffuses through 
the PDMS membranes, allowing long-range communications between sub-devices (h). This 
allowed the synchronisation of 2.5 million cells spread over a 5mm-long setup (i). Fluorescence 
measurements show very high consistency and synchronicity of oscillations (j). Figures a-c from 
[50]. Figures d-f from [51]. Figures g-j from [72].
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rapidly induce precise modifications at a whole-genome scale [59, 
60]. In 2012-2013, major contributions to the field of genome ed-
iting described the use of E. coli immune response machinery. The 
clustered regularly interspaced short palindromic repeats (CrIS-
pr)-CrISpr associated system (Cas), was repurposed to generate 
pinpoint modifications in both prokaryotic [61, 62] and eukaryotic 
[63-65] genomes.
Later, a new version of the Cas9 enzyme was used as a DNA-bind-
ing molecule for generating steric hindrance at any instructed loca-
tion[66-68]. This mutated Cas9 (dCas9) was capable of binding any 
target sequence via sgrNA instruction but had lost its enzymatic ac-
tivity for the cleavage of the DNA target. For this reason, dCas9 could 
virtually allow the repression on transcription from any sequence, as 
well as prevent transcription termination with a very high level of or-
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thogonality. Fused with a transcription factor, dCas9 was also capable 
of promoting transcription by increasing the affinity of a transcription 
factor around the promoter region [68]. More recently, viral inhibi-
tors of the Cas9 protein have been used in both bacteria and human 
cells for preventing the binding of Cas9 to the target [69].  This could 
open new possibilities for more complex operations using the CrIS-
pr-(d)Cas9, such as a reversible binding with an increased “off ”  rate.
Industrial and medical applications also rapidly increased in number 
and complexity. progress in metabolic engineering allowed the syn-
thesis of complex secondary metabolites with high added value for 
industry, such as isoprenoids (for review [70]), and fuel production 
(for review [71])
The synthesis of artemisinic acid by S. cerevisiae with a much increased 
titer was also a major achievement as it demonstrated the transition 
from a feasible project to a concrete industrial application [35, 73]. 
Three years after Sanofi announced their interest for the production 
of semi-synthetic artemisinin by S. cerevisiae, a large majority of the 
drug is still extracted from A. annua, as the farming source still pro-
vides prices that are consistently lower than the SB source. The case of 
artemisinin however remains a major proof of the possibilities offered 
by synthetic biology.  
In 2016, Lu and co-workers presented another pharmaceutical ap-
plication. By engineering a new inducible promoter and a dual tog-
gle switch in Pichia pastoris, authors demonstrated the possibility to 
alternatively produce two different drugs, the recombinant human 
growth hormone (rHGH) and the interferon IFNα2b, in a single mi-
crofermentor. At such a scale, fermentation allows the portable pro-
duction of daily doses of drugs [74]. 
This second period of synthetic biology was a period of diversifica-
tion. Major achievements consisted in increasing the complexity of 
synthetic gene networks, including an expansion of orthogonal tran-
scriptional and post-transcriptional module libraries, as well as quo-
rum sensing. Applications in industrial microbiology concretised the 
potential of synthetic biology, while the previous period mostly con-
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sisted of a collection of proof-of-concept projects. The interaction be-
tween host organism and synthetic circuits however remains a major 
limitation for the fast development of new functional networks. 
1.2. The growing issue of resource 
burden
Through evolution, cells usually maximise their fitness in a context 
of limited resources. In order to maintain homeostasis or divide, cells 
require a precise allocation of their enzymatic and metabolic resourc-
es [75, 76]. The increasing complexity of synthetic circuits makes the 
reallocation of those resources more likely, which might in conse-
quence jeopardise the cell growth and viability (Fig. 1.7a). resource 
burden occurs when a cell is no longer capable of correct functioning, 
due to the presence of a synthetic circuit.
resource burden can have multiple, interdependent origins, such as a 
reallocation of the machineries dedicated to transcription [77], trans-
lation [78] or protein degradation [79] (Fig. 1.7b). Saturation of the 
degradation machinery generally induces cellular stress, as the cell is 
no longer capable of recycling misfolded proteins. High levels of het-
erologous protein will generally lead to an inflation of cell in order to 
decrease the activity of the heterologous protein [80] (Fig. 1.7c). This 
increase in volume consequently decreases the endogenous DNA, 
rNA and protein concentrations, which strongly limits the cellular 
growth. Due to the cost of such burden on the viability of the cell, ran-
dom mutations affecting the synthetic circuit will often become strin-
gent criteria for the selection of bacteria presenting the best fitness. 
Such form of selection generates so-called escape mutants, which 
leads to an inactivation of the synthetic circuit over a few generations 
[81]. In absence of careful optimisation for minimising the impact of 
a synthetic circuit of the host physiology, synthetic networks display-
ing the best compatibility with their host will often tend to be simple 
and lead to limited levels of heterologous protein production.
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Figure 1.7: Growing issue of host resource burden. The synthetic 
circuit requires resources investment which generates a burden 
for the host (a). When the synthetic circuit is present in the cell, 
ClpXP protease complex can become saturated, which generates 
cellular stress induced by the accumulation of endogenous proteins 
(b). in order to compensate the increase in heterologous protein 
concentration, bacterial volume increases, which in turn decreases 
the concentration of essential molecules such as DNa, mrNa of 
expression machinery (c) From [3]
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Strategies to increase the host-circuit compatibility:
In order to increase the tolerance of the host for the synthetic cir-
cuit, different strategies have been recently described. These strategies 
consist in:
• Monitoring, characterising, and predicting, the burden in-
duced by individual modules in order to tune expression levels 
prior to full implementation of the circuit.
• Creating pathways alternative to those used by the cell: alter-
native degradation machinery, alternative ribosomes
• Implementing stress-sensitive negative feedbacks for regulat-
ing expression levels of a synthetic circuit
• using combinatorial approach in order to find expression 
levels allowing optimal circuit performance in a context of re-
source burden
reporter modules were developed in order to precisely monitor 
the burden generated by a new functional module [82]. ellis and 
co-workers showed that the level of reporter GFp produced by ca-
pacity monitor modules depended of the level of burden generated 
by different synthetic modules. This allows the characterisation of in-
dividual modules in term of resources reallocation and might help 
in the choice of modules displaying the least impact on cell viability 
(Fig. 1.8a). 
In order to spare cellular resources, one strategy consists in produc-
ing alternative machineries inside the cell. Firstly, Cameron and Col-
lins proposed a method to prevent the saturation of the endogenous 
protease machinery by using heterologous, tuneable, expression of 
Mesoplasma florum Lon protease (mfLon) (Fig. 1.8b) [83]. proteins 
produced by the synthetic circuit were channelled to an alternative 
orthogonal protease pathway unused by E. coli, which strongly mi-
nimised the degradation resource burden. Secondly, orelle and 
co-workers described the production of an alternative ribosome, the 
ribo-t [84] . The ribo-t consists in a ribosome with tethered 23S 
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Figure 1.8: Strategies for decreasing host resource burden. Reporter modules allow the monitoring 
of host burden (a). orthogonal degradation machinery can be expressed in order to decrease the 
saturation of the endogenous ClpXP machinery (b). The synthetic circuit can be sensitive to stress 
signal feedbacks. The circuit activity is therefore adjusted to a level acceptable for the host cell. (c). 
synthetic circuits can be tested in vitro using cell-free gene expression platforms. This allows the 
characterisation of individual modules and an evaluation of the burden they can generate in vivo 
(d). From [3].
and 16S subunits, which allows more resilience towards mutations of 
the rrNA sequence without functional loss. For instance, authors in-
duced mutations in order to recognise ribosome binding sites (rBS) 
alternative to the canonical Shine-Dalgarno sequence. Such muta-
tion is normally lethal to bacteria. Authors demonstrated that ribo-t 
could be used as translational machinery orthogonal to the original 
bacterial ribosomes. This could allow translation of problematic pep-
tide sequences involving unnatural amino acids or peptides inducing 
ribosome stalling.
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Another interesting strategy consists in implementing stress-depen-
dant negative feedbacks to down-regulate the activity of the synthet-
ic circuit when the burden increases. As a cell experiences burden, 
new transcription factors are produced to either activate or repress 
the activity of specific genes and stress-responsive promoters. By 
controlling the activity of the synthetic circuits with stress-respon-
sive promoters, Dragosits et al. implemented a burden-sensitive neg-
ative feedback loop [85]. In a similar approach, Dahl et al. used the 
metabolic stress generated by a toxic secondary metabolite in order 
to decrease the activity of the circuit when toxicity would reach to a 
non-viable level (Fig. 1.8c)[86]. 
In order to avoid resource burden and reach functionality, individual 
genetic modules require extensive characterisation (expression and 
degradation rate, function, etc..) and their expression rates need to 
be balanced. Characterisation of individual modules in cellular sys-
tems, as well as rate tuning, is time consuming [87]. to circumvent 
this problem, one rapid and efficient method, using combinatorial 
approch was proposed by egbert and Klavins [88]. By varying the 
length of the spacer between the rBS and the first codon of individ-
ual modules, and therefore their translation rate, authors generated 
combinatorial libraries of circuits. This allowed the identification of 
optimal combinations leading to efficient circuit assemblies and re-
duced cellular burden.
Another strategy consists in characterising individual genetic mod-
ules using a cell-free gene expression system. Such a system allows 
the rapid testing of modules both at a functional and at a resource 
requirement level (Fig. 1.8d).
1.3. The case for cell-free synthetic 
biology
Cell-free protein synthesis (CFpS) systems mimic the cell via per-
forming one of the most essential cellular processes, which is gene 
38
CHApter 1
expression. In contrast with cellular system, CFpS systems are readily 
tuneable and versatile platforms that can be used for:
• The rapid testing of new circuit designs
• Fundamental biology as a model of prebiotic system
• The synthesis of valuable products incompatible with living 
systems
In this section, I will discuss recent achievements in cell-free synthet-
ic biology which illustrate the unique potential of CFpS platforms at 
both applied and fundamental levels.
1.3.1. From cell burden evaluation to forward 
engineering of new genetic networks
Cell-free gene expression platforms, consisting of a mixture of en-
zymes performing transcription and translation coupled with sub-
strates for rNA and protein synthesis, allow the in vitro production 
of proteins from any synthetic gene template.  In vitro transcrip-
tion-translation (IVtt) systems have been used from the 1960s, first 
by Matthaei and Niremberg for their pioneering work on decipher-
ing the genetic code using mrNA of known sequence as an input for 
the IVtt system [89-91]. Later, IVtt systems were used, starting 
from DNA templates, introducing the concept of coupled transcrip-
tion-translation systems [92, 93]. Most of the systems used in the 
past decades were based on transcription by the t7 rNA polymerase 
(t7rNAp) for high yields of protein production. Alternatively, σ70-
based systems can be used, although their productivity is far lower 
than the productivity of living bacteria. 
During the past 20 years, major improvements of the IVtt reaction, 
such as increased productivity and lifetime, transcriptional diver-
sification, and miniaturisation, have allowed cell-free platforms to 
mimic aspects of the cell that are essential for circuit design and op-
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timisation. Note that productivity and lifetime improvements will be 
discussed in more details in Chapter 2.
In 2010, an IVtt platform developed by Shin and Noireaux allowed 
reaching high levels of protein production with the use of endoge-
nous σ70 polymerase [94, 95]. In their system, the mrNA and protein 
degradation machineries were characterised in vitro, opening pos-
sibilities for the implementation of complex reactions in vitro, and 
eventually estimation of resource burden [96]. A first coarse-grained 
model was also proposed to describe the IVtt reaction using only 
ten kinetic parameters [97]. Following up on their initial work, the 
authors then demonstrated the possibility of using the complete set 
of E. coli σ-factors for performing the transcription reaction. This al-
lowed the design of transcriptional cascades (Fig. 1.9a) and regula-
tion patterns using three different repressor proteins (Fig. 1.9b) [98]. 
This work represented a considerable step towards the transcriptional 
diversity available in living cells. Many regulation patterns were also 
successfully used to implement logic gates based on transcriptional 
factors [98, 99] and toehold switches [100]. 
The first non-genetic transcriptional oscillators had been developed 
in vitro in 2011 [101, 102], but Niederholtmeyer et al. [103] (Fig. 1.9c), 
followed by Karzbrun et al. [104] (Fig. 1.9d) showed that systems as 
complex as oscillators could also be implemented using IVtt plat-
forms and flow reactors. 
During that same period, IVtt platforms were used for rapid charac-
terisation of linear DNA obtained directly from pCr reactions [105]. 
Later, the same approach was used to monitor the resource usage and 
the burden originating from a synthetic circuit [106] and evaluate the 
performance of rNA-based circuits [107]. 
using the potential offered by the cell-free gene expression platform 
for reproducing both the transcriptional diversity and the complexity 
of genetic networks, Niederholtmeyer et al. demonstrated the pos-
sibility to use the IVtt platform they had developed to character-
ise and rapidly test multiple ring oscillator topologies [108]. By us-
ing a modelling approach and iterative testing, authors were able to 
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Figure 1.9: Cell-free synthetic biology increases in diversity and complexity to mimic cellular 
behaviour. Transcriptional diversity: transcriptional cascades were implemented, requiring a set of 
5 different modules to produce a GFP output (a). Inducible repression was also implemented in vitro, 
here using LacI protein and IPTG. Network complexity: Open reactors allowed the maintenance of 
IVTT reactions in a steady-state, compatible with the implementation of oscillations. Niederholtmeyer 
et al. used a microfluidic device allowing the sequential replacement of every component of the IVTT 
reaction (c). Karzbrun et al. used immobilised DNA brushes and controllable flow of IVTT mixture 
(d). Rapid-testing and forward-engineering: using the platform described in c, Niederholmeyer et al. 
proposed a method for the rapid testing of genetic oscillators in vitro. after thorough characterisation 
of individual parts and successful implementation of an oscillator, the circuit could be transformed in 
E. coli, which allowed the forward-engineering of genetic oscillators from in vitro conditions to in vivo 
applications (e). Figures a-b from [98]. Figure c from [103]. Figure d from [104]. Figure e from [108]
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determine which topology could lead to the most robust oscillatory 
behaviour. Finally, the most robust designs were successfully imple-
mented in bacteria, demonstrating the possibility of using the IVtt 
approach for fast-forward engineering of new complex gene networks 
from in vitro platforms to bacteria (Fig. 1.9e). Because most of the key 
parameters, such as DNA template, transcription factors, substrates 
and cofactors, can be tuned, the IVtt platform offers a high versatil-
ity that can be used to reconstitute a given cellular environment. This 
allows the tweaking of selected parameters in order to better under-
stand their influence on the system in a cell-like environment. IVtt 
platforms were for instance used to understand fundamental mecha-
nisms of the gene expression, such as the influence of macromolecu-
lar crowding on expression rates [109] or noise inherent to stochastic 
gene expression [110].
1.3.2. Cell-free synthetic biology for the 
construction of minimal and artificial 
cells
 “It is absurd to represent synthetic biology as an attempt 
to reproduce a very complex living organism at once. 
As for every production, human or not, one can only 
proceed progressively, by the separated reproduction 
of phenomena in life, phenomena that one should later 
associate, combine, in clusters of increasing complexity.” 
Stephane Leduc, in La biologie synthétique [1].
Cell-free gene expression systems are also used in a bottom-up ap-
proach for minimal cell or artificial cell projects. Such projects seek to 
determine the minimal set of cellular functions required for a system 
to become alive, such as crucial genes and their products, necessary 
regulation patterns and minimal metabolism. In an attempt to give 
a canonical definition of life, Alexander oparin wrote: “Any system 
capable of replication and mutation is alive” [111]. Main efforts have 
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focussed on the three essential properties of minimal living systems, 
which are the information reproduction [112-114], the metabolism 
reproduction [95, 115-119], and self-organisation [84, 113, 114, 120-
123]. Noireaux and co-workers showed that entirely functional t7 
bacteriophage could be synthesised and assembled using bacterial 
IVtt mixture supplemented with the complete t7 bacteriophage 
DNA [113]. Interestingly, addition of deoxyribonucleoside triphos-
phates (dNtps) yielded up to a 100-fold increase in viral particles, 
demonstrating DNA replication inside the IVtt mixture. The mol-
ecule of viral DNA was capable of replication, although this replica-
tion entirely relied on the presence of E. coli proteins. A similar work 
had previously been done in human cell extract [124]. efforts also 
focussed on the reconstitution of division machinery in vesiculo. The 
MreB protein is a constituent of the bacterial cytoskeleton, display-
ing a function analogous to actin in eukaryotes. It interacts with the 
MreC and MreD membrane proteins to form filaments at the inter-
face with the internal membrane. Although division could not be ob-
served, MreB and MreC were successfully expressed in vitro, allowing 
the assembly of MreB filaments inside vesicles [122]. Danelon and 
co-workers demonstrated the possibility of synthesising new mem-
brane lipids from enzymes which were produced using a cell-free 
protein synthesis platform inside vesicles [119]. This work suggested 
that an artificial system had the potential to produce its own mem-
brane in anticipation of cell division.   
one major achievement towards the implementation of reproductive 
function in cell-free systems was the de novo synthesis of functional 
ribosomal rNA subunits 5S, 16S and 23S. Jewett and co-workers suc-
cessfully produced rrNA from DNA templates using a CFpS system 
lacking of endogenous ribosome (ultracentrifuged S150 lysate) [114] 
. This integrated synthesis, assembly and translation (iSAt) platform 
was obtained in presence of additional ribosomal proteins. In more 
recent work, the iSAt platform was encapsulated inside liposomes, 
as a milestone towards the construction of model system capable of 
reproduction [123].
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1.3.3. Applications of cell-free synthetic 
biology for the production of 
problematic biological products and 
diagnosis
one major advantage of cell-free synthesis platforms is their high tol-
erance for conditions normally lethal for living organisms. For this 
reason, cell-free synthesis systems can be used to produce high titres 
of toxic material [113, 126]. They can also be rewired or enriched 
with cofactors that are not available in the original cell [118]. In this 
section, I illustrate the strong potential of cell-free synthesis platforms 
by briefly reviewing four applications. The first two involve the pro-
duction of virus-like-particle and entire bacteriophage viruses using 
IVtt systems. The third application describes the use of cell-free sys-
tems for the synthesis of problematic products. Finally, I will focus on 
the use of IVtt systems for the diagnosis of viral infections.
Virus-like-particles (VLps) consist of viral capsid proteins that as-
semble into a supramolecular structure resembling a virus. The very 
high degree of multimerisation, the possibility to decorate the sur-
face of the proteins forming the capsule, and the absence of infectious 
genetic material, make VLps particularly valuable for the develop-
ment of new vaccines with improved immunogenic response [127]. 
Interestingly, their production using a cell-free approach is not lim-
ited by issues usually encountered with bacterial production, such as 
cytotoxicity for bacteria or control over the degree of multimerisation 
[128]. In contrast with cells, easy integration of unnatural amino ac-
ids by in situ synthesis of dedicated trNAs and the possibility to opti-
mise the composition of the IVtt mixture for reaching higher yields 
of production are also intrinsic features of cell-free production. In 
2008, Bundy and co-workers reported the cell-free synthesis of MS2 
bacteriophage coat protein exceeding by 14 fold yields obtained using 
cell-based production [129].  Such features allowed the production of 
VLps decorated by a bacterial flagelin protein, which generated a 10-
fold improvement of immune response in comparison to the injection 
of free flagelin [130].  Interestingly, the synthesis of such VLp-flagelin 
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fusion protein was made possible by rapidly reducing protease activi-
ty of the IVtt platform using protease inhibitors.
Bacteriophages can be engineered using a synthetic biology approach 
in order to induce toxicity in specific bacteria, for applications such as 
biofilm dispersion [131], and can also be used as reporters of bacterial 
contamination [132-136]. As mentioned by Lu and co-workers [137], 
recent progress in synthetic biology, such as large-DNA synthesis and 
assembly [57] allow the generation of large libraries of newly engi-
neered bacteriophages. However, two major issues limit cell-based 
virus engineering. Firstly, viruses are toxic for the productive host, 
which strongly limits the final virus titer. Secondly, cell-based virus 
engineering requires the transformation of the initial virus genome 
into the host. This step is problematic, considering that not every host 
bacteria can be transformed [138]. Instead, IVtt platforms avoid 
these two bottlenecks as they can readily be used to test synthetic vi-
ral DNA and produce high titters of newly engineered bacteriophages 
without being limited by virus toxicity [113, 139]. 
Cell-free synthesis platforms can be used for the production of indus-
trially relevant chemicals[118, 126], human phosphoproteins [140] 
and problematic non-ribosomal peptides [141]. one very interesting 
cell-free metabolic engineering approach consisted in combining cell 
extracts from various microorganisms selected for their enzymatic 
composition [118]. This allowed high-titer production of mevalonate 
in vitro by exploiting the possibility of tuning every enzyme and co-
factor concentrations. This strategy, which did not require time-con-
suming strain engineering or enzyme purification, illustrates the 
strong potential of chemical production using tailored synthesis plat-
forms.
Due to safety regulations, as well as technical requirements, the use 
of engineered organisms using a synthetic biology approach is limit-
ed mostly to laboratory applications. In contrast to in vivo synthetic 
biology, the cell-free synthetic biology offers a unique working en-
vironment for applications outside of the laboratory. First, cell-free 
systems are, by definition, abiotic, which means that most regulations 
concerning genetically modified organisms (GMos) do not apply to 
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the handling of cell-free gene expression platforms. Furthermore, re-
cent technical developments showed that IVtt ingredients could be 
soaked and freeze-dried in paper, allowing the long-term storage of a 
proactive IVtt mixture at room temperature [100]. The preparation 
of the IVtt mixture from the infused paper only requires rehydra-
tion of the reagents, which strongly decreases the technical level nor-
mally required for all-liquid-phase IVtt reactions. 
By using toehold switches design methods developed by Green et al 
[32], pardee and co-workers proposed a successful method for im-
plementing AND-logic gates from transcriptional cascades. As a final 
proof-of-concept, their method also allowed the rapid prototyping 
of a cost-effective diagnostic assay for the detection of ebola viruses. 
Their IVtt mixture contained a cis-repressed toehold switch, which 
could be activated by a trans-activating rNA present in ebola mrNA 
sequence. The assay could also discriminate between the Sudan and 
the Zaire strains of ebola virus. The output of such assay consisted 
in the production of LacZ protein, allowing a simple, apparatus-free, 
colorimetric readout. 
In 2016, pardee et al proposed another similar method for the detec-
tion of Zika viruses, with the possibility to discriminate between two 
forms of this virus [142]. The workflow for delivering the diagnosis 
was particularly efficient as the sensor was developed in less than a 
week, the assay stored over a year at room temperature and the re-
sult delivered within 3 hours after sample collection (Fig. 1.10a).  By 
performing the amplification of viral rNA using a nucleic acid se-
quence-based amplification (NASBA) in combination with a primer 
integrating the complementary sequence of an rNA trigger, authors 
were able to generate a double-stranded DNA template that could be 
used to trigger the activation of a toehold switch after transcription 
by t7 rNAp (Fig. 1.10b). Such an assay allowed the diagnosis of an 
infection specific to Zika viruses. During the recent Zika epidemic, 
two main strains of the Zika virus either from African or American 
lineage, could be identified. Microcephaly and Ghilain-Barre syn-
dromes are the two main clinical consequences of an infection by 
Zika virus from American lineage, while the African lineage does not 
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give rise to these symptoms. For this reason, an assay discriminat-
ing between the two lineages would be highly interesting during an 
epidemic [143, 144]. The African and the American lineages display 
sequence variabilities that were used for strain-specific cleavage me-
diated by Cas9. The full-length DNA template, corresponding to the 
African strain, could be used to trigger the toehold activation, while 
the cleaved DNA template, corresponding to the American strain, no 
longer encoded the activator sequence. This second phase of the di-
agnostic could therefore provide a valuable assay in order to identify 
the Zika virus strain responsible for an infection.
1.4. Aim of the project and thesis 
outline
Cell-free synthetic biology is becoming a reference approach for 
design and testing of new genetic networks. Minimal cell projects 
will also require efficient and diversified regulations networks. At 
present, only a few regulation patterns, such as transcriptional re-
pression by a few repressor proteins, and translational repression 
by a few rNA toeholds, are available [99, 108].  Furthermore, very 
few complex networks, including oscillators, have been reported in 
vitro. The expansion of regulation building blocks available for im-
plementing complex networks in vitro is of particular relevance for 
the diversity of functions both in the fields of cell-based and cell-
free synthetic biology.
The aim of my project was to design new genetic networks using an in 
vitro approach. I wanted these networks to lead to the emergence of 
complex regulation patterns, such as oscillations. The new regulatory 
systems could be used to expand the complexity of the IVtt system, 
establishing new pathways in order to regulate biological functions 
such as resource allocation and regulation of protein concentrations.
This thesis describes my efforts towards the implementation of new 
synthetic gene networks in vitro. In chapter 2 I present the protocols I 
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Figure 1.10: Paper-based IVTT allows rapid diagnosis of Zika virus infection. Workflow 
of the assay development, from the design of the sensor to the delivery of the diagnosis 
(a). The assay is performed in two steps. The first step detects whether the RNA of the 
Zika virus is present in the patient sample. Upon a positive detection of Zika virus, 
selective cleavage by Cas9 offers the possibility to discriminate between two strains of 
the Zika virus (b). From [142].
used for the production of a functional bacterial lysate. I also present 
my approach to optimise the IVtt reaction by adjusting the critical 
buffer composition. Chapter 2 finally describes the method I used in 
order to develop a biochemical reporter for monitoring the transcrip-
tion reaction.
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Maintaining the IVtt reaction in a steady-state appeared to be a key 
approach for implementing complex gene networks in vitro. In Chap-
ter 3, I discuss the different methods I followed for preparing such 
implementation. My work consisted in establishing simple methods 
for tuning the mrNA and protein degradation rates. I present my at-
tempts to extend the lifetime of the IVtt reaction to up to 40 hours. 
An alternative approach for the rapid testing of new network designs 
is the use of a flow reactor. I discuss my attempt to develop such a 
simple flow reactor that could be used to screen new network designs.
In the final two research chapters of this thesis, I describe my work on 
the design and the implementation of two genetic networks. The first 
oscillator design, described in Chapter 4, involves a delayed negative 
feedback generated by LacI proteins, and a positive feedback loop 
generated by the t7 rNA polymerase. The activities of both positive 
and negative feedback modules of this circuit were characterised in 
vitro but did not lead to robust behaviour. I therefore propose a sec-
ond, improved, design in Chapter 5, making use of modules I had 
previously successfully tested. In contrast with the design described 
in Chapter 4, the new topology in Chapter 5 is based on an enzymatic 
negative feedback generated by the MazF ribonuclease. After a suc-
cessful characterisation of the MazF module in batch, the module was 
used in a flow reactor. results suggest that the production of MazF 
could be used to implement a new generation of enzyme-based neg-
ative feedbacks. A mathematical model used to describe the system 
also supported this conclusion.
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111. Gánti, t., The principles of life. 2003, 
oxford ; New York: oxford university 
press. 201 p.
112. Kumar, G. and G. Chernaya, Cell-free 
protein synthesis using multiply-primed 
rolling circle amplification products. 
Biotechniques, 2009. 47(1): p. 637-
639.
113. Shin, J., p. Jardine, and V. Noireaux, 
Genome Replication, Synthesis, and 
Assembly of the Bacteriophage T7 in a 
Single Cell-Free Reaction. Acs Synthet-
ic Biology, 2012. 1(9): p. 408-413.
114. Jewett, M.C., et al., In vitro integration 
of ribosomal RNA synthesis, ribosome 
assembly, and translation. Mol Syst 
Biol, 2013. 9: p. 678.
115. Jewett, M.C., et al., An integrated cell-
free metabolic platform for protein 
production and synthetic biology. Mo-
lecular Systems Biology, 2008. 4.
116. Kuruma, Y., et al., A synthetic biology 
approach to the construction of mem-
brane proteins in semi-synthetic min-
imal cells. Biochimica et Biophysica 
Acta-Biomembranes, 2009. 1788(2): 
p. 567-574.
117. Bujara, M., et al., Exploiting Cell-Free 
Systems: Implementation and Debug-
ging of a System of Biotransformations. 
Biotechnology and Bioengineering, 
2010. 106(3): p. 376-389.
118. Dudley, Q.M., K.C. Anderson, and 
M.C. Jewett, Cell-Free Mixing of Esch-
erichia coli Crude Extracts to Prototype 
and Rationally Engineer High-Titer 
Mevalonate Synthesis. Acs Synthetic 
Biology, 2016. 5(12): p. 1578-1588.
119. Scott, A., et al., Cell-Free Phospholipid 
Biosynthesis by Gene-Encoded En-
zymes Reconstituted in Liposomes. plos 
one, 2016. 11(10).
120. Hovijitra, N.t., et al., Cell-Free Syn-
thesis of Functional Aquaporin Z in 
Synthetic Liposomes. Biotechnology 
and Bioengineering, 2009. 104(1): 
p. 40-49.
121. Matthies, D., et al., Cell-Free Expres-
sion and Assembly of ATP Synthase. 
Journal of Molecular Biology, 2011. 
413(3): p. 593-603.
55
INtroDuCtIoN
122. Maeda, Y.t., et al., Assembly of MreB 
Filaments on Liposome Membranes: A 
Synthetic Biology Approach. Acs Syn-
thetic Biology, 2012. 1(2): p. 53-59.
123. Caschera, F., et al., Cell-free compart-
mentalized protein synthesis inside 
double emulsion templated liposomes 
with in vitro synthesized and assembled 
ribosomes. Chem Commun (Camb), 
2016. 52(31): p. 5467-9.
124. Kobayashi, t., et al., Synthesis of en-
cephalomyocarditis virus in a cell-free 
system: from DNA to RNA virus in 
one tube. Biotechnology Letters, 2012. 
34(1): p. 67-73.
125. Caschera, F. and V. Noireaux, Inte-
gration of biological parts toward the 
synthesis of a minimal cell. Curr opin 
Chem Biol, 2014. 22: p. 85-91.
126. Kay, J.e. and M.C. Jewett, Lysate of 
engineered Escherichia coli supports 
high-level conversion of glucose to 
2,3-butanediol. Metab eng, 2015. 32: 
p. 133-42.
127. patel, K.G. and J.r. Swartz, Surface 
functionalization of virus-like particles 
by direct conjugation using azide-
alkyne click chemistry. Bioconjug 
Chem, 2011. 22(3): p. 376-87.
128. rodriguez-Limas, W.A., K. Sekar, and 
K.e.J. tyo, Virus-like particles: the fu-
ture of microbial factories and cell-free 
systems as platforms for vaccine devel-
opment. Current opinion in Biotech-
nology, 2013. 24(6): p. 1089-1093.
129. Bundy, B.C., M.J. Franciszkowicz, 
and J.r. Swartz, Escherichia coli-based 
cell-free synthesis of virus-like parti-
cles. Biotechnol Bioeng, 2008. 100(1): 
p. 28-37.
130. Lu, Y., et al., Escherichia coli-based cell 
free production of flagellin and ordered 
flagellin display on virus-like particles. 
Biotechnol Bioeng, 2013. 110(8): 
p. 2073-85.
131. Lu, t.K. and J.J. Collins, Dispersing 
biofilms with engineered enzymatic 
bacteriophage. proc. Natl Acad. Sci. 
uSA, 2007. 104: p. 11197-11202.
132. Schofield, D.A., N.J. Sharp, and C. 
Westwater, Phage-based platforms for 
the clinical detection of human bacte-
rial pathogens. Bacteriophage, 2012. 
2(2): p. 105-283.
133. Schofield, D.A., et al., Bacillus an-
thracis diagnostic detection and rapid 
antibiotic susceptibility determination 
using ‘bioluminescent’ reporter phage. 
J Microbiol Methods, 2013. 95(2): 
p. 156-61.
134. Sharp, N.J., et al., Rapid Detection of 
Bacillus anthracis in Complex Food 
Matrices Using Phage-Mediated Biolu-
minescence. J Food prot, 2015. 78(5): 
p. 963-8.
135. Schofield, D.A., D.J. Wray, and I.J. 
Molineux, Isolation and development 
of bioluminescent reporter phages for 
bacterial dysentery. eur J Clin Micro-
biol Infect Dis, 2015. 34(2): p. 395-
403.
136. Sharp, N.J., et al., Rapid Detection 
of Viable Bacillus anthracis Spores in 
Environmental Samples by Using Engi-
neered Reporter Phages. Appl environ 
Microbiol, 2016. 82(8): p. 2380-7.
137. Lu, t.K., J. Bowers, and M.S. Koeris, 
Advancing bacteriophage-based micro-
bial diagnostics with synthetic biology. 
trends Biotechnol., 2013. 31: p. 325-
327.
138. pires, D.p., et al., Genetically Engi-
neered Phages: a Review of Advances 
over the Last Decade. Microbiol Mol 
Biol rev, 2016. 80(3): p. 523-43.
139. Chan, L.Y., S. Kosuri, and D. endy, 
Refactoring bacteriophage T7. Mol. 
Systems Biol., 2005. 1: p. 2005.0018.
140. oza, J.p., et al., Robust production of 
recombinant phosphoproteins using 
cell-free protein synthesis. Nat Com-
mun, 2015. 6: p. 8168.
141. Goering, A.W., et al., In Vitro Recon-
struction of Nonribosomal Peptide 
Biosynthesis Directly from DNA Using 
Cell-Free Protein Synthesis. ACS Synth 
Biol, 2016.
142. pardee, K., et al., Rapid, Low-Cost 
Detection of Zika Virus Using Pro-
grammable Biomolecular Components. 
Cell, 2016. 165(5): p. 1255-66.
143. Calvet, G., et al., Detection and se-
quencing of Zika virus from amniotic 
fluid of fetuses with microcephaly in 
Brazil: a case study. Lancet Infect Dis, 
2016. 16(6): p. 653-60.
144. Mlakar, J., et al., Zika Virus Associat-
ed with Microcephaly. N engl J Med, 
2016. 374(10): p. 951-8.
Chapter 2
Development of a 
cell-free protein 
synthesis system 
and quantification 
of transcription and 
translation reactions
Our project required an IVTT system that allowed reproduc-
ible protein production. Long lifetime and cell-like composi-
tion were also important parameters for the IVTT system we 
wanted to use. In this chapter, we first give a brief overview of 
the different IVTT systems available for our project. We then 
describe the development of the IVTT system we will use for 
the implementation of complex genetic networks. In the last 
section, we introduce the method we used for the design of 
molecular beacons, which are small sensors used to detect 
nucleic acids, such as mRNA produced in IVTT reactions.
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2.1 Introduction
Cell-free protein synthesis (CFpS) systems allow the in vitro produc-
tion of recombinant proteins from a genetic template in a controlled 
chemical environment. They have been used since the 1960s for 
the production of proteins outside the cell [1]. CFpS reaction relies 
mainly on four concomitant sub-reactions (Fig. 2.1). Firstly, the tran-
scription reaction produces messenger rNa from a DNa template. 
Secondly, in the aminoacylation reaction, amino acids are coupled to 
trNa molecules, recycling activated trNas for translation. Thirdly, 
during translation, which is carried out by ribosomes and translation 
factors, the peptide chain is synthesised from aminoacyl-trNas fol-
lowing the mrNa codon sequence. Finally, an energy regeneration 
reaction reconstitutes the chemical potentials that have been dissi-
pated during the CFpS reaction (adenosine triphosphate (atp) and 
guanosine triphosphate (Gtp)). 
Note that the fundamental work of Nirenberg and Matthaei for de-
ciphering the genetic code was based on the use of mrNa templates 
with predefined sequence and in vitro translation. Later, protocols 
for coupled in vitro transcription-translation (IVtt) allowed protein 
synthesis directly from DNa templates [2]. 
progress in molecular cloning techniques and polymerisation chain 
reaction (pCr) allowed the production of a wide range of proteins 
from recombinant DNa. The low yield of production and the cost of 
reagents however strongly limited the use of IVtt systems for casual 
protein production. Improvements of IVtt protocols allowed major 
increase in yield of protein synthesis along with a drastic drop in re-
agents cost [3]. 
Strikingly, modern protocols do not differ strongly from initial proto-
cols proposed in the 1970s [4-7]. Instead, the improvements of IVtt 
systems originated from a comprehensive preparation of the IVtt re-
action, with particular focus on allowing more resources for coupled 
transcription and translation, maintaining homeostasis and improv-
ing the reproducibility of the preparation method, such as cell lysis 
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techniques.IVtt systems can be divided into two main groups. The 
first group is based on the reconstitution of the expression machinery 
from individually purified components. reconstituted systems, also 
known as protein synthesis using recombinant elements (pUre) sys-
tems, have the major advantage to be made of proteins only dedicated 
to gene expression [8]. every concentration can be adjusted and back-
ground reactions originating from cellular life, such as metabolism or 
competitive translation, are avoided.  The main drawbacks of pUre 
systems are the time-consuming steps for production and purifica-
tion of 32 recombinant enzymes (initiation factors, elongation fac-
tors, release and termination factors, 20 aminoacyl-trNa synthetases 
and the methionyl-trNa transformylase, ribosomes and t7 rNa 
polymerase). pUre systems are commercially available. however, 
like for most systems that are commercially available, the complete 
composition of such system remains generally unknown.
The second group consists in the extraction of the gene expression 
machinery from the cytosol. Many organisms can be used for lysate 
preparation, such as E. coli for extract from prokaryote origin, S. cer-
evisiae, wheat germ, insects, rabbit reticulocytes or hela cells for ex-
tracts from eukaryotic origin. In contrast to pUre systems, compo-
sition of cell extracts is less controlled, as it is mostly inherited from 
Figure 2.1: Summary of the IVTT reaction. 
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the cytosol composition. Cell extract is therefore representative of the 
source organism, which can be an advantage when a circuit is tested 
for a specific host different from regular E. coli cells.
E. coli extracts have the main advantage to be the most productive, 
with the least preparation time and difficulty, and reduced cost. as 
eukaryotic extracts are less productive and more difficult to prepare, 
they will often only be used for the production of complex proteins, 
involving post-translational modifications, large assemblies of pro-
teins, or complex protein folding driven by chaperone activities. our 
project focussed on bacterial gene networks so we naturally chose to 
work with E. coli extracts.  
For comparison, the main differences between pUre systems and 
bacterial extracts are summarised in Figure 2.2. Some of the different 
items will be discussed throughout this chapter.
Figure 2.2: Main differences between PURE and extract-based IVTT systems
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The use of IVtt system was an essential requirement for our proj-
ect. Several E. coli IVtt systems and protocols were available and 
our choice for the most suitable system was done after evaluating the 
main differences between those systems. our choice for a particular 
IVtt platform was guided by a few key criteria, which were:
• Lifetime of the reaction: In batch, the IVtt reaction rapidly 
dies out. This strongly limits the clarity of rapid module testing 
experiments. Negative feedback modules, in particular, are 
designed to prevent expression of other genes. Their effect can 
be masked in a reaction limited by a short lifetime.
• Versatility: The chemical and enzymatic composition of the 
reaction can be adapted to our needs. For instance, implemen-
tation of complex reactions requires mrNa or protein dissi-
pation, which can be done by tuning enzymatic activities (nu-
clease and protease). Commercially available CFpS systems, 
which are dedicated to high-yield protein production, might 
however contain nuclease and protease inhibitors and other 
unknown chemical species.
• Reproducibility: a good reproducibility from one experiment 
to another, as well as from one reaction batch to another, was 
essential for rapidly and reliably characterising new modules 
and for implementing complex reaction on a quantitative ba-
sis.
In order to analyse in vitro genetic networks in optimal conditions, 
our main objectives in this chapter were i) to develop a good cell-
free expression system that could sustain reactions for a long time, 
and ii) develop molecular tools for quantifying main products. In situ 
detection of mrNa, in particular, is challenging and requires specific 
methodological efforts.
In the next section, we will review the main protocols available for 
the production of cell extract-based IVtt system. Then we will give a 
brief overview of the different techniques allowing in situ protein and 
mrNa detection.
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Further, we will discuss the methods we used for developing, optimis-
ing, and evaluating an IVtt system suitable for our project. 
Finally, we will discuss a general method for developing molecular 
beacons, which are probes designed for mrNa detection. after giv-
ing an overview of the design approach, we will briefly discuss a series 
of applications using molecular beacons in our lab.
2.1.1 Considerations regarding the choice of 
bacterial system
Increasing the stability and the diversity of expression 
substrates for improved lifetime and yield
S30 bacterial IVtt systems have, for a long time, suffered from a lim-
ited reaction lifetime in batch, less than 20 minutes in the 1990s [9]. 
Note that the term “S”, very often encountered in cell-free synthetic 
biology, refers to the acceleration used to clarify the cell extract used 
in IVtt reactions (S30 means: centrifuged at 30000 g0).   IVtt re-
actions consume large amounts of atp and Gtp, with about 5 mole-
cules of atp [10] and 2 molecules of Gtp invested per peptide bond 
[11], while transcription generates residual inorganic phosphate. 
Lack of atp gradient regeneration, coupled with an accumulation 
of inorganic phosphate (pi), is main causes of premature arrest of the 
reaction [9, 12, 13]. 
The traditional method for regenerating atp involved phosphoryla-
tion of aDp by phosphate transfer from creatine phosphate catalysed 
by creatine kinase. This method suffered from high reagent costs 
while providing no solution for preventing accumulation of inorgan-
ic phosphate. alternatively, phosphoenol pyruvate (pep) [4] or acetyl 
phosphate [14] could be used to regenerate atp, but the typical initial 
concentration used, in the tens of mM, would often lead to a con-
sumption of pep by low-affinity phosphatases [13, 15]. 
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In 1999, Kim and Swartz proposed an alternative method for atp 
regeneration which was based on the use of pyruvate and pi by 
pediococcus sp. pyruvate oxydase [13]. authors reported an in-
crease of reaction time up to 2 h, unprecedented at the time, along 
with a consequent decrease in reagent costs. another interesting 
method for increasing the stability of expression resources was de-
scribed by Kim and Choi [15]. In order to reduce the activity of 
alkaline phosphatases and hexose phosphatases in the S30 extract, 
authors used an enriched growth medium (2ytpG) supplement-
ed with glucose and phosphate buffer. this led to an increased 
stability of the pep substrate and a cell extract up to 50% more 
productive. Later, Calhoun et al. used glucose-6-phosphate (G6p) 
to reach comparable levels of atp regeneration, suggesting that all 
intermediate of the glycolytic pathway could be used for fuelling 
aDp phosphorylation [16]. Maltose and maltodextrine, two in-
expensive carbohydrates were also used to fuel an IVtt reaction, 
allowing a batch reaction to produce up to 2.3 mg/mL of protein 
over 10 hours [17]. 
Versatility of bacterial extract-based systems
Versatility, which is the possibility for a productive system to be 
adapted to a broad range of functions in various conditions, is one 
of the major advantages of bacterial extracts. This versatility can take 
several aspects. Firstly, strain selection allows production of cell ly-
sates with enzymatic activities inherited from what characterised the 
strain. Bacterial extracts do not only produce proteins but can also 
be tuned in order to perform secondary reactions, such as metabolic 
transformation [18], mrNa degradation [19] and protein degrada-
tion [19]. Such reactions are allowed by the presence of enzymes and 
other compounds directly inherited from the cytosol. 
This has the main advantage of avoiding time-consuming protein pu-
rification steps. For this reason, selection of a specific strain for the 
cell extract preparation can be a very rapid and efficient way of influ-
encing the reactions occurring in the IVtt mixture. 
64
Chapter 2
For instance, E. coli rosetta 2 cells produce trNas rarely used by E. 
coli but often involved in eukaryotic protein synthesis. 
The use of productive strains, such as rosetta and BL21 strains, in 
their De3 version, allows the presence of high concentration of t7 
rNa polymerase inside the lysate, for high level of protein synthe-
sis from DNa templates with t7 promoter [7]. In Chapter 3, we will 
describe the use of such De3-based lysate in order to produce and 
purify a recombinant form of the MazF protein.
Secondly, the choice of a microorganism for producing cell-extracts 
is no longer limited to E. coli. Moving forward from the traditional 
synthetic biology workhorses that are E. coli and S. cerevisiae, new 
microorganisms have been used for recent SB applications and might 
become the new so-called chassis for future SB developments [20]. 
Interestingly, new CFpS platforms based on such microorganisms are 
being developed. That is for example the case of like with B. subtilis 
[21], which illustrates the strong link between rapid cell-free proto-
typing and cell-based applications described in Chapter 1.
Finally, the chemical composition of home-made extract-based CFpS 
systems can be tuned according to the productive purpose. as it be-
came clear that cell-free expression platforms could be used to inves-
tigate fundamental questions in biology, the development of IVtt 
protocols for the reconstitution of reaction mixtures close to the cy-
toplasm composition became an important objective. polyethylene 
glycol (peG) has been often used in IVtt protocols for four decades 
[4, 14], but its core impact on gene expression, especially as a crowd-
ing agent, remains unclear. In 2004, Jewett and Swartz published the 
first protocol uniquely based on cellular components [5]. after serial 
optimisation of magnesium glutamate and potassium glutamate salt 
concentrations, and addition of natural polycations such as putres-
ceine and spermidine, the so-called cytomim platform allowed pro-
tein production yields strictly comparable to those obtained using 
polyethylene glycol (peG), 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (hepeS) and other unnatural additives. Furthermore, 
it has been established that simple components, such as salts, could 
be adjusted in order to favour transcription by certain transcription 
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factors [22]. The versatility of IVtt reactions towards basic changes 
makes such platforms particularly interesting for mimicking the bac-
terial cell regarding to its metabolic and transcriptional diversity. 
Reproducibility and simplicity of the bacterial extract 
production protocol
In contrast with other platforms, such as pUre systems, homemade 
bacterial-extract based IVtt systems have the major advantage to 
be rapidly prepared in a more or less reproducible way and for a de-
creased cost in comparison to commercially available systems [23]. 
although many preparation protocols are currently available, they 
usually follow similar procedures [7]. Such procedures involve (Fig. 
2.3):
• Cell culture. Cells are usually cultivated in fermentors or in 
shake flasks. In order to display high translational activity, 
cells are harvested at the maximal optical density during the 
exponential growth phase. as previously mentioned in section 
2.1.1.1, broths can be adjusted in order to influence the enzy-
matic composition of the cell extract. 
• Cell lysis. Different methods, mostly based on mechanical 
stress, have been used, such as French press homogenisers [4, 
17], sonication [7, 24], or bead-beating [6, 24, 25]. although 
all methods are valid, French press homogenisers allow the 
enrichment of the cell extract with respiration enzymatic chain 
for the use of pyruvate as an energy source [26]. additionally, 
sonication methods seem to yield the most robust and repro-
ductive extracts [7].
• Centrifugation. Centrifugation is probably the step with the 
most crucial influence on the cell extract. The acceleration 
and the centrifugation time used directly impact the extract 
composition, the ribosome concentration in particular. Low 
“speed” centrifugation (~12000 g0) yields to the most produc-
tive extracts [7], while ultracentrifugation (~150000 g0) usually 
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leads to the complete removal of ribosomes [27]. Ultracen-
trifugation allowed Jewett and co-workers to produce extracts 
free of endogenous ribosomes in order to use exclusively new 
ribosomes that were produced in situ [27, 28].
• Run-off reaction, also termed as incubation step. This step 
consists in an incubation of the cell lysate at 37°C. This step 
allows the degradation of endogenous mrNa by cytoplasmic 
nucleases. The importance of this step strongly differs from 
one strain to another, as it can alternatively be crucial, faculta-
tive or completely avoided [7].
Figure 2.3: Overview of bacterial extract protocols. From [7].
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• Dialysis. Dialysis was inherited from the original S30 protocol 
[4]. It ensures a full control towards chemical composition and 
ph inside the extract[6, 25, 29]. although dialysis appears to 
be facultative, tight control over the salt concentration can be 
critical for precise tuning of transcriptional rates [22]. Dialysis 
is therefore of particular importance for the implementation of 
transcriptional cascade networks [30]. In his thesis “Macromo-
lecular crowding: physicochemical implications for the cytoso-
lic environment”, Joost Groen also established that undialysed 
extracts are prone to generate irreproducible levels of enhanced 
green fluorescent protein variants (eGFp and deGFp)[31]. They 
do however allow very high productivity of IVtt reactions, 
with up to 10 μM eGFp produced in less than 4 h.
homemade cell extracts appear to be the most suitable system for 
our project. They allow long reaction lifetime, up to 16 h instead of 
1-2 h using pUre systems. They are cheaper and display productiv-
ity similar to commercially available bacterial extracts. Finally, their 
exact composition is known and can be changed according to the 
needs (transcriptional cascades, mrNa and protein degradations or 
enzyme enrichment). For these reasons, we chose to develop and use 
a homemade bacterial extract-based IVtt system for our project.
2.1.2 Genetic templates
IVtt systems can use a broad variety of genetic templates, which 
makes them particularly interesting for the rapid testing of new mod-
ules and circuits. 
The first cell-free expression systems consisted in studying translation 
of purified mrNa molecules [2]. Later, coupled transcription-trans-
lation platforms allowed protein production from recombinant 
DNa[4]. This greatly improved the relevance of cell-free expression 
systems for the rapid testing of genetic templates as no mrNa iso-
lation was required and proteins were produced in a more cell-like 
environment. 
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In 1991, pratt and co-workers proposed the first protocols for coupled 
transcription-translation based solely on transcription by t7 rNa poly-
merase [32]. This work was particularly relevant as most of cell-based 
recombinant protein production was based on orthogonal transcription 
by t7 rNa polymerase (t7rNap). Therefore, most of the IVtt sys-
tems used during the following 20 years were based on t7 rNap. 
It is only recently, with the growing interest for diversified transcrip-
tional networks (see Chapter 1), that new protocols making use of the 
complete E. coli transcriptional machinery emerged as new standards 
in cell-free SB [6, 22, 23, 30, 33, 34]. 
also, the possibility of rapidly producing proteins from linear DNa 
templates obtained by polymerase chain reaction (pCr) is a unique 
feature of IVtt systems. This greatly contributed to shorten the time-
lines necessary for the development of new applications in cell-free 
synthetic biology [35-37]. recent studies further describe the utilisa-
tion of GamS protein for increasing the stability of such linear tem-
plates by inhibiting cytosolic nucleases, which are the main source of 
linear template degradation [30]. 
Finally, recent works provide guidelines for the design of genetic tem-
plates used specifically in IVtt reactions. In a first systematic study, 
Mansy and co-workers established the main rules concerning opti-
mal distances and sequences surrounding the ribosome binding site 
(rBS) [38]. They suggest, for instance, that the rBS is ideally situated 
between 4 and 8 bases from the first codon, with an optimal sequence 
as follows: aaUaaUCU. More recently Mansy and co-workers also 
suggested that GC-rich coding sequence could yield higher levels of 
protein production [39].
2.1.3 Monitoring transcription and translation 
reactions
Considering the importance of rate tuning for the implementation of 
complex genetic reactions, monitoring mrNa and protein concen-
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trations over time is of major importance for our project. our criteria 
for selecting the most suitable probes or reporters were:
• Fast response. as one objective was to determine production 
rates, the signal should quickly relate to a change in concentra-
tion
• In situ detection of proteins and mrNa, as external measure-
ment involves a delay in concentration determination. 
• Detection should ideally be direct, or highly specific.
Protein detection
historically, performances of IVtt reactions were evaluated at the 
protein level. protein concentration was often determined by using 
radiolabeled aminoacids and autoradiography after protein sepa-
ration using SDS-paGe [9, 12, 40, 41]. other methods of concen-
tration determination using enzymatic activity measurements were 
used, such as β-galactosidase colorimetric assay [4, 42], or luciferase 
luminometric assay [6]. The production of recombinant green fluo-
rescent protein GFp and its multiple mutants drove a considerable 
change in detection methods, as it allowed direct detection of pro-
teins [43]. one considerable issue was however the time required 
for most fluorescent protein variants to fold and maturate, as the 
fluorophore is the product of an internal reaction. This problem 
of intrinsic delay in the appearance of fluorescent signal was cir-
cumvented by the generation of GFp variants, selected for their fast 
maturation rate constant [6, 44]. Since, the broad use of fluorescent 
protein reporters allowed the simultaneous detection of multiple 
module expressions, which is of particular importance in circuitry 
development [34, 45].
mRNA detection
Detection of mrNa in situ is often more challenging than protein 
detection as nucleic acids are not intrinsically fluorescent. For this 
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reason, mrNa detection involves the utilisation of probes that recog-
nise a specific structure or a specific sequence of mrNa. 
Structure-based detection
Nucleic acids, particularly rNa, are able to fold into a broad variety 
of three-dimensional structures. Some structures confer the ability 
to bind small ligands with high specificity and affinity. This property 
was for example used for the development of the first generation of 
cis-regulated theophylline switches described in chapter 1[46].
Some aptamers are capable of forming a stable structure with fluores-
cent molecules. The structure formation can lead to a strong enhance-
ment of the fluorescence signal of the ligand. one interesting tech-
nique for mrNa detection in cell-free expression systems consists in 
including an aptamer sequence in untranslated regions of the mrNa 
of a protein of interest (Fig. 2.4). When this mrNa is produced, the 
aptamer sequence folds and binds the fluorescent ligand. The bind-
Figure 2.4: Spinach aptamer allows fluorescence monitoring of mRNA 
concentration. From [47].
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ing increases the fluorescence signal, allowing the quantification of 
the mrNa concentration. There are currently a few groups using this 
method of detection in cell-free SB [33, 47, 48]. one advantage of us-
ing aptamer-fluorescent ligand approach for mrNa detection is the 
relatively high signal to noise ratio. Nevertheless, one disadvantage of 
the technique is the limited diversity of aptamer-fluorescent ligand 
couples available. In consequence, the number of different mrNa 
that can be detected at the same time is also limited. In addition, 
transcription of aptamer sequence involves consumption of extra re-
sources (Ntps), which is problematic in the context of resource lim-
itation often encountered in batch IVtt reactions.
Sequence-based detection
a method using binary probes has been successfully used by Nieder-
holtmeyer et al. [49]. Briefly, this method is based on the binding of 
two fluorescently labeled nucleotides to the mrNa, allowing Fret 
between the two dyes. The Fret ratio can be measured over time in 
order to monitor the mrNa concentration. This efficient approach 
was developed and described when we were developing the molecu-
lar beacon-based in vitro mrNa detection.
Molecular beacons (MB) are powerful tools for the detection of oli-
gonucleotides [50]. They are very versatile probes that can be used for 
detecting point mutations at a genomic level, measuring a transcript 
concentration and even for the tracking of transcripts [51] (Fig. 2.5). 
Molecular beacons are oligonucleotides labelled at both ends by dyes. 
at least one of these dyes is fluorescent. Molecular beacons can be 
found in two different states, a closed state in absence of their tar-
get or an opened state in presence of their target. The state of the 
molecular beacon can be reported by dynamic or static fluorescence 
quenching. Molecular beacons display a very high affinity for their 
target mrNa. Furthermore, tiny molecular beacons with a 4-5 nu-
cleotide long stem, provide a rapid fluorescence signal change, which 
is easy to detect. tiny molecular beacons are particularly suitable for 
the detection of various mrNas produced in our designs (lacI, GFp, 
t7 rnap).
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2.2 Development of the homemade 
IVTT system
In this section, we will describe the development of two homemade 
IVtt systems. The first protocol was reported to yield high levels of 
protein production and perform transcription reaction using E. coli 
endogenous polymerase. This was of particular interest for imple-
menting complex networks from diverse transcription factors. how-
ever, we were not able to produce a cell-extract efficient for endoge-
nous transcription. after a phase of optimisation of the first protocol, 
we preferred to use a second protocol that was more productive, re-
producible and easier to produce. This second protocol also excluded 
the use of polyethylene glycol (peG), a synthetic polymer with am-
biguous effects on IVtt reactions and multimerisation of proteins. 
Such influence could be problematic in a context of repression by 
multimeric proteins, LacI for instance
2.2.1 First homemade IVTT reaction 
framework
our base protocol for producing functional lysate was built on the 
protocol by Shin and Noireaux [6]. This protocol was selected because 
Figure 2.5: Detection of target nucleic acid using a molecular beacon. Adapted 
from [52]
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it allowed transcription from the endogenous rNa polymerase, which 
had the advantage of allowing protein production using a broad range 
of transcriptional factors and a more cell-like environment.
Briefly, this protocol consists in growing a large mass of bacteria (few 
grams) in 2xyt broth. Bacteria are harvested at their peak of growth 
activity (oD600=1,5), when the ribosomal machinery is at its most ac-
tive point. every following step is done on ice or at 4 °C, except the 
incubation. Cell are washed twice and resuspended. Lysis is achieved 
by using 0,1 mm glass beads that crush the cells leading to an ex-
traction of the cytoplasm. The lysate is centrifuged at high speed. The 
supernatant is incubated at 37 °C during 80 minutes, presumably for 
allowing the endogenous nucleases to degrade what remains of the 
genetic material that could interfere with the IVtt reaction. The ly-
sate is dialysed and stored directly at -80 °C without flash-freezing.
In a preliminary work, we observed that our system was not produc-
tive if transcription was performed by the σ70 rNa polymerase. We 
did observe however, that our cell lysate was capable of producing 
GFp if:
• It was mixed with a commercially available feeding buffer 
containing the substrates and cofactors required for the IVtt 
reaction such as Ntps, amino acids, NaD, cyclic aMp, etc… 
(For full description, see method section)
• and it was supplemented with t7 rNa polymerase and a t7 
promoter-based reporter module (prSet-(his)-gfp)
This result indicated that our lysate was functional for translation, but 
displayed a defect related to transcription by the endogenous rNa 
polymerase. We therefore decided to base transcription on the supple-
mentation of recombinant t7 rNap to the homemade IVtt mixture. 
Magnesium and potassium are essential to cell-free gene expres-
sion. Both are involved in the folding of DNa and rNa. potassium 
is one of the cations that are mainly responsible for the stabilisation 
of the folded state of proteins. Conjugated to glutamate, it is also the 
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most abundant salt in the E. coli cytoplasm. Magnesium coordinates 
many biological reactions involving hydrolysis, such as hydrolysis of 
atp, by stabilisation of the bipyramidal intermediate. Finally, peG is 
known for increasing transcription rate and has been very often used 
in IVtt protocols. Shin and Noireaux had optimised potassium glu-
tamate, magnesium glutamate and peG 8000 concentrations for their 
σ70-based system. hence, we proceeded by optimising the magnesium 
glutamate, potassium glutamate, and peG 8000 concentrations for t7 
rNap-based transcription.
Potassium glutamate optimisation
In order to optimise the potassium glutamate, we performed a series 
of IVtt reactions with a range of K-glutamate concentrations (30, 
50, 100, 150, 200, 250 and 300 mM) in the feeding buffer. Figure 2.6a 
shows the end fluorescence signals from the IVtt reactions produc-
ing his6-GFp. K-glutamate concentration did not have a significant 
impact on his6-GFp production. our results are in agreement with 
later work of Shin and Noireaux, who found an optimal concentra-
tion of approximately 100 mM in the feeding buffer (80 mM final 
concentration after mixing with cell extract) [22].
Magnesium glutamate optimisation
We performed a series of IVtt reactions producing his6-GFp with 
a range of Mg-glutamate concentrations (3, 5, 10, 15, 20 and 25 mM) 
in the feeding buffer, and maintained the potassium glutamate at the 
30 mM. 
The concentration initially used was 5 mM. as observed in figure 2.6b, 
the reaction performed with 10 mM of Mg-glutamate in the feeding 
buffer led to about 100% higher signal than while using the original 
5 mM Mg-glutamate condition. Concentrations between 10 to 25 mM 
did not generate significant differences in his6-GFp production. our 
optimal Mg-glutamate concentration differs from the optimal concen-
tration found by Shin and Noireaux for optimal expression using t7 
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rNap (2 mM). as the experiment of Shin and Noireaux is based on 
in situ production of t7 rNap from an endogenous promoter system, 
we hypothesise that the slight difference in experimental design can 
explain the higher value of the optimal concentration in our protocol.
PEG-8000 optimisation
optimisation of peG-8000 concentration was done by performing a 
series of IVtt reactions producing his6-GFp with a range of peG 
8000 concentrations (0, 1, 1.5, 2, 2.5, 3 and 5 % m/v). results indicate 
that increasing concentrations of peG 8000 from 0 to 3% lead to an 
increase in his6-GFp production (Fig. 2.6c). The optimal concentra-
tion we find, 3%, is not too different from peG concentrations gener-
ally used in t7 rNap based protocols (2%) [6]. 
This base protocol however suffered from a low level of reproducibil-
ity from batch to batch. We reason that the lysis method, based on 
bead beating, is a potential source of irreproducibility. This is due to 
rapid heating of the cell suspension during the beating, and unwant-
ed presence of air bubbles that can disrupt protein structure. We also 
note that, at present, Noireaux and co-workers use an alternative lysis 
method based on cell press [53]. In addition, the necessity to use peG 
8000 in this protocol is problematic, as it can influence expression 
rates (transcription and translation rate constants, association and 
dissociation of t7 rNap with DNa, etc..), as well as dimerisation 
and tetramerisation of repressor proteins and their binding to DNa.
a protocol alternative to the Noireaux protocol was successfully de-
veloped by our colleague Joost Groen. This protocol was inspired by 
the cytomim extract protocol developed by Jewett and co-workers 
[5]. The cytomim cell extract, whose composition is close to the E. 
coli cytoplasm, does not require the use of peG 8000. This makes the 
cytomim cell extract prone to create a more “cell-like” environment, 
which can be useful for implementing new genetic networks with fur-
ther cell-based applications. For this reason, we did not reproduce 
the peG range experiment. Instead, we evaluated the new protocol 
following perspectives of reproducibility and tuneability.
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2.2.2 Cytomim-based protocol
In 2004, Jewett et al. proposed the Cytomim lysate protocol. Main 
features of the cytomim protocol were a reaction mixture contain-
ing exclusively natural compounds, high productivity, comparable to 
commercially available systems, and allowing an increased reaction 
time. Finally, the protocol involved ultrasonic lysis of bacteria on ice, 
which might increase the reproducibility from batch to batch.
Figure 2.6: Optimisation of our first homemade IVTT system. Optimisation of the 
potassium glutamate concentration (a) (n=3). Optimisation of the magnesium 
glutamate concentration (b) (n=3). Optimisation of the PEG 8000 concentration 
(c)(n=1).
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Bacteria are grown in a rich medium that was first used by Kim and 
Choi [25]. Such buffer was designed to promote glycolytic metabo-
lism and decrease the phosphatase activities usually compromising 
the high potential of phosphorylated molecules such as atp, pep or 
3-pGa. Interestingly, complete protocol can be performed in one day 
and does not involve freeze-thawing step that can negatively impact 
on enzymatic activity. Instead, protocol involves the preparation of 
spheroplasts, which are the cells after the removal of the outer mem-
brane (Fig. 2.7). This is done by an osmotic shock using ice-cold su-
crose and ice-cold MilliQ water. Importantly, spheroplasts are lysed 
by sonication treatment. Ultrasound treatment is particularly inter-
esting as it allows the lysis of up to 15 mL of spheroplasts suspen-
sion at once and as it can be entirely performed on ice. This has two 
main advantages. Firstly, cells can be rapidly processed, as 15 mL 
usually correspond to the volume of suspension obtained from 1 L 
culture. For comparison, bead-beating lysis only allows the process 
of 1 mL tube if performed at a laboratory scale. Secondly, cell sus-
pension is constantly kept on ice or ice-cold water, which allows a 
rapid heat-transfer. This is of particular importance, considering that 
mechanical treatments, such as bead-beating or ultrasounds, lead to 
fast increase in temperature in absence of cooling system. In the final 
step of the protocol, dialysed cell extract is aliquoted and flash-frozen 
prior to the storage at -80°C. Complete protocol can be found in the 
materials and method section.
The new system had to match three main requirements:
• The system should allow a long reaction lifetime, ideally over a 
few hours.
• The system should allow reproducible IVtt reactions.
• The system should be tuneable, for instance in order to pro-
gram reaction rates.
We evaluated the adapted cytomim protocol according to those cri-
teria.
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Figure 2.7: Current protocol for cell extract preparation involves growth in rich 
medium and ultrasound lysis of spheroplasts.
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1. Reaction lifetime and reproducibility
an IVtt reaction producing eGFp-Ssra was reproduced 31 times 
(Fig. 2.8a). eGFp-Ssra is adapted from a fast-folding eGFp protein 
engineered by Shin and Noireaux. The presence of the Ssra tag allows 
degradation by the E. coli ClpXp protease complex. The genetic tem-
plate used was prSet-5d-egfp-ssra, a plasmid with a t7 promoter. 
The plasmid and the t7 rNap concentrations used were constant, at 
1 nM and 1 µL respectively. results show that the system is capable 
of maintaining a linear production of eGFp-Ssra over 2 h. Moreover 
the system is still productive over 4 h. after 4 h, the system displays a 
standard deviation of approximately 500 nM, which represents about 
15% of the eGFp-Ssra concentration. The system was therefore suit-
able for testing new genetic modules, such as negative feedback mod-
ules, in term of reaction lifetime and reproducibility. 
2. Plasmid range
Concentration of genetic template influences the reaction rate and 
the final level of protein production [54]. In order to check wheth-
er eGFp-Ssra production could be tuned by changing the template 
concentration, we performed a series of IVtt reactions with a range 
of prSet-egfp-ssra plasmid (0, 50, 100, 250, 500, and 1000 pM). Fig-
ure 2.8b shows the end value of eGFp-Ssra concentration after 5 h 
reaction. results show that an increase of prSet-egfp-ssra leads to 
a linear increase of eGFp-Ssra concentration. We conclude that to-
tal template concentrations between 0 and 1 nM do not saturate the 
system. For this reason, modules involved in the construction of a ge-
netic circuit can be used at a final concentration between 0 and 1 nM.
3. T7 RNAP range
In contrast with endogenous polymerase transcription, a controlled 
volume of t7 rNap can be supplemented in the IVtt reaction mix-
ture. We hypothesise that an increasing dose of t7 rNap leads to 
an increased overall production rate. We performed a series of IVtt 
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reactions with a range of t7 rNap volumes (0.2, 0.4, 0.8, 1, 1.8, 2.4 
and 3 µL). The volumes used result in t7rNap activities estimat-
ed at 0.25, 0.5, 1, 1.25, 2.25, 3 and 3.75 U/µL. results indicate that 
the eGFp-Ssra expression rate increases linearly with an increase in 
t7 rNap concentration (about 0.67 nM.min-1. µL-1) (Fig. 2.8c). We 
conclude that changes in t7 rNap volume between 0 and 3 µL per 
100 µL of reaction mixture can be used to further tune the produc-
tion rate of the IVtt reaction without saturation effect. We did not 
use stronger t7rNap concentrations because the enzyme is kept in 
a storage buffer containing glycerol which is toxic for the IVtt reac-
tion. Furthermore, we estimate that this experiment was conclusive 
and its reproduction was not necessary.
The t7rNap was provided by our collaborators Frank Nelissen and 
Dr. hans heus. 
In conclusion to this section, we evaluated the cytomim-based cell ex-
tract protocol according to three main criteria, which were reproduc-
ibility, longevity, and tuneability of the reaction. We conclude that the 
cytomim-based IVtt system is suitable for the rapid and conclusive 
testing of new genetic modules as well as for the implementation of 
complex genetic networks designed for our project.
Figure 2.8: Evaluation of the IVTT system utilising the new lysate preparation method. Reproducibility 
and lifetime test (a) (n=31). Sensitivity to DNA template concentration (b) (n=1). Sensitivity to RNA 
polymerase activity (c) (n=1).
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2.3 Use of molecular beacons for 
monitoring transcription
In order to detect mrNa in situ, we designed a first molecular 
beacon recognising a part of his-gfp mrNa sequence. according 
to the predictions of the mfold server (http://unafold.rna.albany.
edu/?q=mfold), the molecular backbone was preferentially fold-
ing into a hairpin structure, with a ΔG of -15,06 kJ/mol at 37 °C. 
our first aim was to evaluate if the beacon could detect mrNa that 
was produced in a transcription-only reaction. We performed tran-
scription reactions and we detected transcribed mrNa using two 
methods: i) Urea paGe combined with “Stain all” staining and ii) 
molecular beacon. transcription reactions were performed using 
two conditions. one series of reactions was using a circular version 
of t7-his-gfp gene template (plasmid) whereas a second series was 
using a linear version of the template. The linear template was pre-
pared by digesting the t7-his-gfp plasmid before the t7 terminator 
sequence.
Figure 2.9 a shows the electrophoretic profile of the transcription 
mixture obtained at different time points. We could not observe tran-
scription in absence of template. transcription reactions using circu-
lar template showed a rapid production of mrNa in the first 45 min. 
after 45 min, mrNa was still produced but at an apparent slower 
rate. Note that the paGe profile showed an intense band correspond-
ing to the main transcript, as well as a mixture of transcription prod-
ucts. transcription from linear template showed production of a sin-
gle population of mrNa at a slower rate than when transcription was 
performed from circular template. 
We reason that transcription is performed faster when the template 
used is circular, although linear template yields a more pure transcrip-
tion product. This can be explained by a decreased transcription rate 
from linear template, due to a dissociation of t7 rNap polymerase 
in a catalytic state that prevents a rapid association with new DNa 
template in absence of terminator sequence. 
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Concerning the mixture of products observed with the circular tem-
plate, we reason that larger mrNa molecules correspond to “run-
off ” transcription products, which are produced when t7 rNa poly-
merase does not cease transcription at the terminator region. another 
population, corresponding to smaller rNa, appears over time. We 
reason this corresponds to rNa degradation, explained by sample 
contamination by a trace of nuclease.
Figure 2.9 b shows the fluorescence signal of the molecular beacon 
obtained by direct measurement inside transcription reactions. In ab-
sence of template, we could not observe any signal increase. presence 
of circular t7-his-gfp template (3 nM, red curve) led to a rapid in-
crease in fluorescence (667 nm). presence of linear template also led 
to an increase in fluorescence signal, but with a 50% lower intensity 
than the signal obtained using circular template.
This result is consistent with the results obtained using paGe-“Stains 
all” staining. although the paGe profile obtained with circular tran-
script shows a lower production of the main transcript, we reason 
the “run-off ” transcript also display the MB recognition sequence. 
We explain the apparent transcription rate being higher using circu-
lar template by assuming molecular beacons are capable of binding 
“run-off ” transcripts in a similar way they bind the main transcript. 
The molecular beacon was then used for detecting mrNa in IVtt 
reactions. In order to estimate the best MB concentration to use, we 
performed a series of IVtt reactions using a range of MB concentra-
tion (0, 0.5 µM, 1 µM and 1.5 µM). Figure 2.9 c shows fluorescence 
signal obtained at 667 nm, which corresponds to the emission of MB. 
results show that a concentration of 1.5 µM of MB provided the best 
signal/background ratio (6.25 after 270 min), while concentrations of 
0.5 µM and 1 µM MB provided a signal/background ratio of 3 and 
3.7, respectively. Concentration higher than 1.5 µM was not tested, as 
it would limit the amount of experiments performed using the same 
batch of MB. 
The molecular beacon binds mrNa and therefore can influence 
translation rates. In order to verify MB did not have a negative impact 
83
DeVeLopMeNt oF a CeLL-Free proteIN SyNtheSIS SySteM…
Figure 2.9: Behaviour of his-gfp molecular beacon in vitro. In vitro transcription reaction was 
performed from linear and circular template by non-native PAGE (a) or by in situ detection 
using his-gfp MB (b) (n=3). Influence of MB concentration on signal/noise ratio in IVTT reaction 
(c) (n=3). Influence of MB concentration on His6-GFP production in IVTT reaction (d) (n=3).
84
Chapter 2
on IVtt reaction, we simultaneously monitored the production of 
his-GFp. MB concentration did not have a significant influence of 
his-GFp production.
We conclude that a concentration of MB of 1.5 µM allows detection of 
mrNa with a satisfactory signal/background ratio with no negative 
impact of his-GFp production.
We further developed molecular beacons for the detection of laci and 
t7 rNa polymerase mrNas. 
The molecular beacon design to bind laci mrNa formed a hairpin 
with a predicted ΔG of -23.18 kJ/mol at 37 °C We performed a series 
of expressions with a range of placI plasmid concentration (0, 0.1, 
0.25, 0.5, 0.75, 1 and 1.5 nM) in order to check whether the fluores-
cence signal from the molecular beacon was sensitive to the placI con-
centration. The concentration of molecular beacon used was 1 µM.
Unfortunately, the molecular beacon could not be used for the reli-
able detection of transcription, as the beacon opened even in absence 
of lacI template or t7 (Fig. 2.10 a). Nevertheless, fluorescence seemed 
to increase upon addition of higher plasmid concentrations. Figure 
2.10b shows the data plotted in figure 2.10a after subtraction with 
the average of the signals obtained from both blanks. results indicate 
that the transcription rate increased with the placI concentration. The 
signal increased and reached a maximum at 100 min. The decrease 
in fluorescence is puzzling; it might indicate that mrNa is degraded 
over time while transcription is arrested (leading to a net decrease 
in mrNa). Furthermore, we note that the signal/background ratio 
is particularly low, with a maximal difference of approximately 100% 
between the fluorescence measured with 1,5 nM of lacI template and 
the fluorescence measured in the blanks. There are a few possible ex-
planations for this poor signal/noise ratio. one possibility is that the 
molecular beacon is hydrolysed by some endoribonuclease that is not 
sensitive to the presence of the methoxy group at the 2’ position of 
the ribose. This possibility, although not likely, is supported by the 
fact that the fluorescence signals converge to one homogenous level 
that remains stable. This level is independent from the placI concen-
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tration. The final fluorescence level could therefore correspond to the 
signal emitted by the fully hydrolysed molecular beacon. Moreover, it 
was previously noticed in our group that the increase of fluorescence 
of the blanks was only observed in presence of cell lysate; monitor-
ing of mrNa concentration was reliably performed by using the lacI 
molecular beacon in isolated in vitro transcription reactions [55-57]. 
In further attempts to reproduce these results, we realised that the 
background signal of the beacon could strongly vary from one syn-
thesis batch to another. The company in charge of the synthesis, IDt, 
was contacted and insured there had been no change in the route of 
the beacon synthesis. They suggested that resuspension of the molec-
ular beacon in autoclaved MilliQ could be a cause of hydrolysis and 
offered another batch for resuspension in tris ph 7. This alternative 
protocol did not stabilise the beacon either. We also experienced sim-
ilar issues when using a MB for detecting t7 rNa polymerase mrNa.
Figure 2.10: Influence of placI concentration on its transcription. (a) Transcript levels were 
monitored by using a molecular beacon. (b) Fluorescence intensity after removal of the 
average intensity from the blanks (no T7 and no plasmid) (n=1).
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2.4 Conclusion
after an initial phase of optimisation, we successfully obtained a 
homemade IVtt system that could efficiently perform t7 rNap 
transcription-based protein production. This system was however 
not completely biologically relevant as productivity strongly relied on 
the presence of peG 8000, a compound absent in cells. hence, a sec-
ond protocol, which required no peG, was evaluated. This protocol 
allowed the production of a bacterial extract that matched our main 
requirements. The new IVtt system could be used to produce up 
to 4 µM of eGFp-Ssra protein in 4 h. also, the reaction displayed a 
high reproducibility, which is particularly interesting for testing the 
functionality of new genetic modules. overall expression rate could 
be tuned by changing both the genetic template and the t7 rNap 
concentrations. This tuneability is of particular importance for im-
plementing genetic circuits, as expression rate must be tuned at the 
individual module level as well as at the system level. We note that we 
were not able to produce proteins from endogenous transcriptional 
system. The reproduction of transcriptional diversity found in E. coli 
will be particularly interesting for future research. Finally, following 
the method used by Bratu et al., we successfully designed a molecular 
beacon suitable for monitoring transcription of his-gfp in vitro [58]. 
Further attempts to design new molecular beacons were not success-
ful, due to instability in contact with cell extract. Molecular beacons 
can be used in further research for estimating activity of genes that 
do not produce easy-to-detect proteins or evaluate the efficiency of 
rNa-based gene networks. This will require a more thorough charac-
terisation of the sensitivity and of the specificity of the molecular bea-
cons, as well as a stronger protection of the MB integrity. This could 
be achieved by using Locked Nucleic acid (LNa) backbone.
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2.5 Material and methods 
2.5.1 IVTT system
Standard cytomim-based IVTT protocol, preparation and 
fluorescence detection
Without further specification, IVtt reactions were prepared as follows:
For 100 uL of reaction (final concentrations are indicated)
• hepes ph8 50 mM
• K-glutamate~10-30 mM, to be calibrated for every lysate
• Mg-glutamate~5-10 mM, to be calibrated for every lysate
• 10X basis (cosubstrates) 6.67 µL (reconstituted feeding buffer 
represents 66.7% of the total reaction volume)
• 3-pGa (disodium salt) 20 mM
• Spermidine 670 µM
• amino acids mixture 10 mM
• atp 1 mM
• Gtp 3 mM
• Ctp 1 mM
• Utp 1 mM
• Lysate 33.3 µL
• prSet-5d-degfp standard concentration 1 nM
• his-t7rNap standard volume 1 µL (1.25 U/µL final activity)
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10X basis buffer contained, for 5 mL stock:
Compound Concentration Amount
caMp 7.5 mM 13.8 mg
NaD 3.3 mM 10.9 mg
Coenzyme a 2.6 mM 10.0 mg 
Folinic acid 0.68 mM 1.6 mg
trNas 2 mg/mL 10 mg
amino acids were prepared according to Caschera and Noireaux pro-
tocol [59]
all reagents can be purchased from Sigma.
Cell lysate
Cells were cultivated as follows. a starting culture was grown over 
night at 37 °C by inoculating typically 50 mL to 100 mL of LB me-
dium with a glycerol stock of the desired bacterial strain. E. coli ro-
setta 2 was typically used as it yields a productive extract free of t7 
rNap, in contrast to BL21 De3. another advantage of using rosetta 
2 was the presence of eukaryotic trNas in the lysate, which we could 
have exploited for the production of eukaryotic proteins. early in the 
morning, the starter culture was used to inoculate 2 L of culture of 
2yt broth supplemented with a phosphate buffer (0.22 M Nah2po4, 
0.55 M Na2hpo4, titrated to ph 7.0, autoclaved) and glucose, 18.02 
g/L of broth. This very rich growth medium ensured optimal condi-
tions for the cultivation of fast growing bacteria like BL21. The start-
ing oD (optical density in relation to the turbidity of the sample at 
600 nm) was 0.2, the growth temperature 37 °C, stirring at about 200 
rpm. after a few hours, when the direct oD of the culture reached a 
value of 1,8, the culture was transferred into Ja10 rotor vials and cen-
trifuged at 5500 r.p.m. (~5300 G) during 10 minutes at 4 °C. The su-
pernatant was discarded and cells were resuspended with ice cold ly-
sis buffer (20% sucrose solution, egg white lysozyme 1 mg/mL, eDta 
1 mM, filter sterilized). typically, 16 mL of lysis buffer was used per 
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Ja-10 vial. This step was crucial as it allowed the permeation of the 
cell envelop by the lysozyme, as well the diffusion of highly concen-
trated osmolite between the cell envelop and the cell membrane. The 
suspension was left 10 minutes on ice for incubation and the content 
of three Ja-10 vials was gathered into one. after this first incubation, 
we added 24 mL of ice-cold MiliQ to the 48 mL of cell suspension, 
and let incubated on ice for 5 more minutes. The suspension was cen-
trifuged at 7500 rpm (~10000 G) during 10 minutes at 4 °C. The su-
pernatant was discarded and cell pellets were weighted and carefully 
resuspended in ice-cold milliQ water (0,75 mL per 1 g of cell). This 
step induced a strong osmotic shock, as the water molecules rapidly 
flowed towards the sucrose gradient. The space between the envelope 
and the membrane swelled, eventually leading to the disruption of the 
envelope.
Cells, also called spheroplasts at that point, were very sensitive to any 
mechanical stress. We made use of this property to easily break the cell 
membrane by applying ultrasound waves to the cells. It is important 
to note that the amount of water used in the last suspension strongly 
influences the final protein concentration in the lysate. 0,75 mL per 
gram of cell is given as an indication, one can use a different volume 
of MilliQ to tune the lysate concentration.
The spheroplasts were lysed by ultrasonic treatment on ice (wave-
length 10 µm during 10 seconds, followed by 30 seconds resting, for 
10 cycles in total). The lysis mixture was spread in Ja-20 vials and 
centrifuged at 10000 rpm for 10 min at 4 °C. The supernatant was 
then incubated for 30 minutes at 37 °C, which might have helped 
to degrade the mrNa remaining in the cell lysate, and centrifuged 
at 15700 rpm during 10 minutes. The lysate was next dialysed at 4 
°C against 50 times its volume of 0,5X dialysis buffer (1X is 5 mM 
tris-Cl, 30 mM potassium glutamate, 7 mM magnesium glutamate, 
autoclaved. 0.5 mM Dtt were added after autoclaving) during 45 
minutes, followed by a dialysis against 50 times its volume of 1X di-
alysis buffer, three times 45 minutes. The dialysis was performed in 
ThermoFicher dialysis cassette G2, 10 kg/mol (or kDa) cut-off, usual-
ly containing up to 15 mL, but lower volumes can also be used.
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2.5.2 Fluorescence measurements
IVtt reactions and fluorescence measurements were performed in 
black Nunclon flat bottom 96-well plates with a transparent lid. his-
GFp fluorescence was measured using a tecan M200 plate-reader 
with λexc=395 nm and λem=507 nm, t=30 °C, with an agitation ev-
ery 5 min. his-gfp MB fluorescence was measured using tecan M200 
plate-reader at λexc=637 nm and λem=667 nm, t=30 °C, with an ag-
itation every 5 min. deGFp fluorescence was measured using a tecan 
M200 plate-reader with λexc=485 nm and λem=520 nm, t=30 °C, ag-
itation every 5 min, or a Berthold triStar plate-reader with λexc=485 
nm and λem=520 nm, t=30 °C, agitation every 5 min
2.5.3 Isolation & purification of His6-tagged 
T7 RNA polymerase
Growth
Cells were cultivated as follows:
a single colony was picked from a streak of freshly or glycerol stock 
cells. The LB-agar plate contained 50 μg/mL ampicillin (amp50). one 
colony was used to inoculate 5 mL of LB-amp50. The culture was shak-
en at 250 rpm, 37 °C for 8 hours. 100 μL of culture were used to inoc-
ulate 25 mL of LB-amp50. Culture grew overnight at 37 °C at 250 rpm.
Next morning, 20 mL of overnight culture were transfered to 1000 mL 
of LB-amp50 in a baffled erlenmeyer flask (1 liter) at 37 °C, 250 rpm.
optical density was monitored at 600 nm, around ~0.6 – 0.8. IptG 
was added to a final concentration of 1 mM. Growth continued for 
another 3 hours. 
Cells were harvested by centrifugation at 5000 rpm in a Ja-10 rotor 
for 7.5 minutes at 4°C.
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Cell pellet were resuspended in 80 ml of lysis buffer [22 mM Nh4Cl, 
20 mM tris-hCl ph=8.0, 10 mM eDta, 5% Glycerol, 300 mM NaCl, 
10 mM imidazole, 5 mM β-mercaptoethanol, 20 μg/ml pMSF and 
0.25 mg/ml lysozyme]. Cells were stored overnight at -80°C.
Cell lysis
The frozen cell suspension was thawed in a beaker with tap water.
Cell suspension was sonicated on ice 3 times for 60 seconds at maxi-
mum power (the sonication tip inserted in the cell suspension) with 
intervals on ice of 2 minutes between each sonication cycle. 
Lysate was centrifuged at 15000 rpm in a Ja-20 rotor for 45 minutes 
at 4 °C.
Supernatant was carefully decanted. This was followed by a column 
purification.
Supernatant had to be filtered if any insoluble matter was present, as 
it might have clogged the column; alternatively, centrifugation could 
be ran a second time in a fresh centrifugal tube.
Supernatant was kept at 4 °C from this point on.
Column purification
a histrap hp column (5 ml, Ge healthcare) was equilibrated in 
the cold room with buffer [50 mM tris-hCl ph 8.0, 300 mM NaCl, 
5 mM β-mercaptoethanol, 10 mM imidazole, 5% glycerol].
The clarified supernatant was loaded onto the column using a peri-
staltic pump and non-binding proteins were washed out with 10 col-
umn volumes of equilibration buffer.
The bound t7 rNa polymerase was eluted with buffer [50 mM tris-
hCl ph 8.0, 300 mM NaCl, 5 mM β-mercaptoethanol, 300 mM im-
idazole and 5% glycerol]. 
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Fractions of ~3 ml were collected. 
Usually, the vast majority of t7 rNa polymerase was present in the 
second and third fraction.   
Checking 2.5 μl of this fraction on SDS-paGe showed a thick blob of 
protein with minor contaminations. assessing 2 μg of t7 rNa poly-
merase after dialysis and determination of protein concentration gave 
a single band of t7 rNa polymerase with the visual absence of con-
taminating proteins.
Dialysis
Fractions containing the purified t7 rNa polymerase wre dialised 
against 1 liter of [40 mM tris-hCl ph8.0, 200 mM NaCl, 2 mM 
eDta, 2 mM Dtt] for 4 hours at 4°C
after 4 h, dialysis solution wass changed for overnight dialysis.
preferably, dialysis tubing with a MWCo of 6000-8000 Dalton and ~1 
ml/cm of tubing was used. 
Dialysed protein was harvested from the dialysis bag, allowing an es-
timation of the isolated volume. 
an equal volume of 100% glycerol was slowly added, while the t7 
rNa polymerase was kept on ice. Mixture was homogenised by gen-
tly but thoroughly inverting the tube or by slow vortexing 
The t7 rNa polymerase was aliquoted in 1.5 ml portions in sterile 2 
ml eppendorf tubes and stored at -20°C.
protein concentration could be determined at this point and brought 
to the desired value by diluting with dilution buffer [20 mM tris-hCl 
(ph 8.0), 100 mM NaCl, 0.1 mM eDta, 1 mM Dtt and 50% glycer-
ol].  typically, purification yielded 1 mg/mL pure t7 rNap, display-
ing an activity on 125 U/µL.
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2.5.4 Transcription reaction
a 2X master mix was prepared for 15 reactions as follows (concentra-
tions refer to the stock concentrations):
• 75 μL tris-hCl 400 mM ph 8.1 
• 37.5 μL Dtt 100 mM
• 30 μL Spermidine 25 mM
• 18.7 μL MgCl2 1 M
• 120 μL Ntps 25 mM
• 37.5 μL GMp 100 mM
• 15 μL t7 rNap (See 2.5.2)
• 15 μL peG 50 % v/v
• DNa template final concentration 3 nM
reaction was split (25 μL per reaction) and adjusted to experiment 
conditions (MB, etc..)
MQ to 50 μL
2.5.5 Molecular beacons
Molecular beacons were designed following Bratu’s protocol for de-
sign of tiny molecular beacons [58]. The oligonucleotide backbone 
used 2’-methoxy ribonucleotides.
MB for his-gfp mrNa: 5’-alexa 647-GCGCaaaUaaaUUUaaGG-
GUaaGCGC-BlackholeQuencher2-3’
MB for laci mrNa: 5’-alexa 647-CCCUGaGaGaGUUGCaGGG- 
BlackholeQuencher2-3’
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In this chapter, we discuss our approach to maintain IVTT re-
actions in a steady state, which is an essential requirement for 
implementing a sustained complex gene network in vitro. An 
IVTT reaction reaches a steady state when mRNAs and pro-
teins are produced and dissipated at equivalent rates. After 
discussing our approach for implementing the specific mRNA 
and protein degradation, we present a microfluidic platform 
that we used in order to sustain IVTT reactions over 40 h. We 
also discuss the use of flow reactors as a good alternative for 
maintaining the IVTT reaction in a steady state. Although the 
platforms we developed suffer from a lack of robustness, they 
will be useful for testing our new gene network designs in our 
future research.
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Implementation 
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3.1 Introduction
The main goal of our project is to develop a gene network that could 
be used to generate complex regulatory patterns, such as oscillations, 
in a cell-free gene expression system. Such behaviour will only be ob-
served when the system is kept out-of-equilibrium. Before developing 
and testing new synthetic gene networks, a good understanding of 
the conditions allowing the reaction to produce complex dynamics 
was essential. One requirement for sustaining a complex behaviour is 
to maintain the reaction in a steady state. essentially, this means that 
the system must be ‘open’: there has to be a constant consumption or 
turnover of energy and building blocks. In practice, this means that 
thermodynamic equilibrium will be avoided by carrying out the reac-
tion in a flow reactor, in which new reagents are constantly supplied. 
Under certain conditions, the implementation of a delayed negative 
feedback will allow the system to display interesting out-of-equilibri-
um dynamics, such as oscillations. These conditions are [1]:
• The system must have negative (and ideally also positive) feed-
back loops, which essentially means that the products of reac-
tions must be able to affect the kinetics of that reaction.
• resources are constantly available, and by-products, which 
might have an inhibitory effect, need to be removed or de-
graded. This condition is reached when the system is open, or 
when resources are not limiting.
• The kinetics of the reaction generating the delayed negative 
feedback must lead the system to follow a strong non-linearity. 
Some examples of oscillating networks based 
on DNA templates
Before implementation of in vitro genetic networks [2-4], a few bio-
chemical oscillators, based on DNa templates, had been described. 
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In this section we will give a brief overview of these oscillators, which 
were interesting for their proximity with in vitro genetic networks.
In their seminal work, montagne et al. successfully implemented a 
DNa-polymerisation based oscillator [5]. The topology of the oscil-
lator consisted of three oligonucleotide components, α, β, and Inh. 
Oligonucleotide α was capable of priming its own replication from 
the DNa template t1, therefore constituting a positive feedback loop. 
Oligo α also primed the generation of oligo β from the template t2. 
Oligo β then primed the generation of oligo Inh. Inh was an inhibitor 
of α replication. hence, production of Inh, which was dependent of β 
production, constituted a delayed negative feedback. Degradation of 
oligonucleotides regulating the complex network was achieved by us-
ing the recJf exonuclease (fig. 3.1 a and b). montagne et al. used con-
centrations of deoxy nucleoside triphosphates (dNtps, 100 µm each) 
that theoretically allowed many amplification cycles, considering the 
length of the oligos (~11 nucleotide long). Such concentrations could 
drive over 40 oscillation cycles on a time scale of 20 hours and more 
(fig 3.1b). The system however slowly decayed because of the de-
crease of resources combined with the accumulation of by-products 
such as pyrophosphate. This work shows that oscillations in closed 
systems can be sustained for a few cycles if the amount of substrate 
available for the reaction is large compared to its consumption rate. In 
further work, rondelez and co-workers were able to expand the com-
plexity of their networks, implementing complex behaviour such as 
molecular memory [6], predator-prey systems [7], oscillating spatial 
waves [8], and more recently programmable activation of DNa-func-
tionalised microparticles for propagation of information controlled 
in space  [9].
In a comparable approach, Kim and Winfree used ribonuclease h 
(rNase h) to degrade rNa molecules driving in vitro transcriptional 
oscillations (fig. 1 c) [10]. 
In contrast to replicative and transcriptional oscillators, implemen-
tation of in vitro gene oscillators requires the degradation of mrNa 
intermediates and proteins regulating the network. Such degradation 
can be achieved by using nuclease and protease enzymes. however, 
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Figure 3.1: Examples of batch biochemical oscillators. Topology and behaviour 
of a replicative oligonucleotide oscillator developed by Montagne et al. (a) [5]. 
Degradation is provided by the RecJf exonuclease (activity symbolised by ø). The 
oscillator performs over 40 oscillations with 100µM of each dNTP in batch. The 
transcriptional oscillator developed by Kim and Winfree [10] is based on the RNAse 
H activity. RNAse H cleaves the RNA of RNA-DNA hybrids. Its activity is symbolised by 
-• in the oscillator topology. The transcriptional oscillator can perform over 5 cycles 
with a starting concentration of 11mM of each NTP in batch (b). The Kai proteins A, B 
and C enter oscillating cycles of phosphorylation/dephosphorylation (c). 1mM of ATP 
is enough to drive a full circadian cycle (approximately 24h). a was taken from [5]. b 
was taken from [10]. c was taken from [12]
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some rNa molecules, such as transfer rNas (trNas) and ribosomal 
rNas (rrNas) are essential for performing in vitro transcription and 
translation (IVtt) reactions. This is also the case for proteins, such 
as, rNa polymerases, elongation factors or ribosomal proteins. The 
degradation of mrNa intermediates and regulatory proteins must 
therefore be specific, unless the reactor is continuously replenished 
with a flow containing all the necessary ingredients. 
In order to achieve such specific degradation, Shin et al. proposed 
a method based on the use of mazf endonuclease and ClpXp pro-
tease. The IVtt reaction system described in Chapter 2 uses a cell 
lysate which naturally contains these enzymes. It was therefore prob-
able that such degradation machinery would already be present in the 
system. Degradation rates could however be limiting factors for the 
implementation of artificial gene networks. 
In contrast to the recJf and rNase h enzymes previously mentioned, 
mazf and ClpXp enzymes are not commercially available in an active 
form [11]. furthermore, all the in vitro gene oscillators that were im-
plemented so far were based on the dissipation of mrNa and proteins 
by dilution in a flow reactor. Therefore, the use of mazf and ClpXp 
for in vitro gene network implementation remains a challenge as no 
degradation rate has ever been exclusively based on their activity. 
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IVTT reaction in a steady state
The Kai proteins a, B, and C also form an oscillator, based on sequen-
tial phosphorylation events that drive circadian rhythms in cyano-
bacteria (fig. 3.1d). Kondo and co-workers reconstituted the system 
in vitro and drove oscillations over a day with a starting concentration 
of 1 mm atp (fig. 3.1e) [12, 13]. Similarly to the oscillator imple-
mented by montagne et al., the concentration of atp used for the 
phosphorylation of KaiC was high in comparison to its consumption. 
for this reason, oscillations could occur even in a closed system, al-
though they rapidly became damped.
In contrast to the systems used by montagne et al. and Kondo and 
co-workers, cell-free gene expression reactions rapidly consume re-
sources such as atp and Gtp (see Chapter 2). The initial concen-
tration of such resources displays an optimum and cannot be fur-
ther increased in order to prolong the reaction’s lifetime. finally, the 
IVtt reaction is very sensitive to the formation of by-products, such 
as inorganic pyrophosphate (ppi). These by-products have to be con-
stantly degraded, recycled, or removed from the system. two main 
approaches have been used in order to extend the IVtt reaction life-
time and maintain it in a steady-state.
The first approach uses dialysis exchange. In this case, the reaction is 
continuously fed with new substrates, and by-products are removed. 
The second approach uses a flow reactor. In this case, all reagents are 
continuously replenished. The flow also dilutes by-products.
Inspired from the initial work of Spirin and co-workers [14], Shin et 
al. proposed a platform based on the use of dialysis for maintaining 
all reagent concentrations constant and extending the reaction life-
time [15] (fig. 3.2a). The dialysis platform yielded a constant expres-
sion for more than 15 h and high yields of protein production per 
volume of lysate (fig. 3.2b). however, this system had the disadvan-
tage of using a large quantity of substrates, considering the volume of 
feeding buffer required for sustaining the reaction in a volume ratio 
of approximately 1/10. 
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flow reactors are a good alternative to the microdialysis platform. 
So far, flow reactors have been the only way to implement in vitro 
genetic reaction networks [2-4]. two systems have been described in 
the literature. The first one, described by Niederholtmeyer and co-
workers, was based on the use of micropumps allowing the controlled 
injection of fresh IVtt material, such as DNa template and pUre 
kit components (fig. 3.3a). as the reaction volume was kept constant, 
injection of fresh material consequently diluted the reacted materi-
al. This allowed the system to remain in steady state for over 30 h. 
The second platform, developed by Karzbrun et al., consisted in the 
refreshment of IVtt reaction mixture inside microchambers where 
DNa templates (negative feedback, readouts, etc..) were immobilised 
(fig. 3.3b) [3]. 
Importantly, implementation of out-of-equilibrium gene network us-
ing dialysis requires a coupling with mrNa and protein degradation, 
which is made possible by using mazf and ClpXp for instance. In 
contrast, a flow reactor facilitates both the maintenance of the reac-
tion in steady state and the dilution of mrNa and protein products 
(thereby effectively ‘degrading’ them). 
Figure 3.2: Dialysis platform used by Shin et al. (a) While batch mode IVTT 
reaction generally ceases after 2-5h, the dialysis platform allows an extended 
reaction time (b). Adapted from Shin et al. [15]
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MazF, a sequence-specific ribonuclease
In E. coli, the mazf protein is a small endoribonuclease mediating 
the cleavage of single-stranded rNa at a sequence-specific recogni-
tion site: aCa. Cleavage occurs at the 3’ end of the first a [17, 18]. 
In bacteria, the majority of the rNa molecules, other than mrNa, 
are either extensively folded, like trNa, or buried in large molecular 
complexes, like rrNa. most of the aCa sites from such rNa mole-
cules are, therefore, not accessible for cleavage by mazf. however, it 
has been reported that the 16S ribosomal subunit is cleaved by mazf 
in the case of cellular stress [19]. This leads to a selective translation 
of specific stress-related proteins. On the other hand, bacteria pro-
duce proteins by coupling transcription and translation reactions. as 
a consequence, mrNa molecules are often found in a linear form, 
rendering them the most common candidates for mazf cleavage. a 
Figure 3.3: Flow reactors used to implement in vitro gene oscillators. In the 
platform used by Niederholtmeyer et al., flow  is created by repeated injections 
of essential ingredients, including genetic templates (a). The system used 
by Karzbrun et al.  consists of a chamber containing a patch of immobilised 
DNA brush and a continuous flow of IVTT mixture (cell-free extract) (b). The 
refreshment rate is determined by the diffusion time of molecules between 
the main channel and the chamber, which is determined by volume of the 
connection. (a) from [16]. (b) from [3]
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cleavage in the mrNa molecules will usually lead to the production 
of a shortened peptide chain. Cleavage has critical consequences if 
the cleaved site is located in the ribosome Binding Site or close to 
it. mazf activity is usually regulated in three ways. first, gene activi-
ty can be decreased by transcriptional feedback (fig. 3.4 a). Second, 
mazf can degrade its own mrNa, which constitutes a fast enzymatic 
negative feedback (fig. 3.4 b). finally mazf activity can be inhibit-
ed by a very specific antitoxin protein called maze (represented as 
a green ovoid in figure 4). regulation mechanisms of mazf will be 
described in more detail in chapter 5.
Figure 3.4: Regulation mechanisms of MazF activity. MazF toxin can bind its cognate 
antitoxin, MazE. MazE dimer is able to regulate its own concentration by transcriptional 
repression (a). The complex MazE-MazF has a higher affinity for the operator region than 
MazE alone. In the case of cellular stress such as starvation, MazE is degraded which releases 
MazF toxin (b). MazF is then able to degrade mRNA, which eventually leads to growth arrest 
and ultimately to cell death. MazF concentration is also regulated by the protein degrading 
its own mRNA. From [20]
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Tag-specific ClpXP protease complex
ClpX and Clpp proteins form a large complex used by bacteria to 
ensure degradation of specifically tagged proteins. In cells, the tag 
is usually added by transfer-messenger rNas (tmrNa, also known 
as Ssra rNa or 10Ss rNa) to proteins that are only partially syn-
thesised due to ribosome stalling [21-23]. Consequently, the ClpXp 
complex can be seen as a recycler participating in the quality con-
trol of bacterial proteins (fig. 3.5). It is interesting to note that the 
ClpXp complex ensures a very similar function in eukaryotic cells 
inside mitochondria. ClpX is a hexameric atp-dependant unfoldase. 
It belongs to the superfamily of aaa+ chaperones. aaa+ proteins 
share a similar motif of about 250 residues that is capable of coordi-
nating the hydrolysis of the gamma phosphate of atp with a confor-
mational change. This allows aaa+ proteins to convert a chemical 
gradient into a mechanical force. This mechanical force can be used 
for many different purposes such as molecular motion of dynein pro-
teins along microtubules, or chaperone activity. Chaperone activity 
allows the unfolding of misshaped proteins and their refolding into 
a correct tertiary structure. ClpX displays a chaperone activity. It is 
capable of binding substrates carrying an 11 residues long peptide, 
called the ssra tag, on their C-terminus. The consensus sequence of 
the ssra tag is aaNDeNyalaa. however, it has been demonstrated 
that the leucine residue 9, the two alanine residues 10 and 11, and a 
free carboxyl, are chiefly responsible for ClpX recognition [24]. ClpX 
can also be aided by adaptor proteins, such as SspB, that has a high 
affinity for both ssra-tagged proteins and ClpX complex. The adaptor 
proteins can decrease the apparent Km of protein degradation by play-
ing the role of a shuttle between substrate molecules and ClpXp com-
plex. SspB recognises the sequence aaND—y----. a mutation in this 
determinant sequence prevents substrate recognition by SspB. Con-
sequently the Km for Gfp-ssra degradation switches from less than 
0.3 µm with SspB recognition to 6.2 µm in absence of SspB recogni-
tion. after binding its substrate, ClpX hydrolyses atp which induces 
a conformational change that will apply a mechanical stress on the 
substrate. This leads to a local loss of tertiary structure on about 10 
residues. The unfolded part of the substrate is then pushed, or trans-
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located, into a proteolytic pore of Clpp. Clpp protein forms heptamers 
able to dimerise, leading to the formation of a large complex with a 
central pore of about 5 nm diameter. The surface of the pore forms 
catalytic triades displaying serine protease activity. Interestingly, the 
local concentration of catalytic triades inside the pore is strongly in-
creased due to confinement (about 350 mm) [25]. The size of the pore 
allows small peptides to be digested but excludes the random diges-
tion of larger molecules such as folded proteins. for this reason, the 
Clpp complex requires the coupling with ClpX in order to hydrolyse 
larger proteins. This ensures that only the proteins labeled with an 
ssra tag are degraded. Complete ClpXp complexes are estimated to 
be present in low concentration in E. coli, at about 100 to 150 mol-
ecules (100-150 nm). Nevertheless, the highly specific recognition 
by ClpX and the high catalytic power of Clpp seem to be adapted to 
the rate of incomplete protein production naturally occurring during 
protein expression.
Objectives
The aim of this chapter is to maintain the IVtt reaction in a steady 
state in order to better characterise individual genetic modules and 
eventually implement out-of-equilibrium genetic networks. This aim 
can be reached by following two different approaches.
The first approach combines the tuning of the reaction turnover with 
mazf and ClpXp enzymes, in combination with the maintenance of 
the reaction in a dialysis platform. Our goal is to develop methods 
allowing the global tuning of mrNa and protein degradation rates 
in the IVtt reaction, and to design a dialysis platform, which would 
extend the reaction times of the IVtt reaction. 
Concerning degradation enzymes, a complete control over degrada-
tion rates is not necessary. however, the tuning should allow a robust 
decrease in the overall expression rate in order to study the artificial 
gene networks in a dynamic state. 
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Concerning dialysis, Niederholtmeyer et al. reported that typical in vi-
tro genetic oscillations they obtained had a period ranging from 5 to 15 
hours [2]. Our objective was therefore to extend the reaction lifetime 
in a steady state to at least 30 hours. We note that the relative amount 
of substrate available for the IVtt reaction could be increased by de-
creasing the volume of the reaction chamber. We therefore propose 
the miniaturisation of the dialysis platform in order to allow a larger 
feeding buffer/reaction volume ratio for an increased reaction lifetime. 
moreover, the possibility of an automated measurement with a fluores-
cence microscope is an important feature we aim to implement. 
alternatively, a second approach involves the development of a flow 
reactor. Due to time limitations, our aim is to develop a simple flow 
reactor. This flow reactor must be easy to fabricate and with a less so-
phisticated design than those used by Niederholtmeyer et al. or Karz-
brun et al. 
Figure 3.5: ClpXP protease complex can degrade proteins tagged with ssrA 
peptide. ClpX forms a hexamer capable of recognising proteins carrying the 
ssrA tag at their C terminus. ClpX6 converts an ATP chemical gradient into a 
mechanical stress resulting in the local unfolding of the substrate. The unfolded 
piece of substrate is translocated to the ClpP complex. The ClpP complex is 
formed by a dimer of heptamers resulting in the formation of a pore decorated 
by serine protease triads.  Figure from the Chien group website. University of 
Massachusetts, Amherst. http://openwetware.org/wiki/Chien
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3.2 Results and discussion
3.2.1 mRNA degradation
Expression of MazF from linear template T7-mazF (no 
ACA) decreases the level of eGFP production
after overexpression of the protein in bacteria, Shin et al. prepared 
a cell lysate enriched in mazf toxin. They showed that a complete 
control of mrNa lifetime was made possible by modulating the 
mazf concentration in the IVtt reaction system. as a consequence 
of the production of mazf toxin, the bacteria used for production 
experienced an immediate growth arrest. This led to a limited yield 
of mazf production (between 1.8 and 2.8 µm in the enriched lysate). 
Nevertheless, a final concentration of 36 nm mazf was sufficient to 
decrease the eGfp production to 50%. The low yield of mazf produc-
tion had therefore no strong impact on the efficiency of this method. 
This is the only method described in the literature, and no other pub-
lication mentions the use of mazf protein for tuning mrNa lifetime 
in genetic reaction networks.
The IVtt reaction offers the possibility to rapidly produce proteins 
from linear templates obtained by pCr. This is an alternative to 
time-consuming cloning work and in the case of mazf, an efficient 
method to circumvent the problem of bacterial growth arrest after 
induction. 
We tested whether mazf could be produced from a linear template 
using the IVtt system. The enzyme should also exhibit an activity 
high enough to efficiently degrade mrNa produced in IVtt. This 
linear template was used with the IVtt platform to produce mazf-
(his)6. We engineered the mazf coding sequence using redundancy 
of the genetic code, so it would not include any aCa which would 
prevent efficient protein expression. 
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The new mazf protein sequence matched the “wild-type” sequence, 
augmented by a polyhistidine tag at the C-terminus.
please note that from now on, mazf (-) template refers to the t7-
mazf (no aCa)-(his)6 gene template, egfp template to prSet-egfp 
template and maze template to the t7-maze template. finally, mazf 
refers to the polyhistidine-tagged mazf (mazf-(his)6).
In order to check whether the mazf protein was efficiently pro-
duced in vitro in an active form, we coupled the expression of 
egfp plasmid (1 nm) to the expression of the mazf (-) template 
(0.5 nm). results show that the addition of mazf (-) template re-
sults in a large decrease (80% drop) of eGfp production (fig. 3.6). 
In order to check whether this decrease was due to the production 
of mazf toxin, we tested the effect of maze antitoxin production 
on mazf. addition of maze template (1 nm) led to a strong, but 
incomplete, recovery of the eGfp fluorescence, limiting the drop 
to only 30% of the reference reaction. We propose that the incom-
plete recovery is due to the presence of aCa site in maze cod-
ing sequence. this leaves maze mrNa susceptible to cleavage by 
mazf protein, decreasing the potential maze antitoxin concentra-
tion. alternatively, the simultaneous production of three different 
proteins from a total gene template concentration of 2 nm con-
sumes more IVtt resources than when the egfp template is alone 
(1 nm). this prevents the full recovery of eGfp production by ad-
dition of maze template. Nevertheless, the drop in eGfp produc-
tion observed by adding the mazf template is not due to resource 
dilution only, otherwise the addition of the maze template would 
not have a positive effect on eGfp production.
These results clearly show that the production of mazf toxin by 
using IVtt reaction is possible. In situ production of the toxin 
leads to a decrease in eGfp production rate that can be recovered 
by expressing the specific antitoxin maze. Our objective was to de-
termine qualitatively whether mazf could be produced using the 
IVtt system, so the experiment was not reproduced for quantita-
tive analysis.
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Purified MazF yields control of protein production by 
degrading mRNA
although co-expression of the mazf gene is an efficient way to im-
plement mrNa degradation, the continuous production of the toxin 
from a linear gene template might lead to an accumulation of mazf 
protein. This would generate an uncontrollable increase in mrNa 
degradation rate, hardly compatible with the implementation of a 
gene network. This problem could be circumvented by controlling the 
degradation of the linear template in order to create a transient pro-
duction of mazf by using DNase. a second possibility was to gener-
ate a self-regulating loop limiting the increase of mazf concentration. 
another possibility was to produce mazf and purify it, which was the 
most reliable way to obtain a stable protein concentration leading to a 
controlled mrNa degradation rate (fig. 3.7).
Figure 3.6: Qualitative effect of MazF-(His)6 production on mRNA degradation. 
Co-expression of T7-mazF (-)(his)6 (0.5 nM) and pRSET-egfp (1 nM) templates 
leads to a decrease of fluorescence level. Expression can be rescued by the co-
expression of T7-mazE template. Final fluorescence values were normalised on 
the control value (pRSET-egfp 1 nM) after 4 h. n=1.
114
Chapter 3
Figure 3.7: Scheme of the MazF production and purification method, followed by activity 
tests on a model substrate and in IVTT reaction
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Because the t7rNap protein normally used for expression was also 
fused with a polyhistidine purification tag, we used a lysate that was 
obtained from a Bl21 De3 E. coli strain containing a gene coding 
for an untagged version of t7rNap. This lysate allowed us to per-
form IVtt reaction without co-purifying t7rNap and mazf. The 
efficiency of the IVtt reaction was checked by supplementing pr-
Set-egfp (1 nm) template to a sample isolated from the main IVtt 
mix. This allowed us to monitor the activity of the IVtt reaction 
producing mazf-(his)6.
an SDS-paGe was performed in order to rapidly check if the puri-
fied protein had a correct mass and to eventually estimate its concen-
tration. We used Coomassie blue staining to reveal the protein. The 
paGe showed a very faint migration band close to the 15kDa band 
from the migration ladder. This was consistent with the mass of mazf 
(12kDa). however, the weak intensity of the band with Coomassie 
staining did not allow us to estimate the concentration of the purified 
protein, nor to obtain a picture of the band.
In order to verify that the enzyme was active towards mrNa degra-
dation, the purified protein, presumably mazf-(his)6, was added to 
a mixture containing IVtt feeding buffer and a 28 bases-long linear 
rNa substrate. This rNa substrate had one aCa site in position 4, 
so a cleavage by mazf would result in the production of 24 and 4 
bases-long nucleotides. The substrate was incubated in three different 
conditions: without enzyme, with rNase a (~100 µg/ml) or with the 
purified mazf. The first condition (fig. 3.8a) was used as a negative 
control to estimate background hydrolysis. The second condition was 
used to show that the buffer used for incubation was compatible with 
the hydrolysis of the substrate, so a general purpose nuclease should 
be active. The last condition was to check qualitatively that the protein 
we purified had a specific effect on the single strand rNa cleavage. 
The first condition led to a weak but observable degradation of the 
substrate, although the substrate band was still observable after 2 h 
of incubation. In the rNase a control, the substrate was completely 
digested even at time t0, showing that the buffer conditions we used 
were compatible with rNa degradation.  The third condition led to 
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the appearance of two products over time and to the complete disap-
pearance of the substrate. although we did not have any rNa lad-
der matching such small molecules, their relative masses were differ-
ent and both lower than the mass of the substrate. Surprisingly, one 
product obtained after incubation with mazf matches the mass of the 
product obtained with the control condition. This indicates a slight 
contamination of the control by the mazf protein, or a contaminant 
common to both conditions. 
We conclude that the isolated protein matched the expected charac-
teristics of mazf protein in terms of mass and specific activity. 
We checked whether the mazf protein we isolated was also capable 
of degrading mrNa in IVtt reactions. Our objective was to reach 
Figure 3.8: Purified MazF decreases eGFP production by cleavage of mRNA. A model 
substrate with one ACA site was incubated with feeding buffer, RNAse A or purified 
MazF (a). Samples were taken after the incubation started (t0), and after 1 and 2 hours. 
Samples were analysed on a 20% polyacrylamide denaturing gel in presence of 8M urea. 
A series of expressions was performed using a range of MazF concentrations (b). Final 
fluorescence values obtained after 11 h of reaction are presented in b, normalised to the 
value obtained with no MazF added. (n=1)
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an activity that could effectively decrease the amount of protein be-
ing produced. We coupled egfp expression to increasing amounts of 
purified mazf toxin. results show that addition of mazf consider-
ably decreased the production rate of eGfp, with a maximum drop 
of 60% for 10 µl added (fig. 3.8b). Our method therefore allows a 
significant increase in mrNa degradation rate. These results are in 
accordance with the results obtained by Shin et al. [11]. It is sur-
prising that a saturation of enzyme activity was reached with 5 µl, 
as the addition of 10 µl mazf did not lead to a complete quenching 
of eGfp production. One major difference between our experiment 
and the experiment performed by Shin et al. lies in the transcrip-
tion reaction. While Shin et al. use the endogenous polymerase for 
transcription, our reaction is based on transcription by t7rNap. 
although the endogenous polymerase is less active than the t7r-
Nap, the strong coupling between transcription and translation us-
ing only bacterial proteins leads to a high yield of translated protein 
per transcribed mrNa. This coupling might maintain a large part 
of the mrNa population in an unfolded form as the ribosomes re-
main bound to mrNa for several cycles of translation. On the other 
hand the coupling between t7 transcription and bacterial transla-
tion is poor. It is compensated by the production of large amounts 
of mrNa. This mrNa is however not often translated and has a 
higher chance of folding, which makes it less sensitive to degrada-
tion by mazf.
In conclusion, we demonstrated a method to rapidly produce and pu-
rify mazf toxin. although further improvements would certainly be 
needed, we considered that these results were sufficient to validate 
our rapid method of mazf production using IVtt and the linear 
coding template. addition of purified mazf to an IVtt reaction al-
lowed the coarse tuning of mrNa degradation rate, which resulted 
in a maximum 60% decrease of eGfp production. These results are 
comparable to those obtained by Shin et al., although their method 
yielded a complete degradation of the mrNa. We hypothesise that 
the difference between the two methods mainly originates from the 
high coupling between transcription and translation found in σ70-
based IVtt system used by Shin et al.
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3.2.2 Protein degradation
ClpXP bacterial expression and purification
Shin et al. presented a method to degrade proteins marked with a spe-
cific degradation tag using an alternative proteolytic complex called 
ClpXp [11]. In contrast to the approach used with mazf, Shin et al. 
did not propose a method to control the protein degradation rate. 
Their degradation method relied on the ssra-tagging of proteins in 
combination with the endogenous ClpXp activity present in the ly-
sate. Our objective was to tune the ClpXp activity so the production 
`of tagged protein would strongly decrease and allow a higher turn-
over. as for mazf, we purified ClpX-(his)6 and Clpp-(his)6 in order 
to maintain a constant degradation rate. a few ClpX and Clpp purifi-
cation protocols have been described in the literature. One challenge 
of the purification was the uncertainty concerning the compatibility 
between the purified enzymes, their storage buffer, and the IVtt re-
action. Some traditional ingredients of the storage buffer, especially 
glycerol, were poorly compatible with the IVtt reaction.
While maintaining the proteins at low temperature is a requirement 
for avoiding their denaturation, formation of ice crystals also has a 
critical effect on protein structure. Glycerol is a molecule broadly 
used in protein biochemistry for its role as cryoprotectant. The chal-
lenge was therefore to find a reliable protocol for protein purification, 
identify ingredients incompatible with the IVtt reaction and replace 
or remove them without influencing the activity of the enzymes. 
Our protocol mostly followed the purification protocol from [26], 
although glycerol was removed from the buffers because of its inhib-
itory effect on the IVtt reaction. to compensate for the absence of 
glycerol, we proposed a method based on the flash-freezing of small 
aliquots of ClpX and Clpp in liquid nitrogen.
ClpX-(his)6 and Clpp-(his)6 proteins were purified after overexpres-
sion in E.coli ros2 and E.coli Bl21. Overexpression and purification 
were successful, although some precipitation of ClpX-(his)6 was ob-
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served after dialysis in the storage buffer. a second purification was 
performed and did not lead to precipitation of ClpX-(his)6. 
purified fractions obtained after overnight dialysis were analysed by 
SDS-paGe (fig.3.9). The ClpX purified fraction shows a major puri-
fication product with a molecular mass between 35 and 55 kDa. The 
Clpp fraction shows a single band with a molecular mass around 25 
kDa. 
ClpX has an expected mass of 46 kDa, which matches the electro-
phoretic pattern. Nevertheless, the gel indicates presence of unidenti-
fied contaminants in the purified protein fraction. Contaminants are, 
however, in clear minority.
Clpp has an expected mass of 23 kDa, which strongly indicate a match 
with the band observed in the purified protein fraction. 
Both purifications yielded a final concentration estimated around 
2 mg/ml. We conclude that both ClpX and Clpp have been purified 
at a satisfactory grade
Figure 3.9: SDS-PAGE of ClpX and ClpP purified fractions
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Next, we tested the activity of ClpX and Clpp proteins by adding them 
to a reaction expressing eGfp-ssra, a version of eGfp tagged for deg-
radation. prSet-egfp-ssra was used at a concentration of 1 nm. 
results show that the storage buffer used for the protein purification 
has a positive effect on prSet-egfp-ssra expression, leading to an 
increased production (150%) compared to the reference (fig. 3.10). 
addition of 5 µm ClpX-(his)6 protein alone (in 5 µl storage buffer), 
along with another 5 µl of storage buffer has no effect on the refer-
ence level of eGfp-ssra, although the positive effect of the buffer is 
no longer observed. addition of 5 µm Clpp-(his)6 protein alone (in 5 
µl storage buffer) along with 5 µl of storage buffer led to a decreased 
production of eGfp-ssra, with a production drop of 50% in compari-
son to the reference. The drop was 70% in comparison to the reaction 
with 10 µl storage buffer. 
The addition of both ClpX and Clpp proteins (5 µm each) only had 
a limited effect on the production of eGfp-ssra, with a drop of 30% 
compared to the reference and 60% compared to the reaction with 10 
µl of storage buffer. 
We explain the effect of the storage buffer on eGfp-ssra production 
by the presence in the buffer of salts (NaCl), Dtt and tris that can 
positively impact the cell-free expression. The purified ClpX-(his)6 
has only a limited effect on eGfp-ssra production on its own, which 
we explain by a poorly active purified enzyme. On the other hand, 
result shows that the purified Clpp-(his)6 subunit displays an enzy-
matic activity leading to eGfp-ssra degradation. Clpp only degrades 
protein substrate that has been recognised and unfolded by ClpX. The 
latter observation implies that the lysate either contains some ClpX 
that is not yet associated with Clpp. alternatively, the purified Clpp 
replaces other, less active, Clpp molecules that are present in the ly-
sate. Nevertheless, the combination of both purified proteins has less 
impact than the addition of Clpp alone. We explain this result by the 
addition of poorly active ClpX-(his)6  molecules, which decreases 
the concentration of active ClpX molecules and associate with active 
Clpp-(his)6.
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We did not attempt to reproduce these results because they already 
indicated that ClpX-(his)6 and Clpp-(his)6 had an activity that was 
too limited to reach our objective. The tuning of the degradation rates 
in the reaction was not achievable, even not at a very coarse level, as 
the maximum volume available for tuning the reaction was already 
reached. Increasing ClpXp concentration could not be achieved with-
out diluting the IVtt reaction and decreasing its efficiency. Optimi-
sation of the purification protocol was necessary, but expression and 
purification of ClpX-(his)6 and Clpp-(his)6 were too time-consum-
ing, and will be considered in future research. 
In conclusion, complete degradation of eGfp-ssra was not achieved. 
Our attempt to adapt a purification protocol and make it compatible 
with the IVtt reaction was not successful, although the purified ClpX 
and Clpp show signs of activity. Some ingredients such as glycerol 
might play an important role in the preservation of enzymatic activity, 
and future work should involve the optimisation of the storage buffer.
Figure 3.10: Activity test of purified ClpX and ClpP. A reaction producing eGFP-
ssrA (black bar) was supplemented with 10  µL of storage buffer (red bar), a 
mixture of 5 µL ClpX in storage buffer with 5 µL storage buffer (blue bar), a 
mixture of 5 µL ClpP in storage buffer with 5 µL storage buffer (yellow bar), or a 
mixture of ClpX and ClpP (5 µL each, green bar). Bars indicate the fluorescence 
value at the end of the experiment. (n=1)
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While exploring other possibilities concerning the tuning of pro-
tein degradation, we learned from conversations with Dr. Christo-
phe Danelon (tU Delft) and Dr. henrike Niederholtmeyer (UCSD) 
that ClpXp complex required large quantities of atp to be active or 
maintain its quaternary structure. however, addition of extra atp 
(2 mm instead of 1 mm) did not increase the degradation rate (data 
not shown). finally Dr. Vincent Noireaux (University of minneso-
ta) suggested that the ClpXp complex could be strongly sensitive 
to a decrease of atp hydrolysis gradient which results from the ac-
cumulation of aDp and amp. Unpublished work of Dr Zachary Z 
Sun (Synvitrobio, Inc) from 2014 mentions the instability of purified 
(his)6-ClpX. Sun reports that inactive (his)6-ClpX could be replaced 
by a large protein consisting of a linked hexameric form of ClpX. ad-
dition of purified SspB could in theory decrease the Km of degrada-
tion. We learned in a conversation with Dr. Danelon that SspB did not 
have the expected drastic effect on protein degradation.
One alternative method to ClpXp purification was proposed by Nie-
derholtmeyer et al. [2]. The authors were able to change the protein 
degradation rate by expressing the ClpXp complex in situ in an IVtt 
flow reactor. although the dynamic state of their system was not in-
sured by the use of ClpXp, they demonstrated that efficient ClpX and 
Clpp could be produced in parallel to other proteins. This method 
could eventually be used to tune protein degradation rate.
In situ expression of ClpX-SsrA and ClpP-SsrA provides a 
tuning of eGFP-SsrA degradation
ClpXp complex and ClpX in particular exhibited stability issues. We 
hypothesised that a constant expression of ClpX and Clpp from a sta-
ble genetic template should yield a stable concentration of protease 
complex over time. Our objective was to reproduce results from Nie-
derholtemeyer et al. by producing ClpXp complex in situ and tune 
eGfp degradation rate. Our aim was to coarsely tune the protein deg-
radation rate and eventually find a plasmid concentration that would 
allow the complete degradation of the eGfp-ssra readout. In order 
to insure a better control over ClpXp activity, we decided to insert 
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Figure 3.11: Topology of the ClpXP-ssrA expression system for regulating the protein 
degradation.
the clpX and clpp genes in an expression plasmid based on t7rNap 
transcription and lacI repression. furthermore, we hypothesised that 
we could implement a negative feedback by adding an ssra tag at the 
C-terminus of ClpX and Clpp proteins (fig. 3.11). This negative feed-
back could be used to let the ClpXp complex enzymatically regulate 
its own concentration.
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Figure 3.12: In situ production of ClpX-ssrA and ClpP-ssrA decreases eGFP-ssrA concentration. 
(a) (b) and (c) A series of pRSET-egfp-ssra expressions was performed using a concentration 
range of clpX-ssra and clpP-ssra gene template (stoichiometric ratio). The series was performed 
three times using different lysates. (b) Reaction was supplemented with 440nM IPTG
Standard prSet-egfp-ssra template (1 nm) was used as a reference 
expression. We performed a series of experiments using a range of con-
centration placO-t7-lacO-clpX-ssra and placO-t7-lacO-clpp-ss-
ra templates, first at 10, 50,100, 250, 500 and 1000 pm (fig. 3.12 a), 
and later reproduced at 10, 100, 250 and 500 pm (fig. 3.12 b and c). 
plasmids were kept at a stoichiometric ratio. This experiment was re-
peated three times, using three different batches of lysate. The exper-
iment presented in figure 3.11b was performed in presence of IptG 
(440 nm). The three lysates were produced using same protocol, al-
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though the medium used for bacterial growth of the lysate used in 
(a) was supplemented with maltose according to Caschera et al. [27]. 
results consistently showed that a concentration as small as 10 pm 
of each template led to a decrease of the eGfp-ssra production level 
(from 20% to 65% less eGfp-ssra produced compared to the control). 
at such a low concentration, resource competition between the pro-
ductions of different kinds of proteins can be excluded. This means 
that the clpX and clpp templates produce proteins that strongly influ-
ence the eGfp-ssra degradation rate. Ultimately, reaction coupled to 
500 pm of both templates lead to a very large decrease of eGfp-ssra 
level (from 85% lower, to complete degradation).
as our experiments were performed at different times, we had to use 
three different lysates. however, results indicate that the presence of 
IptG has a strong impact on the decrease in eGfp-ssra production. 
for further research, this experiment would be interesting to repro-
duce in order to better establish the influence of IptG on ClpXp ex-
pression levels and their impact on eGfp-ssra degradation.
although the in situ expression of the protease complex was a very 
efficient way of tuning the protease activity, it was not clear whether 
the degradation rate was constant. to get more information on the ac-
tivity of ClpXp-ssra, we decoupled the production of eGfp-ssra and 
ClpXp-ssra. The eGfp-ssra was pre-expressed to serve as substrate 
for ClpXp. The ClpXp-ssra complex was expressed and aliquots of 
the reaction were mixed with the eGfp-ssra substrate
Measuring the protease activity generated by the pT7-
LacO-clpXP-ssrA template
a batch of fresh eGfp-ssra substrate was produced using IVtt. 
When the fluorescence reached a plateau, a second IVtt reaction, 
producing ClpX-ssra and Clpp-ssra was started. The placO-t7-la-
cO-clpX-ssra and placO-t7-lacO-clpp-ssra plasmids were supple-
mented at the same concentration (250 pm) to the IVtt mixture and 
samples were periodically taken from the expression mixture. These 
samples were then mixed with eGfp-ssra already produced with 
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IVtt. fluorescence from eGfp-ssra was subsequently monitored for 
10 min in order to determine the protease activity of the ClpXp-ssra. 
The protocol for measuring ClpXp-ssra activity over time is shown 
in figure 3.13
The experiment was carried out in duplo and results are shown in 
figure 3.14. experiment 1 is represented by the blue curve and exper-
iment 2 by the red curve. for experiment 1, values were normalised 
on the value obtained after 1.25 h. for experiment 2, values were nor-
malised on the value obtained after 1.15 h. These two values corre-
sponded to local maxima obtained after the first increase in activity. 
The initial activity, originating from residual ClpXp in the cell lysate, 
was measured at t0 and values that did not consistently exceed the 
initial activity were marked by a red cross.
results show that in experiment 1, the activity raised after an incuba-
tion time of 0.75 h. activity reached a maximum at 1.25 h and rapidly 
decreased. after 1.5 h, activity remained stable around 0.5 for the rest 
Figure 3.13: Protocol used for measuring ClpXP-ssrA activity over time.
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of the experiment. In experiment 2, incubation time was estimated at 
0.5 h. activity rapidly increased and reached a local maximum after 
1 h. activity remained stable for 0.4 h and rapidly decreased to reach 
0.3 after 1.5 h. another peak of activity was reached after 1.9 h followed 
by another decrease at 2.2 h. The experiment was stopped because the 
mixture expressing ClpXp had been exhausted. In absence of regula-
tion, we expect the ClpXp activity to increase and stabilise at a plateau 
value when the expression is complete. This kind of expression profile 
is, for example, the one followed during eGfp production. Our results 
show that the protease activity raises and decreases in both experi-
ments, which is an indication of potential regulation. It is impossible to 
conclude whether the presence of the ssra tag allows the ClpXp com-
plex to regulate its own concentration and if this system could be used 
for reliable tuning of protease activity. further testing of the ClpXp-ssra 
system should be performed, ideally in a flow reactor, in order to de-
scribe the behaviour of the system at a steady state. 
Figure 3.14: Monitoring of the ClpXP-ssrA activity over time of expression. 
Experiment was carried out in duplo. Activity of experiment 1 is presented in 
blue circles, and activity of experiment 2 in red circles. 
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In conclusion, we showed the different approaches we used for tun-
ing protein degradation rates. Due the low stability of the molecular 
complex, use of purified ClpXp proteins only leads to a limited and 
uneven degradation rate over time. The method could however be 
optimised by a full adaptation of the buffer used for storage of the en-
zymes. This would allow the enzymes involved in gene expression and 
the ClpXp complex to be maintained at their best possible activity. In 
situ expression provided the most efficient method for increasing the 
protein degradation rate. Our method allows the complete quench-
ing of eGfp-ssra production, which has not yet been described in 
the literature. Nevertheless, in situ expression of the ClpXp complex 
could lead to an increase in protein degradation rate over time. We 
therefore designed mechanisms that should provide enzymatic auto-
regulation by ClpXp-ssra. We have strong indications that the feed-
back limits the increase of ClpXp activity. however, this feedback was 
not completely characterised and did not provide a fully controlled 
regulation pattern. While the use of in situ production appears to be a 
good method for tuning protein degradation rate, more efforts in the 
feedback implementation will have to be done.
3.2.3 Cell-free expression using a dialysis 
platform
Cell-free gene expression in microdialysis allows constant 
expression over time
Our system used a pDmS chamber supporting a dialysis tube, the 
same as used by Shin et al. [15] The dialysis membrane sealed the top 
of the reaction chamber. figure 3.15a shows a scheme of our micro-
dialysis platform. The advantage of our platform was that the reaction 
volume used was scaled down from 35 µl to 5 µl. The platform there-
fore required fewer reagents and allowed a higher reaction/feeding 
buffer volume ratio (5 µl/200 µl, or 1/40, instead of 1/10 for Shin 
et al.) for an increased reaction time. miniaturisation also allowed 5 
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of the reactors to fit on a microscope glass plate. This allowed us to 
automate the fluorescence measurements. The prototype was later op-
timised by addition of a temperature control unit. a disadvantage of 
this miniaturised system is the absence of a stirrer bar. Thus, homog-
enous distribution of reagents in both the reactor and the feeding buf-
fer could not be guaranteed. however, diffusion of biomolecules in a 
low volume (5 µl) and on a large time scale (several hours) should 
not be limiting. 
Figure 3.15: Miniaturisation of the dialysis system. Scheme of our miniature platform 
(a). The dialysis reaction produces eGFP-SsrA for over 50h, but with a strong standard 
deviation (n=4) (b). For comparison, eGFP-SsrA was produced in batch multiple times 
(n=31) (c). 
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figure 3.15b shows the expression from prSet-egfp (1 nm) repro-
duced 4 times at 30 °C activity of t7rNap used was 1.25 U/µl. re-
sults showed that expression in the microdialysis platform was possi-
ble over 50 hours but a strong variability existed between expressions, 
with a standard deviation of about 1000 a.U. at the end of the exper-
iment. In comparison, production of eGfp-ssra in batch generates 
a standard deviation of about 500 nm after 4 h of expression (figure 
15c, n=31). 
We explain the strong variability in our experiments by the absence 
of stirring in the system and an initial variability in batch that can 
increase over time. furthermore, a strong delay of about 5 h was ob-
served before expression started. This delay was not observed in the 
work of Shin et al. although our fluorescence measurement rate was 
higher, allowing acquisition of fluorescence values before 5 h.
Some notes found on the website of the protein expression and pu-
rification core facility of the emBl also mention a longer incubation 
time and a lack of robustness in dialysed reaction, which is in agree-
ment with our observations.
T7 RNAP range in dialysis
although the dialysis system produced variable results, we performed 
a series of prSet-egfp-ssra expressions using a range of t7 rNap 
concentrations (0, 0.16%, 0.3%, and 1% v/v). Our collaborators frank 
Nelissen and Dr. hans heus (Department of biophysical chemistry, 
Imm, radboud University) provided us with the t7rNap. They per-
formed in vitro transcription reactions in order to estimate the ac-
tivity of the isolated enzyme. Such volumes correspond to t7rNap 
activities estimated at 0, 0.2, 0.38 and 1.25 U/µl respectively. Our aim 
was to determine whether the dialysis system responded to the t7r-
Nap concentration, as was the case in batch mode.
results showed that the system responded linearly to the increase in 
t7rNap, with an increase of about 270 a.U. per % (v/v) of t7 rNap 
(fig. 3.16). This experiment was not reproduced because of time lim-
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itations but it indicated that the reaction was following a similar trend 
in dialysis and in batch reactions (see Chapter 2).
In conclusion, the miniaturised dialysis reactor can be used for long-
term reactions. It allows an extension of the reaction lifetime from 
4-5 h up to 50 h. This extension corresponds to twice the extension 
achieved by Shin et al. We also have strong indications that the eGfp 
production rate can be tuned by changing the t7rNap concentra-
tion. Nevertheless, the variability of the standard prSet-egfp 1 nm 
expression levels shows that a significant time investment is required 
in order to improve experimental reproducibility. 
Figure 3.16: Range of T7RNPA concentration using the dialysis system. 
eGFP production rate was determined calculating the slope of fluorescence 
increase in the linear regime of expression in dialysis (a). eGFP production rate 
increases linearly with low T7 activity (b). 
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3.2.4 Cell-free gene expression in flow reactor 
flow reactors are, to date, the only platform that led to the success-
ful implementation of in vitro gene oscillators. performing reactions 
in flow became a well-established approach to guarantee the mainte-
nance into a steady state [2-4]. We could use a flow reactor as a refer-
ence for steady state IVtt reactions and rapid testing of new genetic 
designs.
We constructed a flow reactor consisting of a cylindrical chamber of 
62 µl with two inlets. One inlet provided a mixture of feeding buf-
fer and gene templates, the other provided a mixture of lysate and 
t7rNap. Gene templates were kept in the feeding buffer to avoid hy-
drolysis by nucleases present in the lysate. The system was stirred by 
using a magnetic stirring ball of 2 µl. The final reaction volume was 
60 µl. The outlet of the flow reactor was connected to a measurement 
chamber via ±30 cm of tubing, with an inner diameter of 0.3 mm (to-
tal volume 20 µl). The measurement chamber consisted of a pDmS 
circular chamber, with a height of 100 µm, and a diameter of 7 mm, 
bound on a glass cover. fluorescence inside the chamber could be 
measured with a fluorescence microscope. Our flow reactor design is 
shown in figure 3.17 a.
In a flow reactor, a reaction reaching the steady state maintains stable 
concentrations when the production and the dilution rates are in bal-
ance. for example, a reaction produces 100 a.U. of a readout protein 
per hour. The refreshment rate is 100% per hour, which leads to a di-
lution factor of 1 per hour. at t0, the concentration of readout protein 
C0 is 0 a.U. at t1h, C1 is 100/2 (=50 a.U.). at t2h, C2 is (50+100)/2=75. 
C3 is 87.5, C4 is 93.75, C5 is 96.88, C6 is 98.44, and the protein value 
tends to reach 100 a.U. Thus, in absence of feedbacks the fluores-
cence level should increase and stabilise over time. 
We performed expressions from prSet-egfp plasmid (0.5 nm) at a 
flow rate of 60 µl per hour, leading to the refreshment of 100% of the 
reaction per hour. This refreshment rate was one of the rates used by 
Niederholtmeyer et al. for yielding oscillations.
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figure 17 b shows the fluorescence measured in the measurement 
chamber over time.
at a refreshment rate of 100% per hour, the reaction reached the 
steady state after 3 hours and remained stable for 5 hours (average 
fluorescence intensity of 42 a.U.). after 8 h, the reaction started to 
decay. The decay was of 10% an hour.
One possible reason explaining the decay would be an air bubble build-
ing up in the reactor. The reaction volume would change while the flow 
rate would remain the same. however, no air bubble was ever observed 
Figure 3.17: A flow reactor was used to maintain the cell-free gene expression 
in a steady state. Schematic of the PDMS (polydimethylsiloxane) flow reactor 
and PDMS measurement chamber (a). The IVTT reaction was performed at a 
flow rate providing 100% refreshment per hour (b). Red trace represents the 
fluorescence signal from the measurement chamber. (n=3).
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during the experiment. another reason for the reaction decay would be 
some instability of reagents over time at room temperature. In order to 
rule out this possibility, we performed an expression with reagents that 
were replaced every 3 hours. In batch, we can observe that the reaction 
is still active after 3 h. however, the replacement of reagents did not 
provide any significant improvement towards the reaction decay. 
although we could not explain the decay of the protein production, 
we concluded that the reaction was still in a regime close to the steady 
state when using a replacement rate of 100% per hour during a limit-
ed window of 5 to 7 hours. 
The flow reactor could therefore be used for the characterisation of 
new genetic network designs, but on a limited period of time com-
prised between 7 to 10 hours.
for further use of flow reactor, understanding and preventing the de-
cay of the reaction over time would be necessary. 
3.3 Conclusion
In this chapter we described the methods we used to maintain the 
IVtt reaction in a steady state for extended period of time. 
for the tuning of mrNa degradation rate, we proposed a method 
based on the purification and the addition of the mazf toxin as an 
alternative to Shin et al. method. The addition of the mazf protein to 
the IVtt reaction resulted in an increase of mrNa degradation rate 
leading to a drop of more than 50% of eGfp production. 
In order to tune the protein degradation rate, we proposed an original 
method based on the production of ClpXp-Ssra protease complex in 
situ. This allowed the complete degradation of eGfp-Ssra produced 
by the IVtt reaction. although the design of the ClpXp-Ssra sys-
tem should provide a self-regulation by the protease complex, further 
characterisation of the system is required. 
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In order to extend the IVtt reaction lifetime, we developed a minia-
turised version of a dialysis reactor previously described by Shin et al. 
Our miniaturised system allowed a superior reaction lifetime, leading 
to a linear protein production over 50 h, which would be sufficient to 
observe complex genetic patterns multiple times. however, the meth-
od suffered from poor reproducibility.
following the successful methods of Niederholtmeyer et al. [2, 4] 
and Karzbrun et al. [3], we also developed a simple flow reactor that 
supported the tuneable refreshment of the IVtt reaction. We could 
successfully maintain the IVtt reaction in a steady state for up to 10 
hours, which is enough for a rapid characterisation of new genetic 
systems. however, our platform suffered from a variable IVtt re-
action performance, which requires further technical improvements.
The improvement of the reproducibility using the dialysis platform 
will be an important direction of our future work. One key optimisa-
tion should involve the stirring of both the microreactor and the feed-
ing chamber to insure complete homogeneity. Concerning the flow 
reactor, a strong improvement could be reached by miniaturisation, 
which should allow us to perform the fluorescence measurements di-
rectly in the chamber and eventually increase the number of reactions 
that could be run in the same time. 
3.4 Materials and methods
Preparation of the T7-enriched lysate for 
MazF-(His)6 expression
following the optimised protocol described in chapter 2, we pro-
duced a lysate from E. coli Bl21 De3 strain. t7rNap expression was 
not induced but leaky expression was enough to provide a t7rNap 
concentration sufficient for expressing mazf-(his)6 . 
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MazF expression and purification
after three hours of expression, the IVtt mixture was loaded on 
a Ni2+-Nta spin column (Qiagen) and the protein purification was 
performed according to the notice. Note the lysis step was skipped 
since we were already working with cell extract. after elution, the 
protein sample was dialysed against buffer D. Composition of buffer 
D: 10 mm tris ph8, 200 mm KCl, 1 mm Dtt, 0.1 mm eDta
MazF activity test
With purified mrNa substrate model:
at time t0, t1h and t2h, we isolated a sample from every condition for fur-
ther electrophoretic analysis. We prepared a polyacrylamide gel (20% 
aa, 8 m urea) to make the rNa products migrate in non-native condi-
tions (no secondary and tertiary structures). after full migration of the 
reference dye through the gel, we stopped the electrophoresis, soaked 
the gel for 1 h in a Stainsall solution, and let it destain in water over 
night. figure 5 a is a picture of the gel taken after over-night destaining.
With coupling to prSet-egfp expression:
from a master mix containing IVtt mixture and prSet-egfp (1 nm) 
template, we added different volumes of the isolated mazf and mea-
sured the fluorescence of eGfp every 5 minutes (Berthold plate-read-
er, Nunclon flat-black microplate, 96-wells with lid, double-circular 
agitation before each measurement, λexc. 480 nm, λemi. 530 nm, 30°C)
Cloning of ClpX-(His)6 and ClpP-(His)6 into 
Electra expression vectors
electra expression vector pD441-Sr and cloning kit were purchased 
from DNa 2.0. primers used for electra cloning were purchased from 
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IDt DNa according to DNa 2.0 recommendations. Inserts were pre-
pared by pCr. The mass of both pCr products was checked on 0.8% 
agarose gel electrophoresis. pCr products were directly mixed with the 
digestion-ligation reaction mix and incubated for 20 minutes, accord-
ing to DNa 2.0. The digestion-ligation mixture was used for transfor-
mation of E. coli Xl1 blue cells. after 40 minutes of recovery time, cells 
were plated on a petri dish containing lB-agar with kanamycin (50 ug/
ml). after an overnight incubation, 10 colonies of each transforma-
tion were picked and grown in lB-kanamycin. after a Qiagen miniprep 
plasmid extraction, a pCr was used for checking the size of the inserts. 
plasmids containing an insert with the correct size were sequenced.
Expression and purification of ClpX-(His)6 and 
ClpP-(His)6
pD441-Sr is an IptG inducible vector with a t5 promoter. It produc-
es an mrNa with a strong rBS and is found in cells with a high copy 
number.
100 ml of lB-kanamycin were inoculated with e.coli Xl1 blue 
pD441-clpX-his6 or e.coli Xl1 blue pD441-clpp-his6. Initial OD was 
below 0.2.after reaching OD 0.6, cultures were supplemented with 
IptG at a final concentration of 1 mm. 2 h after induction, cells were 
lysed after an incubation of 10 min with lysis buffer followed by a 
sonication. The sonication step consisted in ten cycles of 10 s son-
ication at 15 um, with 10 s break on ice. The lysate was cleared by 
centrifugation at 10000 g during 10 min at 4 degC.
The lysate was loaded on a 5 ml equilibrated Ni-Nta column. after 
two consecutive washing steps using Washing buffer 1 and Washing 
buffer 2, proteins were eluted using elution buffer. eluent was col-
lected in ten 2 ml eppendorf tubes and samples of each tube were 
analysed by paGe (a polyacrylamide gel with concentration ranging 
from 4 to 20% was used). most concentrated fractions were pooled 
and dialysed against storage buffer overnight. Dialysed fractions were 
aliquoted, flash-frozen with liquid nitrogen and stored at -80°C.
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Buffers composition
equilibration buffer: 20 mm tris ph8, 600 mm NaCl, 0.1% triton 
X-100, 5 mm imidazole.
lysis buffer was equilibration buffer supplemented with 1 mm Dtt 
and 5 mg/ml of lysozyme.
Washing buffer 1 was equilibration buffer with 10 mm imidazole.
Washing buffer 2 was equilibration buffer with 50 mm imidazole.
elution buffer was equilibration buffer with 500 mm imidazole.
after the addition of imidazole to the equilibration buffer, ph was 
systematically checked and readjusted to ph8 if necessary.
Storage buffer: 10 mm tris ph8, 200 mm KCl, 1 mm Dtt, 0.1 mm 
eDta.
Construction of pRSET-egfp-ssrA for 
monitoring ClpXP activity
The ssra coding sequence was directly added to the egfp gene in pr-
Set-egfp plasmid by pCr, followed by a digestion by ecorI and an 
intramolecular recombination.
Microdialysis device fabrication and use
a master of a circular chamber (7 mm diameter, 100 µm high) was 
used for the fabrication of the microdialysis reactor. Slide-a-lizer 
500 µl tubes were soaked in milliQ in order to remove the glycer-
ol coating the membrane. Dialysis tubes were then protected by an 
8 mm-diameter disk of aluminium foil (11 µm thick) on the mem-
brane side. The master was left in the bottom of a petri dish. protected 
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dialysis tube was then held tight on the chamber master by using a 
mechanical press. polydimethylsiloxane (pDmS, Sylgard) was mixed 
with curing agent (10:1 mass). The mixture was degassed and poured 
into a layer of approximately 1 cm in height in the petri dish. The 
construction, including the press, was put into an oven at 65°C for 
3 h or more. When the pDmS was completely solid, the press was 
removed and the pDmS block taken from the petri dish. Inlet and 
outlet were pierced with a 1 mm surgical punch. The aluminium foil 
was then cautiously peeled off from the dialysis membrane. a dou-
ble microscope glass slide was cleaned with isopropanol and both the 
clean glass slide and the pDmS device were plasma treated. function-
alised surfaces were then stuck together by applying gentle pressure. 
The dialysis tube contained 200 µl of feeding buffer and was sealed 
using the lid provided by the manufacturer. IVtt mixture was in-
jected using a pipette tip down to the inlet channel until reaching the 
outlet punch. Both inlet and outlet were then covered by a small piece 
of tape. 
for the fabrication of the temperature controlled dialysis devices, a 
brass tube was bent around the devices and connected via hplC con-
nectors to a peristatic pump. polyethyletherketon (peeK) tubes were 
used for connections. The peristatic pump was set at 10 ml/min and 
pumped water from a water bath (lauda) set at 32°C. 32°C were used 
after calibration so the internal temperature of the pDmS, after heat 
loss and transfers, would be 30°C. 
Flow reactor fabrication and use
The flow reactor was made by pouring a degassed mixture of pDmS 
and curing agent (10:1  mass) onto a 62 µl brass cylinder standing 
in the bottom of a petri dish. pDmS would cover entirely the brass 
by 3 mm. after curing (65°C for at least 3 h), the brass was removed 
using tweezers. two inlets were pierced, going horizontally from the 
inside to the outside of the well by using a 1.5 um surgical punch. The 
outlet was pierced at the top of the well, from the inside of the well to 
the outside of the well by using a 0.75 mm surgical punch. 
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after plasma functionalisation of a clean glass slide and of the pDmS 
surfaces, a 2 µl magnetic stirring ball was dropped into the well and 
the glass slide was gently pressed on the pDmS in order to seal the 
well.
Inlets were connected to syringes by 1.6 mm outside diameter tubing. 
Syringes (250 µl and 500 µl hamilton glass syringes, gas tight) were 
filled with lysate and t7rNap or feeding buffer and gene templates 
respectively. Syringes were then mounted on low-pressure nemeSyS 
pumps (Cetoni, Gmbh). The syringes were connected to the inlets 
and the reaction chamber was connected to a measurement cham-
ber by a short tubing of 0.3 mm inner diameter. The measurement 
chamber was mounted on the moving stage of an Olympus Olympus 
IX81 inverted fluorescence microscope, coupled to a mercury lamp 
illumination (100% power, fItC filters) and to an em CCD camera 
(iXon andor). The well was rapidly filled by a mixture of lysate and 
feeding buffer in 1:2 ratio (about 1000 µl/h and 2000 µl/h) and the 
stirring was set to 1000 r.p.m. When the mixture completely filled the 
measurement chamber, flows were set to the experimental value. 
Because we were working with low flow rates, close to the pulseless 
performance of the pumps, we had to determine if pulses of materi-
al could influence the reaction. nemeSyS pumps are controlled by a 
proportional-integral-derivative (pID) controller, which implements 
a feedback in the injection flow rate. The flow rate is continuously re-
ported by the pump-computer interface. We could not observe pulses 
over a period of 1 to 2 seconds, and concluded that such periods of 
pulse would have no influence on the cell-free reaction. 
Measurement chamber fabrication
The measurement chamber was made by pouring a degassed mixture 
of pDmS and curing agent (10:1 mass) into a cylindrical chamber of 
7 mm diameter and 100 um height. The pDmS was cured for at least 
3 h at 65°C. Inlet was pierced with a 0.75 mm surgical punch while 
outlet was pierced with a 1.5 mm surgical punch.
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In this chapter, we present our attempt to build a synthetic 
gene oscillator based on the LacI repressor protein in vitro. A 
self-amplification loop, based on the T7 RNAP-SsrA, showed 
promising results for the implementation of a positive feed-
back. The positive feedback was however weak and not robust. 
The implementation of the negative feedback, based on the 
self-repression by LacI-SsrA, was not successful as signs of re-
pression were poorly reproducible. This chapter is particularly 
relevant for understanding the main challenges of implement-
ing a gene network in vitro. Although the project described in 
this chapter was not successful, the lessons taught while con-
cluding this chapter were particularly useful for further pro-
ceedings. New priorities were for instance given to the rapid 
testing of new modules with well-established activity in vitro.
Chapter 4
Development of a 
genetic oscillator 
based on the LacI 
repressor
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4.1. Introduction
The aim of our project was to design and implement a synthetic gene 
oscillator in vitro. In 2011, when our project started, genetic oscilla-
tors had only been implemented in vivo. hence, our preliminary work 
consisted in identifying the best designs or topologies that would 
constitute ideal starting points for implementing a synthetic gene os-
cillator in vitro.
rules for the design of biochemical oscillators have been described in 
detail by Novak and tyson [1]. Sustained biochemical oscillations are 
all based on a delayed negative feedback occurring in a system main-
tained in a steady-state. In a seminal publication, elowitz and Leibler 
described the design and the implementation of the first synthetic 
gene oscillator in E. coli [2]. Many other topologies of synthetic gene 
oscillators have been reviewed by purcell and co-workers [3]
One design from the group of Jeff hasty seemed to be a particularly 
suitable starting point for in vitro implementation, as it displayed a 
robust oscillatory behaviour and was based on a limited number of 
proteins (LacI and araC), which were both endogenous to E. coli. The 
system entered into an oscillating regime for a longer time than other 
oscillators previously reported. It also allowed oscillations of a broad 
population of cells and displayed a high degree of period tuneability.
This topology inspired the design of in vitro oscillator topologies, 
such as the replication oscillator by Montagne et al. [4].  
4.1.1. Cell-based dual-feedback oscillator
The 2008 hasty oscillator is based on a dual feedback (Fig. 4.1a). This 
dual feedback was based on the work of Lutz and Bujard, who created 
the hybrid operator [5]. The negative feedback relied on the expres-
sion of LacI protein. LacI protein is able to repress its own expression 
by binding to a Lac operator after a step of dimerization. The presence 
of a LacI dimer close to the promoter region creates a steric hindrance 
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preventing the binding of the rNa polymerase. Three versions of the 
Lac operator have been identified: LacO1, LacO2 and LacO3. They 
differ by their sequence, which strongly affects their affinity for the 
LacI dimer [6]. O1 for instance displays dissociation constant lower 
than the nanomolar (~0.2-0.3 nM). In contrast O2 and O3 display a 
much lower affinity for LacI repressor protein, ~3 nM and 110 nM 
respectively  [7]. eventually, the dimerization step is followed by a 
tetramerisation step (dimerization of the LacI dimers). The stability 
of the tetramer is strongly influenced by the motion of the DNa mol-
ecule, and therefore by the distance between the two Lac operators. 
an ideal distance of about 400 base pairs allows the highest stability 
for tetramerisation of LacI proteins. Binding of the tetramer of LacI 
to DNa leads to winding of the DNa on the promoter region, which 
strongly prevents gene expression (Fig. 4.1b). Dimerisation and te-
tramerisation steps also result in an intrinsic delay to the negative 
feedback, which is essential for oscillations. Striker et al. showed that 
isopropylthiogalactoside (Iptg), known for decreasing the affinity of 
LacI for DNa, could be added to the growth medium in order to tune 
the period of the oscillations (Fig. 4.1c). 
The positive feedback was based on the expression of araC protein. 
araC protein forms a dimer which binds cognate sequences (araO2 
and araI1) next to the promoter pBaD. In absence of arabinose, araC 
forms a dimer which prevents the transcription in a similar way to 
LacI (Fig. 4.1d). In presence of arabinose, araC proteins undergo a 
conformational change. The new form of the protein dimer translo-
cates to the araI1-2 positions, which allows transcription. Furthermore, 
the new conformation of araC dimer displays a high affinity for the 
rNa polymerase. The increased affinity for the transcriptional ma-
chinery generates a positive feedback when an araC dimer promotes 
the expression of more araC proteins. 
In the perspective of in vitro implementation, the LacI-araC oscilla-
tor displayed several advantages:
• The oscillating behaviour was robust and consistent inside the 
cell population. This could increase the chances of success in 
case of in vitro implementation.
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Figure 4.1: Original design of LacI/AraC oscillator from Striker et al. (a) 
Schematic of the oscillator. E. coli cells transformed with the oscillator modules 
enter oscillating behaviour. (b) LacI proteins generate a negative feedback by 
preventing the binding of the RNA polymerase. Addition of IPTG promotes the 
dissociation of the LacI protein, allowing transcription. (c) Effect of IPTG on the 
binding of LacI proteins to the operator influences the period of the oscillations. 
(d) AraC proteins also prevent transcription in absence of arabinose, but recruit 
the RNA polymerase in presence of arabinose. (e) Arabinose concentration also 
influences the period of the oscillations.  Adapted from [8] and [9].
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• period of oscillations was tuneable. Importantly, a period as 
low as 13 min-1, which was observed in absence of Iptg, was 
particularly interesting for us as it indicated that oscillatory 
behaviour could be rapidly observed in a timescale compatible 
with Ivtt reaction lifetime.
• a mathematical model reliably described the behaviour of the 
system. Therefore, crucial kinetic parameters could be identi-
fied and adapted with rate constants found in Ivtt systems 
[10-12]
• The system was only based on the expression of two proteins 
from bacterial origin. This was an advantage as only a few 
papers had described multiple protein co-productions using 
bacterial Ivtt system [11-17].
4.1.2. Implementation of the dual-feedback 
oscillator in vitro
We used the LacI-araC oscillator as a starting point for our project. 
Shin et al. showed that the repression by LacI proteins could efficient-
ly regulate gene expression in vitro [11] so we kept the negative feed-
back based on the LacI self-repression. 
The positive feedback, however, was based on increased transcription 
rate by recruitment of the endogenous σ70 rNa polymerase. This con-
stituted a main issue as we had been unable to reproduce the proto-
col of Shin and Noireaux for producing σ70-based Ivtt system (see 
Chapter 2).
Instead, our system could reproducibly express relatively high con-
centration of protein (~3-4 µM egFp-Ssra) (See chapter 2). We had 
also demonstrated that overall expression rate could be tuned by 
changing plasmid and t7 rNap concentration. (See chapter 2 and 
3). We therefore redesigned the LacI-araC gene network so that the 
transcription would be based on the t7 rNap (LacI-t7 rNap). 
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We wanted the positive feedback to be generated by the t7 rNap 
transcribing the t7rnap gene. a starting population of t7 rNap mol-
ecule could therefore amplify by allowing the production of more 
t7rNap molecules (Fig. 4.2).
Concerning mrNa degradation, aCa sites were present over 40 
times in the t7rnap transcript and over 10 times in lacI mrNa, which 
made both t7 rnap and lacI mrNa prone to digestion by MazF ribo-
nuclease. 
The implementation of protein degradation was also a requirement so 
t7rNap and LacI were tagged for enzymatic proteolysis by ClpXp, as 
described in Chapter 3. 
Figure 4.2: Design of the in vitro oscillator based on LacI-SsrA repression and T7RNAP 
transcription
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We designed an expression plasmid pLacO-t7-LacO-gene-ssra that 
should allow the transcription by t7rNap, the repression by LacI and 
the degradation of the target protein by ClpXp complex. For the pro-
moter-operator sequence, we followed the canonical hybrid sequence 
developed by Studier and co-workers and broadly used in expression 
systems such as pet vectors (blue for t7 promoter, red for Lac op-
erator) [18]. For the post-operator sequence (green), which includes 
the ribosome binding site coding sequence and spacing sequence, we 
kept the sequence of the prSet-5d expression vector, with a minor 
difference allowing the replacement of NcoI restriction site by NdeI 
restriction site. prSet-5d vector allowed good expression levels in 
vitro and was also in agreement with template design guidelines es-
tablished by Mansy and co-workers [19]. Sequences were as follows:
prSet-5d (promoter region): 
TAATACGACTCACTATAGGGagaCCaCaaCggtttC-
CCtCtaGAAATAATTTTGTTTAACTTTAAGAAGGAGA-
TATACCatgg 
   (NcoI)
pet-28 (+) (promoter region): 
TAATACGACTCACTATAGGGGAATTGTGAGCGGATAA-
CAATTCCCCtCtagaaataattttgtttaaCt
LacO-t7-LacO (promoter region): 
TAATACGACTCACTATAGGGGAATTGTGAGCGGATAA-
CAATTCCCCtgggaGAAATAATTTTGTTTAACTTTAAGAAG-
GAGATATACatatg 
     (NdeI)
In addition, a first Lac operator LacO1 was placed at a distance of 
400bp upstream from the promoter region (not shown). 
The coding sequence of each gene displayed the ssra coding sequence at 
the 3’ end in order to allow degradation by the ClpXp protease complex. 
Spacer and tag sequences corresponded to the sequences used by Strick-
er et al. [8]. The same expression plasmid was used for the successful 
production of ClpX-Ssra and Clpp-Ssra described in Chapter 3. 
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In this chapter our two main goals are:
• to characterise individual building blocks. establish the ex-
istence of feedbacks and the influence of relevant parameters 
such as plasmid, t7 rNap and Iptg concentration for both 
positive and negative feedback modules.
• to combine modules and study the system in batch and in mi-
crodialysis reactor (see Chapter 3) in order to generate genetic 
oscillations in vitro.
In a first section, we will discuss our results concerning the imple-
mentation of the t7 rNap-based positive feedback. Then we will 
give an overview of our attempt to implement a negative feedback 
based on the self-repression by LacI proteins. Finally, in an attempt 
to implement a gene oscillator, we will discuss the combination of 
both positive and negative feedback modules in both batch and dial-
ysis-fed reactions.
In order to simplify the reading, pt7 will refer to pLacO-t7-LacO-t7r-
nap-ssra, and placI will refer to pLacO-t7-LacO-lacI-ssra for the rest 
of the document.
4.2. Results and discussion
4.2.1. The T7 RNAP positive feedback
We hypothesised that the combination of an initial t7 rNap concen-
tration with the pt7 plasmid could generate an increase in t7 rNap 
concentration. We tested our hypothesis by supplementing it to a 
reference reaction producing egFp via expression from prSet-egfp 
template.
The positive feedback should lead to a clear and robust increase in 
egFp production. Ideally, transcriptional activity of the system 
151
DeveLOpMeNt OF a geNetIC OSCILLatOr BaSeD ON the LaCI repreSSOr
should mainly rely on the t7 rNap-Ssra produced from the pt7 
plasmid (Fig. 4.3). For this reason, observing a few folds increase in 
egFp production rate would be a significant sign of positive feedback
4.2.1.1. Determining the optimal initial T7RNAP 
concentration
In order to obtain the best performance from the positive feedback, it 
was crucial that the system would not be saturated with the starting 
t7rNap concentration. We had already performed a series of ex-
pressions with a range of initial t7 rNap concentrations (see Chap-
ter 2), in order to determine which concentration was not saturating 
the system. We wanted to determine which initial t7rNap concen-
tration allowed the strongest positive feedback. We performed the 
same series of expressions with a range of initial t7rNap concen-
tration (0, 0.2, 0.4, 0.8, 1, 1.8, 2.4, 3 % v/v) in presence or in absence 
of the pt7 template (1 nM). The prSet-egfp plasmid was used at a 
concentration of 1 nM. We did not use initial t7 activity higher than 
3% (~3.75 U/µL) because the t7 rNa polymerase was kept in a buf-
Figure 4.3: Topology of the positive feedback loop in interaction with the T7-
egfp template
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Figure 4.4: Schematic of the experiment performed in order to characterise the 
influence of the initial T7RNAP concentration on the positive feedback. A series 
of IVTT reactions is performed in presence or in absence of positive feedback 
module at different T7RNAP concentrations. Slopes of eGFP productions are 
measured in order to determine which T7RNAP concentration allows the best 
positive feedback performance.
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fer containing 50% m/v of glycerol, which is a molecule toxic for the 
Ivtt reaction We calculated the rate of egFp expression in the linear 
phase and compared the production rate in absence or in presence of 
the positive feedback module (Fig. 4.4). The Ivtt reaction was sup-
plemented with 2 mM Iptg in order to negate repression effects due 
to potential residual LacI protein in the cell lysate.
Figure 4.5 shows the rates of egFp production in absence (black bars) 
or presence (cyan bars) of the positive feedback module. We can ob-
serve that an initial t7 rNap concentration between 1% v/v (~1.25 
U/µL) and 3% (~3.75 U/µL) generates a positive feedback, but the 
effect is negligible. however, results indicate that the reaction is sen-
sitive to the presence of extra t7 rNap. We reason that pt7 did not 
Figure 4.5: Influence of the initial T7RNAP concentration on the positive 
feedback strength. A series of expressions was performed using a range of T7 
RNAP concentrations (0, 0.2, 0.4, 0.8, 1, 1.8, 2.4, 3%). For each concentration, 
the fluorescence of the reaction was monitored in absence or in presence of 
the positive feedback module pt7 (1 nM). The expression rates of eGFP were 
calculated from the linear phase of eGFP production. n=1.
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generate a positive feedback because the concentration of t7rNap 
produced in situ did not reach a concentration important enough to 
increase transcription rate, in contrast with the t7 rNap added in a 
purified form. In agreement with observations from Karzbrun and 
co-workers [10], we had previously established that DNa template 
concentration could strongly impact transcription rate (see Chapter 2 
and 3). We hypothesise that pt7 concentration could be a limiting fac-
tor for generating a positive feedback. hence, we decided to evaluate 
the impact of pt7 concentration on an eventual positive feedback. We 
did not replicate this experiment.
4.2.1.2. Determining the best pt7 plasmid concentration
In order to check whether the positive feedback could be improved 
by increasing DNa template concentration, we performed a series of 
expressions at different pt7 concentrations (0, 0.02, 0.2, 2 nM), cou-
pled with expression of prSet-egfp. In comparison to previous ex-
periments, prSet-egfp concentration was increased (3 nM instead 
of 1 nM) in order to allow an improved sensitivity to additional t7 
rNap that could be produced in situ. The reaction with no pt7 added 
(0 nM) was performed in duplo and used as a reference. 
The addition of 0.02 nM of pt7 plasmid increased egFp production 
by 60% (Fig. 4.6). The addition of 0.2 nM of pt7 plasmid did not have 
significant additional effect and led to an increase of egFp produc-
tion of 70%. The addition of 2 nM of positive feedback module led 
to an increase of 150% in egFp production. however, the increase 
of two orders of magnitude in pt7 plasmid concentration only led to 
an increase of 150% in egFp production, which we cannot explain at 
present. Saturation of the prSet plasmid might be a factor, although 
we previously verified that the initial t7 rNap concentration used 
(1% or 1.25 U/µL) was not saturating. The prSet-egfp plasmid con-
centration had already been increased in order to not be saturated by 
the extra t7 rNap. experiment was not replicated.
We explain the limited impact of the pt7 plasmid on egFp produc-
tion by the limited coupling between transcription by t7 rNap and 
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bacterial translation. This results in the exhaustion of resources and 
a saturation of the translational machinery without leading to a sig-
nificant increase in egFp production rate (resource burden described 
in Chapter 1). Comparable resource burden was observed in cell-free 
expression systems by Siegal-gaskins et al. [20]. 
alternatively, we explain the low impact of pt7 on egFp production 
by the presence of LacI in the cell extract. endogenous LacI proteins 
are found at about 10 molecules per e. coli cell, which represents a 
concentration of approximately 10 nM [21]. given the very high af-
finity found in vitro between LacI and the LacO1 used in our design 
(~12.3 pM) [22], we hypothesised that even low levels of residual LacI 
could negatively impact pt7 expression.
4.2.1.3. Influence of the IPTG
Isopropylthiogalactoside (Iptg) is a synthetic molecule that binds 
LacI repressor. It induces a conformational change of the protein and 
Figure 4.6: Influence of pt7 concentration on the positive feedback. n=1, except 
for (0 nM, n=2).
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suppresses the ability of LacI to bind the operator. The dissociation 
constant between Iptg and LacI has been estimated between 2 and 
7 µM [22-24]. The full inactivation of LacI in vitro was obtained by 
using 660 µM of Iptg [22], so we decided to perform a series of pt7 
(200 pM) coupled to the expression of prSet-egfp (1 nM) and Iptg 
concentrations ranging from 0 to 667 µM.
addition of Iptg had no positive influence on the positive feedback 
(Fig. 4.7). In contrast, the amplification was observed in absence of 
Iptg, while Iptg concentrations ranging from 50 µM to 250 µM had 
no significant impact on egFp level. Strikingly, the maximum Iptg 
concentration used (667 µM) even led to a lower egFp production. 
These results indicate that endogenous LacI repressor is not present 
in amounts that are significant enough to prevent pt7 to express. 
Figure 4.7: Influence of IPTG on pt7 expression. Bars represent normalised eGFP 
levels after 5 h expression (normalisation was done on pRSET-egfp level). n=1.
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In conclusion to this section, we were able to generate a positive feed-
back from the pt7 construct. The positive feedback was generated 
from a genetic template concentration as low as 20 pM. however, the 
impact of the positive feedback on the egFp production was limited 
and far from our initial objective. The optimisation work for increas-
ing the impact of the positive feedback only led to a limited improve-
ment. an increase in pt7 template concentration only partially in-
creased the strength of the positive feedback. 
at comparable concentration, the pclpX and pclpp led to an almost 
complete quenching of egFp-Ssra production, although the enzy-
matic activities are not completely comparable. More efforts would be 
required to improve the efficiency and the robustness of the positive 
feedback.
although pt7 had a limited impact on egFp production, which sug-
gested a defect in design of the positive feedback, previous results 
obtained with pclpx and pclpp encouraged us to further explore the 
generation of negative feedback based on LacI production
4.2.2. The LacI negative feedback
Our objective was to generate a negative feedback by producing La-
cI-Ssra. We wanted to characterise the negative feedback loop and use 
it to produce oscillations. In order to check the activity of the negative 
feedback, we decided to produce the pLacO-t7-egfp-ssra construct. 
This construct should allow the expression of an egFp readout cou-
pled to both the LacI-Ssra and the t7 rNap-Ssra concentrations. 
Unfortunately, our attempts to clone the egfp gene into the pLa-
cO-t7-LacO vector were unsuccessful. It was however crucial for 
us to obtain a readout which would be sensitive to the expression 
of the lacI gene. For this reason, we designed a molecular beacon to 
monitor the transcriptional activity of the placI plasmid. however, as 
explained in Chapter 2, this molecular beacon did not lead to a re-
producible detection of laci mrNa. For this reason, we attempted to 
158
Chapter 4
characterise the LacI-based negative feedback by associating the placi 
module to pt7 and prSet-egfp modules.
4.2.2.1. Coupling the expression of pRSET-egfp to the 
positive feedback module and to the negative 
feedback module
We coupled the expression of prSet-egfp with the positive and the 
negative feedback modules. Note the expression prSet-egfp plasmid 
is not sensitive to repression by LacI protein.
We performed a series of expressions with the regulation modules 
(placI and/or pt7 plasmids) at a concentration of 200 pM while the 
prSet-egfp plasmid was kept at a high concentration (3 nM).  This 
high concentration should allow strong changes in egFp production 
rate if the regulator modules produced strong t7rNap concentra-
tion changes.
The pt7 plasmid provided a 20% increase in expression rate in com-
parison to the standard prSet-egfp expression alone (Fig. 4.8 a). The 
addition of 200 pM of placI did not lead to any significant change in 
egFp production rate, while the combination of placI and pt7 (both 
200 pM) cancelled the effect of the positive feedback (decrease of 4% 
in comparison to prSet-egfp alone). 
a similar experiment was performed using a lower concentration of 
regulating modules (20 pM). Our aim was to check if the impact of 
the placI module on the positive feedback was reproducible at 20 pM, 
which was the lowest concentration we could use to obtain a positive 
feedback.
as observed for 200 pM, the pt7 increases the production rate of 
egFp by 20% (Fig. 4.8b). The addition of 20 pM pt7-LacO-lacI-ssra 
to prSet-egfp alone led to a drop of egFp production rate of 30%. 
The addition of both positive and negative feedback modules led to 
an increase of 15% in egFp production, which was comparable to the 
effect generated by the pt7 plasmid alone. 
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prSet-egfp expression is not directly sensitive to the LacI protein. 
Therefore, the drop observed in presence of placI indicates a deple-
tion of the Ivtt reaction resources. also, the effect of the positive 
feedback was low (+20%) in comparison with the effect observed at 
similar plasmid concentrations (+60% and +70% with prSet-egfp 
3 nM combined with pt7 at 20 or 200 pM respectively). This indicates 
that the system was only weakly sensitive to changes in t7 rNap 
concentration. This can be explained by the lack of robustness of the 
pt7-based positive feedback due to reasons previously discussed 
in section 4.2.1 (resource burden and decoupling between extra t7 
rNap and egFp production .
Figure 4.8: Coupling the placI with pt7 and pRSET-egfp expression. (a) Topology of the gene 
network. In batch, the positive and negative feedback modules are used at a concentration 
of 200 pM (b) (n=1) or 20 pM (c) (n=1). 
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We cannot draw conclusions concerning the generation of a negative 
feedback because of the potential resource limitations in batch mode. 
In order to circumvent the problem of resource depletion, we pro-
posed to test the placI module by using the microdialysis platform.
4.2.2.2. Oscillator modules in dialysed semi-open reactor
We developed the dialysis platform described in Chapter 3 in order 
to sustain reactions that were consuming large amount of substrates. 
Such reactions were transcription, translation, and enzymatic protein 
degradation by ClpXp. Using the dialysis platform would allow us to 
perform long-term gene expression and provide a constant rate of 
protein degradation. We hypothesised that Iptg could have an influ-
ence on the expression of placI and pt7 by decreasing the intensity of 
the negative feedback (Fig. 4.9).
Figure 4.9: Topology of the system used in dialysis. We hypothesise that the presence of IPTG 
should only allow the positive feedback to be effective
We coupled the expression of placI plasmid with the expression of pt7 
and prSet-egfp-ssra plasmids. One reaction was supplemented with 
1 mM of Iptg, which was expected to provide a strong deactivation 
of the repressor proteins. The other reaction was performed without 
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Iptg. We did not observe any robust effect of Iptg on egFp produc-
tion levels (Fig. 4.10).
The reactions had an irreproducible behaviour that we explain by the 
strong variability generated in the dialysis platform (see chapter 3). 
Figure 4.10: Influence of IPTG on coupled expressions of placI, pt7 and pRSET-
egfp-ssra in microdialysis system (n=3). The red and black shades represent 
standard deviations of fluorescence signals obtained from the reaction with 
1 mM IPTG or no IPTG respectively.
at present, we do not have any evidence showing whether the LacI 
repressor is produced or can generate a controllable negative feed-
back in our system. In an attempt to characterise the expression lev-
els of pLacO-t7-LacO-OrF-ssra construct, we decided to generate 
a linear form of pLacO-t7-LacO-egfp-ssra by pCr. We performed 
a series of Ivtt reactions supplemented with this template. howev-
er, these reactions did not show any sign of egFp-Ssra production 
(data not shown). In contrast with the production of enzymes (t7r-
Nap-Ssra, ClpX-Ssra and Clpp-Ssra), neither LacI-Ssra, nor eg-
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Fp-Ssra, could be produced at a detectable level. This indicates that 
the production levels from the LacO-t7-LacO-OrF-Ssra might be 
very low. Such low level of production might still be sufficient for the 
detection of an enzymatic activity, but not sufficient for the detection 
of non-enzymatic proteins. We explain the low level of production by 
the presence of the transcribed LacO sequence in the mrNa, which 
might create a steric hindrance and prevent the optimal access of the 
ribosomes to the rBS. 
4.3. Conclusion
In this chapter, we described the multiple challenges encountered 
in our attempt to implement the LacI-ssra gene oscillator. We im-
plemented a positive feedback based on the self-amplification of the 
t7rNap, which was our first objective. however, this positive feed-
back displayed a strong lack of robustness. More efforts should there-
fore be made in order to better characterise the positive feedback and 
find conditions allowing a strong and robust positive feedback loop. 
The same plasmid backbone had also been used to successfully pro-
duce the ClpXp complex in situ (see Chapter 3). This was a strong in-
dication that the LacO-t7-LacO-OrF-ssra was efficiently expressing. 
Nevertheless, we were not able to establish that the LacI protein could 
be produced from the construct. Because we did not succeed to clone 
the egfp gene in the pLacO-t7-LacO-ssra expression plasmid, we 
generated by pCr a linear fragment corresponding to the regulatory 
sequence together with the coding and the termination sequence. No 
fluorescence could be detected from the Ivtt reactions performed 
using the egfp template (data not shown).
We reason that the expression levels from the LacO-t7-LacO-OrF-
ssra are very low. This leads to insufficient mature protein levels to be 
detected, in the case of egFp, or to generate a negative feedback, in 
the case of LacI. however, such low production levels can impact the 
readout production in the case of enzymes such as t7rNap, ClpX 
and Clpp.
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One crucial aspect of the project, which was proving the efficiency 
of the negative feedback, was not conclusive, neither in batch nor in 
semi-open reactor. everything at that point of the project indicated 
that the efforts to implement the LacI-ssra oscillator could not be 
successful. We decided to investigate the possibility of using other 
proteins to generate a negative feedback that would not be based on 
transcriptional regulation. priority should be given to a protein read-
ily impacting the Ivtt reaction. Moreover, the rapid testing of new 
topologies in batch showed clear limitations, as separating the effects 
of resource limitation and a negative feedback is often difficult. For 
this reason, new topologies should rapidly be tested in a sustained 
Ivtt environment. Flow reactors seem particularly adapted for such 
rapid testing, as they maintain the reaction in a steady-state while 
diluting molecules responsible of a negative feedback (see Chapter 3).
While working on the tuning of mrNa degradation rates, we realised 
the MazF protein had the potential to be used as a negative feedback. 
More efforts were invested in establishing whether MazF could be 
used for creating a complex gene network in replacement of LacI or 
as a key protein for larger gene network regulation.
4.4. Material and methods
Expression mixtures
all expressions were based on the same “current” protocol described 
in chapter 2.
Dialysis expressions
Dialysis expressions were performed according to the method de-
scribed in chapter 3.  Data was analysed using ImageJ, MIpav, and 
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excel. Iptg (Sigma) was supplemented in both reaction mixture and 
feeding buffer in order to insure a constant supply of Iptg, starting 
immediately at the equilibrium.
Cloning
pLacO-T7-LacO-t7rnap-ssra
pLacO-t7-LacO-t7rnap-ssra was  synthesised and cloned into a 
pJ864 vector by DNa 2.0. The  pJ864 is an empty vector with a high 
copy number and a kanamycin resistance gene.
pLacO-T7-LacO-lacI-ssra
We had designed the vector so it would include restriction sites for 
convenient further cloning. One site, NdeI (Catatg) was situated at 
the very start of the gene, atg coding for the first methionine. The 
NdeI potential cloning scars has been reported by Mansy to have a 
very limited effect on cell-free gene expression [19]. a second restric-
tion site, SpeI (aCtagt), was situated between the end of the coding 
sequence of the native protein and the coding sequence of the degra-
dation tag, in the sequence coding for the linker region tS. NdeI and 
SpeI were both purchased from New england Biolabs so they could 
be used in one digestion reaction using the Buffer 4. The lacI gene was 
pCr amplified from the original plasmid obtained from the hasty 
lab, the size of the product was analysed on a tBe-0,8% agarose gel 
electrophoresis and was corresponding to the expected size of lacI 
gene. after digestion of the cloning vector (10 µg) and the pCr prod-
uct (5 µg), the products of digestion were analysed by tBe-0,8% aga-
rose gel electrophoresis and the corresponding migration areas were 
cut out from the gel. after extraction using the Qiagen gel extraction 
kit, we estimated the concentration of purified digested products us-
ing a Nanodrop spectrophotometer. Finally, the digestion products 
were mixed together in a t4 ligation mixture in a vector/insert molar 
ratio of either 1:1 and 1:3 or 1:0 (control) for a final vector concentra-
tion of 1 μg/20 μL, The ligation mixture was incubated at 20°C during 
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1 h. The ligation mixtures were entirely mixed with 200 uL of com-
petent XL-1 blue bacterial suspension (see the protocol for prepara-
tion of competent bacteria using MgCl) The cells were kept on ice for 
30 min, heat shocked at 42,5°C for 30 seconds, brought back on ice 
for 2 min and mixed with LB broth and incubated at 37°C for about 
40 min for further recovery and antibiotic resistance expression. af-
ter incubation, 200 μL of the different transformation mixtures were 
plated on LB agar plate containing 50 μg/mL of kanamycin. petri dish 
was left overnight in an incubator at 37°C. Next morning 6 colonies of 
each petri dish were picked to separately inoculate 5 mL of LB broth 
supplemented with a final concentration of 50 μg/mL of kanamycine. 
after 5-6 h of incubation at 37°C and stirring at 200 rpm, plasmidic 
DNa was isolated using Qiagen Miniprep kit according to the offi-
cial protocol. In order to check the correct insertion of the gene, we 
performed a double digestion using both NdeI and SpeI and anal-
ysed the digestion products by tBe-0,8% agarose gel electrophoresis. 
plasmids presenting the right electrophoretic pattern were sent for 
sequencing and the corresponding cells were stored in glycerol 
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In this chapter, we present our work towards the implemen-
tation of a complex gene network based on self-regulation by 
MazF ribonuclease in a flow reactor. Our findings, supported 
by a mathematical model, suggest that MazF could be used 
to regulate potentially any mRNA concentration in cell-free 
expression systems. Further, we discuss the possibility of 
using molecular sequestration by antitoxin MazE in order to 
generate complex regulatory patterns, such as oscillations. 
We predict that, because of limitation in binding kinetics, the 
MazF-MazE system might not be capable of oscillations in such 
design. However, our results suggest that this system might 
be of particular relevance for further research in the field of 
non-transcriptional regulatory network.
Chapter 5
Development of a 
genetic module capable 
of self-regulation by 
mRNA deactivation: 
reconstructing an E. coli 
MazF regulation loop
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5.1 Introduction
MazF is an enzyme found in bacteria. It is a toxin capable of cleaving 
single-stranded rNa molecules such as mrNa. The MazF found in 
E. coli mediates the hydrolysis of rNa molecules at the 3’ side of the 
first adenosine residue found in aCa triplets.
We previously described in chapter 3 how we used the MazF toxin 
in order to tune the mrNa deactivation rate. In chapter 3 we also 
showed that the co-production of Maze antitoxin together with the 
MazF toxin could strongly prevent mrNa deactivation. after our 
failed attempt to implement an oscillator based on transcriptional 
regulation (See Chapter 4), our priorities were to design a new net-
work with building blocks that could be rapidly tested. MazF-Maze 
toxin-antitoxin system, which was readily available in our module li-
brary, was known for its self-regulatory properties in vivo (See next 
section). For this reason, we investigated the possibility to build a new 
synthetic network based on this toxin-antitoxin system in vitro. In the 
next section, we will give an introduction on the MazF-Maze system, 
with a special focus on structural aspects of the complex, potential 
biomedical applications of the system, and its intrinsic non-linear 
binding properties. Further, we will discuss our encouraging results 
towards the implementation of a self-regulatory post-transcriptional 
network.
5.1.1 MazF-MazE complex, regulation, 
structure, and potential applications in 
the fields of biomedical engineering and 
synthetic biology
 In bacteria, MazF activity is usually inhibited by a constant expression 
of Maze protein. It has also been shown that overexpression of MazF 
in bacteria could be compensated by a concomitant overexpression 
of Maze. For this reason, MazF and Maze, which are situated on the 
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same genetic locus, form a so-called “toxin-antitoxin (ta) addiction 
module”. This genetic module ensures the conservation and the trans-
mission of other genes situated on the same locus. In fact, MazF toxin 
activity is regulated at three different levels.
• Control over gene expression: 
Maze dimer (green spheres in Fig. 5.1a) acts as a transcrip-
tional repressor. When the concentration of free Maze dimer 
increases, a negative feedback loop is generated by repressing 
maze and mazF gene expression [1, 2] (Fig. 3.4a). MazF 
protein (blue shape in Fig. 3.4a) forms dimers that mediate 
mrNa cleavage. These dimers can also associate with Maze 
dimers. The MazF-Maze heterohexamer binds to the operator 
with even more affinity than Maze dimer alone. This generates 
a stronger negative feedback.
• Control by enzymatic inhibition: 
During the formation of MazF-Maze heterohexamer, the 
Maze C-terminal tail (from residues 50 to 82) binds the cata-
lytic groove formed by the MazF dimer. This leads to an enzy-
matic inhibition of MazF toxin by its cognate Maze antitoxin. 
Figure 5.1 shows the crystal structure of the MazF-Maze het-
erohexamer from side view (a) and top view (b).
• Control by autorepression: 
In response to certain cellular stresses, such as starvation, bac-
teria can decrease the Maze concentration using stress-specific 
Clpap protease [1]. The drop in Maze concentration leads to 
an increase of free MazF dimer concentration. This generates a 
higher turnover of mrNa molecules. MazF also alters the 16S 
ribosomal subunit by cleaving the anti-ribosome binding Se-
quence. This mediates the translation of adapted mrNa which 
produces stress-specific proteins. however, a prolonged stress 
condition associated to an increased MazF activity eventually 
leads to cell death (Figure 3.4b). Interestingly, MazF is also ca-
pable of cleaving its own mrNa. This provides a fast negative 
feedback ensuring a tight autoregulation of MazF activity.
172
Chapter 5
The properties of MazF-Maze ta system have recently been explored 
for potential use in medical applications. In a first case, model tumour 
cells were injected to nude mice, leading to solid tumour formation. 
These tumour cells had been engineered to express either MazF toxin 
or MazF toxin along with Maze antitoxin. expression of MazF alone 
led to the shrinkage of solid tumours, while the co-expression of 
MazF and Maze led to a continuous growth of the solid tumours [3]. 
These results open new possibilities in treatments against cancer if the 
mazF gene was vectorised and used in gene therapy.
another potential pharmaceutical application concerns the protec-
tion of MazF-transduced CD4+ t-cells in case of hIv infection. This 
approach aims to increase the survival of t-cells engineered to ex-
press MazF. MazF ribonuclease activity protects those t-cells against 
hIv-1 infection, which could increase the CD4+ t-cells survival and 
delay the apparition of the immune system deficiency syndrome [4] . 
takara bio Inc. and the university of pennsylvania are currently con-
ducting a phase 1 clinical trial, ongoing till December 2016 (National 
Clinical trial number NCt01787994), to determine whether MazF 
gene therapy can be used to maintain the CD4+ t-cells population in 
hIv-infected patients.
as described in Chapter 3, we first used the MazF toxin for tuning 
the mrNa degradation rate. active MazF was either added in a pu-
rified form or co-produced in the system. In order to reach maximal 
yields of expression, we had designed the mazF coding sequence so it 
would be free of aCa cleavage sites. This design prevented the newly 
generated MazF to create a negative feedback by deactivating its own 
mrNa.  
In Chapter 4, we showed that for some unknown reasons, high levels 
of expression could not be achieved by using a lacI-sensitive gene 
template in our Ivtt system. results related to the generation of a 
negative feedback by placI were inconclusive. For this reason, we were 
unable to successfully implement in vitro synthetic oscillations.
In the original dual feedback system of Striker et al., Iptg was used 
to modulate the repressive activity of lacI. Iptg is capable of inacti-
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vating lacI molecules. by maintaining Iptg concentration at a given 
level, the authors could set the concentration threshold at which lacI 
proteins would become active in repression. This approach allowed 
the authors to tune the period of the oscillations by changing the 
Iptg concentration. 
our goal was to find an alternative regulation pattern in order to gen-
erate a delayed negative feedback. because we could not explain the 
issues related to lacI repression, the alternative negative feedback 
should not be based on the alteration of mrNa production rates by 
transcriptional repression.
Figure 5.1: Crystal structure of the complex MazE2-(MazF2)2. MazF proteins 
(pink, red, green and yellow) form active dimers. MazE (cyan and blue) also form 
dimers, which allows the disordered C-terminus region (from residues 50 to 82) 
to interact with MazF and compete with the RNA substrate. (A) side view. (B) Top 
view. From [5]
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as MazF is capable of degrading its own mrNa, we hypothesised 
that MazF enzymatic negative feedback could be a good alternative 
to transcriptional repression. Furthermore, the inactivation of MazF 
protein by Maze antitoxin renders possible the implementation of a 
delay by molecular titration. 
Molecular titration is a regulation mechanism often found in cells to 
regulate protein activities in viral systems [6], prokaryotes [7] and 
eukaryotes [8]. Molecular titration originates from protein seques-
tration, when an active protein a binds an inhibitor b and forms an 
inactive complex ab. If the concentration in b is greater than the Kd, 
b acts as a buffer, sequestrating the protein a. as the total concentra-
tion in protein a (at) increases, the concentration in free protein b 
decreases. eventually, at reaches the equivalence point (at≈bt) and 
the titrant b becomes saturated. Further increase in at leads to an in-
crease in free protein a, as a is in excess. one very interesting conse-
quence of molecular titration is called ultrasensitivity. ultrasensitivity 
occurs when a small increase in at leads to a large increase in free a. 
Conditions for ultrasensitivity are met in the equivalence zone if bt  is 
much greater than the Kd. In this case, 2-fold increase in at leads, for 
instance, leads to 9.8-fold increase in free a (Fig. 5.2). Cataudela and 
co-workers also suggested that toxin-antitoxin systems could display 
ultrasensitive behaviour that could generate complex regulatory pat-
terns such as bistable switches [9]
In this chapter we describe the preliminary results indicating that 
the MazF-Maze toxin-antitoxin system can be used for generating a 
tuneable, delayed, negative feedback. This system could be used for 
implementing a new kind of non-transcriptional genetic oscillator, 
which could universally regulate protein concentration in vitro. our 
first objective was to prove the MazF could be used to generate a neg-
ative feedback in vitro. The presence of an aCa site in the mrNa 
is crucial for the recognition by the E. coli MazF. We show that the 
presence of aCa sites in the mazF mrNa is essential for generating 
a negative feedback. as the implementation of a delay in the negative 
feedback is crucial for generating oscillations, we also investigated the 
use of the Maze antitoxin for implementing such delay. our second 
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objective was to show that Maze antitoxin could be used to cancel 
the MazF negative feedback. Furthermore we propose that the nega-
tive feedback can be delayed by changing the concentration of Maze 
protein
5.2 Results and discussion
5.2.1 MazF production in batch
In order to check whether MazF protein could generate a negative 
feedback, we co-expressed prSet-egfp with two different versions of 
the mazF gene. one version had aCa sites removed from the mrNa 
Figure 5.2: Ultrasensitivity obtained by molecular titration. From [10].
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sequence (figure 3 a), the other version followed the original mrNa 
sequence, which contained 10 aCa sites (figure 3 b). In order to avoid 
the time-consuming process of cloning, linear version of mazF tem-
plates were generated by pCr.
Figure 5.3 c shows the egFp production curves obtained in batch 
from prSet-egfp template alone, or coupled with the production of 
MazF (no aCa) or the expression of MazF (aCa). From now on, 
mazF(-) will refer to the version of mazF gene not including aCa 
sites in the coding sequence and the mrNa, while mazF(+) will refer 
to version with aCa sites.
 The apparent production rate obtained with prSet-egfp and either 
t7-mazF(+) or t7-mazF(-) was about 50% of the reference obtained 
with prSet-egfp. The co-production of MazF protein provides an im-
mediate decrease of egFp production rate, but the presence of aCa 
sites in the mazF mrNa does not have a clear effect on the overall 
behaviour of the system in batch. 
We assume a linear correlation between the concentration in mrNa 
and the egFp production rate. our observations show that the in 
situ expression of MazF, with or without aCa sites in the mrNa, 
decreased the egFp production by a factor of two. We explain this 
decrease in production by a drop in mrNa concentration, which we 
assume to be the consequence of an increase in MazF activity. Shin es-
timated the average lifetime of egfp mrNain cell lysate to be around 
13 minutes [11]. We can estimate the overall mrNa lifetime to be 
6.5 minutes in presence of t7-mazF template.
as mentioned, the presence of aCa sites only led to a small difference 
in egFp concentration between the reaction expressing mazF(+) and 
mazF(-) genes in batch. The difference can only be observed at the 
end of the experiment, when Ivtt reactions are anyway depleted in 
substrate.
For this reason, it was necessary to perform the same experiment us-
ing reactions maintained in a steady-state. We used the flow reactor 
described in chapter 3.
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5.2.2 ACA sites in mazF mRNA allow MazF to 
regulate its own concentration
We performed similar reactions using a flow reactor instead of a mi-
croplate. We wanted the reaction to be kept in a steady-state, as the 
influence of aCa sites might become more apparent over longer time 
periods of expression. after 1 h, batch reactions are still in a linear 
regime of protein production. The flow was therefore set at 100% re-
action replacement per hour.
Figure 5.3: Influence of the ACA sites on the expression of MazF and eGFP. (a) Expression product 
from T7-mazF (no ACA) cleaves egfp mRNA but cannot cleave its own mRNA.  (b) Expression 
product T7-mazF (with ACA) cleaves both its own mRNA and egfp mRNA. (c) Expression of pRSET-
egfp coupled to T7-mazF (no ACA) or to T7-mazF (with ACA) in batch (C; n=2 (average fluorescence)).
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results are presented in figure 5.4 as normalised fluorescence values. 
The reaction containing 1 nM of prSet-egfp was used as a reference. 
linear templates used in 5.2.1 were supplemented to the reference 
reaction. because of time limitations, the experiments could not be 
reproduced.
The egFp production in the reference reaction (prSet-egfp 1 nM) 
increased for 3 h and plateaued. This indicates that the production 
rate and the dilution rate were balanced. a slow decrease of the 
steady-state fluorescence value was observed, with a signal loss of ap-
proximately 7% per hour. This was consistent with previous observa-
tions described in Chapter 3.
The reaction containing t7-mazF(-) template produced egFp until 
reaching a maximum value, after 1 h, corresponding to 10% of the 
reference maximum value. after reaching this maximum, signal de-
cayed towards zero after about 3 h. This indicates that the dilution 
rate was stronger than the expression rate. We explain this decrease 
Figure 5.4: Influence of the ACA sites on the production of eGFP and MazF in an 
IVTT reaction maintained in a steady-state. n=1.
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of apparent expression rate by an increase of mrNa degradation rate 
due to an increase of MazF concentration. In comparison, the reac-
tion supplemented with t7-mazF(+) template (0.8 nM) reached a 
maximum after 1 h, corresponding to 20% of the reference maximum 
value. however, at that point, the reaction stabilised and entered a 
slow decay phase. 
Decreasing the template concentration from 0.8 nM to 0.4 nM allows 
the system to reach a higher egFp level, about 25% of the reference 
maximum, instead of 20% at a template concentration of 0.8 nM. The 
slow decay did not depend on the template concentration as the decay 
was also observed at a template concentration of 0.4 nM. The decay 
also corresponded to a signal loss of 7% per hour .
our observations indicate that the MazF activity is stronger when the 
mazF mrNa does not include aCa sites, in comparison to the mazF 
mrNa including aCa sites. This is a strong indication that the MazF 
protein is able to degrade aCa sites of its own mrNa. This degrada-
tion leads to a regulation of the MazF concentration. 
We then simulated the experiment using a coarse-grained mathemat-
ical model of the MazF systems, with or without the aCa sites. The 
model was inspired by the work of Karzbrun et al., who used Michae-
lis-Menten kinetics to describe the dynamics of the system [12]. The 
flow was also simulated by implementing a dilution rate. The model 
was supplemented, when possible, with rates from literature. rates 
are described in table 5.1. 
The model was designed as follows:
The model was deterministic, which implies a continuum in concen-
tration. For example, a gene template can be present at a concentra-
tion of 1 nM in 60 µl, in contrast with stochastic systems, such as 
a cell, where a low concentration implies either the presence or the 
absence of the gene template.
The mathematical model calculates the concentration of each species 
in time by addition of the flow producing a species (appearance or 
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Figure 5.5: Topology of the MazF(-) (a) and MazF(+) (b) systems. 
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“positive production”) with the flow consuming a species (disappear-
ance or “negative production”). 
gene template concentrations are the primary inputs of the system of 
equations. The figure 5 describes the topologies that we implemented 
in the model. Figure 5 a shows the reactions and the associated rates 
for the system involving no negative feedback loop (MazF(-)). Figure 
5.5b is similar to figure 5.5 a but it describes the system including a 
negative feedback (MazF(-)).
We assume that the starting concentration of mrNa is 0. In other 
words, the physical flow of fresh material does not bring any extra 
mrNa, which means that the appearance of mrNa is strictly due 
to the transcription reaction. mrNa positive production rate there-
fore depends on the concentration in gene template (in nM) and the 
transcription rate constant ktX (in min-1). The disappearance rate is a 
combination of cleavage by MazF2 with a dilution due to the flow of 
fresh Ivtt material.  The cleavage rate depends on the concentration 
in MazF2, on the concentration in mrNa, and on the rate constant 
kdeg (in min-1.nM-1).
The concentration of mazF (+) mrNa, for example, can be described 
at a given time as:
and the concentration of MazF dimer can be described as:
It is noteworthy that for simplification reasons, the formation of com-
plex MazF-Maze involves a stoichiometric ratio (1:1 instead of 1:2). 
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The transcription rate constant was set at 0.06 /min and translation 
rate constant was set at 1/min for both egFp and MazF proteins for a 
reason of simplification. rates were taken from Karzbrun et al. [12] as 
the authors use an expression system very similar to ours.  We expect 
the overall expression rate of MazF to be lower than for egFp, because 
of its linear template origin. Nevertheless, MazF protein (about 12 kg/
mol) and mrNa (333 bases) are faster to produce than degFp pro-
tein (about 32 kg/mol), which might compensate for the lower pro-
duction rate of MazF. 
The maturation rate constant of egFp (0.0617 /(nM.min)) was taken 
from Shin et al. [13]. In absence of any documented rate, we chose to 
assign the same value to MazF folding, although the MazF monomer 
is smaller than egFp and its maturation does not involve a reaction 
to generate an active site, which is the case with egFp fluorophore.
 
Table 5.1: kinetic parameters used for implementing the 
mathematical model
We could not find dimerisation and dissociation rate constants for 
MazF. however, experimental data indicates that egFp production 
is readily impacted by the presence of MazF dimers, suggesting that 
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MazF dimerization is not a kinetic limit. We evaluated the impact of 
the MazF dimer dissociation rate constant on the system behaviour 
by assigning a kr ranging over three orders of magnitude in the reac-
tion coupled to t7-mazF (-aCa) expression (Fig. 5.6 a). We observed 
that the behaviour of the system was very robust, characterised by a 
signal increase followed by a slow decay. Furthermore, the maximum 
value would only change by two-folds if kr would be 100 /min in-
stead of 0.1 /min. For this reason we chose to assign arbitrary values 
to MazF dimerisation rate constants (kf=1 nM/min and kr=1 /min), 
leading to a potential Kd of 1 nM. This Kd was situated in a range of 
values all leading to similar behaviour of the system. 
Finally, we set the degradation rate constant to 0.2 /(nM. min). This 
value approximates what Shin et al. found for the egfp mrNa deac-
tivation rate per nM of MazF in a crude extract (mrNa lifetime of 
5 min in presence of 36 nM of MazF, kdeg=0.056 /(nM.min). Shin et al. 
showed that this rate constant depends on the length of the mrNa, 
as for the firefly luciferase protein (60.7 kg/mol), the kdeg was approx-
imately 0.036 /(nM.min).
another approach, which we did not use for this coarse-grained 
model, would consist in implementing the cleavage rate per aCa site 
instead of considering the cleavage rate per mrNa.
Figure 5.6b shows the results of the simulation, normalised and over-
laid with the results obtained experimentally. overall, our model de-
scribes the dataset we obtained experimentally reasonably well. For 
this reason, we assume that the essential interactions and the kinetic 
parameters driving the behaviour of the system are well implement-
ed. We used the model to estimate the concentration of molecules 
we could not directly measure. The absence of the aCa sites in mazF 
mrNa leads to a rapid decay of the system while the presence of 
self-regulation allows a steady production of egFp (at 800 pM of 
template, maximum of 0.18 experimentally and 0.12 in simulation; 
at 400 pM of template, maximum of 0.25 experimentally and 0.17 in 
simulation). Note that the simulated and experimental data obtained 
for t7-mazF (with aCa) strongly overlap. There are also clear dis-
crepancies between experiment and simulation. We explain these by 
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Figure 5.6: Model of MazF expression in flow. (a) Influence of the MazF dimer dissociation 
constant, screened over three orders of magnitude, on the negative feedback generated by 
the mazF(+) template. (b) Simulations and experimental data (normalised) of the expression 
of pRSET-egfp coupled with T7-mazF (+/- ACA) in flow. 
Figure 5.7: (a) Simulation of the MazF dimer concentration and (b) of the mazF mRNA 
concentration during the expression from T7-mazF (no ACA) (black) or T7-mazF (with ACA) (red).
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differences between simulation rates and actual rates. Furthermore, 
the natural decay of the system, which we cannot explain, is a major 
difference between experiment and simulation.
Figures 5.7a and 5.7b show the corresponding simulations obtained 
for the MazF dimer and mazF mrNa concentrations. In absence of 
aCa, mrNa and protein increase until reaching the steady-state (re-
spectively 3 nM after 1 h and 65 nM after 6 h), while the presence of 
aCa in the mrNa allows a regulation of the mrNa concentration 
after 30 min leading to a rapid stabilisation of the MazF dimer con-
centration at a lower level than without aCa (7 nM after 1 h).
The simulations strongly indicate that the difference of egFp fluores-
cence observed experimentally between the reactions supplemented 
with mazF (-) or mazF (+) templates is caused by the action of a neg-
ative feedback based on the enzymatic degradation of mrNa by E. 
coli MazF proteins
These results can be compared to in vivo observations, where the re-
moval of aCa sites from mazF mrNa were found to be not viable 
for the cells [14]. This means that t7-mazF (+) can be used as mod-
ule to regulate mrNa concentration in artificial gene networks. This 
module is not based on transcriptional regulation and can therefore 
potentially regulate any protein concentration by degrading mrNas 
displaying at least one aCa site.
Furthermore, we conclude that the flow reactor is a very interesting 
platform for the characterisation of complex systems as it allowed us 
to reconstruct the enzymatic self-regulating MazF module in vitro. 
however, our ultimate goal was to use the MazF regulation system in 
semi-open reactors, such as liposomes. The reaction would be kept 
out-of-equilibrium not by using dilution but by making use of the en-
zymatic degradation machinery. For this reason, we checked whether 
the presence of an –ssra tag at the C-ter of MazF, which is a small 
protein, would disturb its activity. 
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5.2.3 Addition of ssra degron does not disturb 
the activity of MazF
our objective was to check if mazF(+)-ssra template could also 
generate a negative feedback comparable to the one observed  with 
the mazF(+) template (Fig 5.8). It is known that the addition of ex-
tra peptide elements, such as purification tags, can affect the tertiary 
and the quaternary structure of proteins and therefore their activity. 
as the Ssra tag is 12 residues long while the MazF protein is 111 
residues-long, there was a risk that the Ssra tag could interfere with 
its activity. on the other hand, the addition of a polyhistidine tag (8 
residues long) to the MazF protein did not critically affect the enzy-
matic activity (see chapter 3). The degradation tag could also lead to 
a strong decrease of protein concentration, below an observable ac-
tivity. It was therefore necessary to check whether the presence of the 
tag would not prevent the MazF to reach a concentration sufficient to 
generate a negative feedback. We performed a series of prSet-egfp 
expressions with a range of mazF (+)-ssra linear template concentra-
tion (0, 0.5,1, 1.5, 2 nM). 
results shown in Figure 5.9a establish that increasing concentration of 
the mazF (+)-ssra template decreases the expression level of egFp. In-
terestingly, expression curves overlap for about 1.5 h after the start of 
the experiment. after 1.5 h, the reaction containing 2 nM t7-mazF-ss-
ra starts plateauing, followed by the reactions containing 1.5 nM, 1 nM, 
0.5 nM template. Increasing the mazF(+)-ssra template concentration 
decreased the final egFp levels. a concentration of 0.5 nM of template 
led to an egFp level of 50% of the reference. however, the production 
of egFp could not be completely switched off, as a maximal drop was 
provided by 2 nM of mazF (+)-ssra template at 35% of the reference 
value. These results show that the mazF (+)-ssra template is able, like 
mazF (+), to negatively impact the production of egFp.
In order to ensure the long-term stability of the template, the mazF 
(+)-ssra had to be cloned into the prSet expression plasmid. We also 
checked whether the cloning into the prSet plasmid would allow the 
efficient expression of MazF-ssra. The mazF (+) gene was cloned into 
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a prSet expression plasmid to prevent template degradation in con-
tact with lysate. We performed a series of prSet-egfp expressions, 
with a range of prSet-mazF(+)-ssra concentrations (0, 0.25, 0.5, 
and 1 nM). because of the importance of the results, this experiment 
was replicated 4 times. We had already observed that Ivtt reactions 
supplemented with a plasmid template are usually more productive 
than when supplemented with a linear template. We therefore used 
a concentration of prSet-mazF(+)-ssra lower than the concentra-
tion of linear template we previously had used. results in Figure 5.9b 
show that the egFp production in presence of prSet-mazF(+)-ssra 
represents 50% of the reference value. Strikingly, this drop does not 
depend on the concentration of template used in our experiment. a 
concentration of 0.25 nM of prSet-mazF(+)-ssra is already enough 
to reach the strongest possible mrNa deactivation. In comparison to 
the delay observed using t7-mazF(+)-ssra, the egfp mrNa deactiva-
tion is observed from the start of the expression, showing that delay is 
not intrinsically present when expressing MazF-Ssra protein. Further 
Figure 5.8: Influence of the –ssra tag on MazF activity. Schematic 
representation of T7-mazF (+ACA)-ssra module. Ø indicates 
degradation by ClpXP protease.
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efforts have to be done for implementing and controlling the delay at 
which the MazF, and therefore the negative feedback becomes active.
Figure 5.9: Influence of the SsrA degron and expression from pRSET plasmid on the behaviour 
of MazF(+). (a) Influence of the SsrA tag on MazF activity produced in situ. (b) Influence of cloning 
into the pRSET plasmid for long-term stability of the mazF gene template.
5.2.4 Addition of MazE delays the action of 
MazF by molecular titration
The presence of a delay in the negative feedback is essential for gener-
ating oscillations. by analogy to the strategy used by Stricker et al. [15], 
we hypothesised that the Maze antitoxin could be used to buffer the 
MazF activity (figure 5.10).  Maze2 and MazF2 form a complex leading 
to the inactivation of MazF. We assume that the dissociation constant 
between Maze and MazF was very low, so no free MazF can be found 
if free Maze remains. In order to become active, the MazF produced 
in situ therefore has to reach a concentration equivalent to the Maze 
concentration before generating a negative feedback. The addition of 
Maze, set to a given concentration, should allow us to tune the delay 
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at which the negative feedback could be generated. our aim was to 
develop a method that would enable the rapid production of the an-
titoxin. This method would allow us to estimate the strength and the 
time at which the MazF produced in situ would become active. 
We wanted to keep the system simple, without a regulation loop that 
could make the analysis of the results more complicated. For this rea-
son, the mazF template used did not include aCa sites. Maze protein 
was pre-expressed for 3 h using an Ivtt reaction supplemented with 
a t7-maze template (Fig. 5.11). Increasing doses of Maze could be 
added to an Ivtt reaction producing MazF (-). by analysing the ki-
netics of egFp production, our aim was to deduce the effect of Maze 
on the MazF activity at the whole reaction level (titration of MazF 
activity) and study the influence of the Maze concentration on the 
time at which MazF effect could be observed (delay).
In order to check whether the effect of the MazF activity could be 
delayed by molecular titration, we performed a series of Ivtt reac-
tions supplemented with increasing volumes of the Maze antitoxin 
(0,0.5,1,2 and 5 µl). prSet-egfp (1 nM) alone was used as a positive 
Figure 5.10: MazE is used to titrate the MazF activity
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control, as well as prSet-egfp coupled with the expression of t7-
mazF (-) (0.5 nM) as a reference for the effect of MazF in absence 
of extra Maze antitoxin (figure 5.11). The addition of Maze solution 
also added t7-maze template, but the final t7-maze concentration 
after dilution was estimated between 15 and 60 pM of linear template. 
Such concentrations are normally not sufficient to lead to significant 
protein expression, considering the strong decay in intact linear tem-
plate after 3 h in contact with lysate DNases. For this reason, we as-
sumed the impact of the addition of Maze-containing Ivtt solution 
to be mainly due to the titration by Maze.
results show that, as expected, the addition of mazF(-) template gen-
erated a strong decrease (-85%) in egFp production (Fig. 5.12 a). In 
contrast, the addition of Maze antitoxin allowed the rescue of the 
egFp production. Compared to the prSet-egfp reference, the drop 
in egFp level was only of 72% with 0.5 µl of Maze, 64% with 1 µl, 
30% with 2 µl and 37% with 5 µl. We presently cannot explain why 5 
µl of Maze extract did not rescue more expression than when using 
2 µl of Maze extract. The amplitude of the drop in egFp level due to 
the addition of the mazF(-) represented the maximal MazF activity 
generated in the reactions and was set to 1. This allowed us to de-
termine the relative MazF activity remaining after addition of Maze 
antitoxin and start the sketch of the MazF toxin titration curve by 
Maze antitoxin. The concentration of Maze reached by pre-expres-
sion in Ivtt could not be determined so volumes are used as relative 
indications. 
Figure 5.12b shows the relative MazF activities obtained with the dif-
ferent Maze concentrations. results indicate that MazF activity is in-
hibited in presence of preexpressed Maze, and that the response to 
Maze is not linear, although more data points are necessary to com-
plete the sigmoidal titration curve. a sigmoidal function was used to 
describe the titration curve: 
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Figure 5.11: Scheme of the method used to check the influence of MazE antitoxin on 
MazF activity. Schematic of the experimental procedure used to test the influence of 
MazE on the activity of MazF toxin produced in situ.
192
Chapter 5
Figure 5.12: Effect of MazE antitoxin on MazF activity. (a) MazE was pre-expressed and a 
series of IVTT reactions producing eGFP and MazF was supplemented with a range of MazE-
enriched volumes. (b) Final fluorescence levels were used to calculate the relative MazF 
activity as a function of the added volume of MazE-enriched solution. The titration curve 
was described by a sigmoidal function in order to find the volume of half-response. (c) The 
first derivatives of the fluorescence signals shown in (a) were calculated in order to unravel 
inflexion points in eGFP production rate. n=1.
We used a boltzmann fit function from origin to describe the sig-
moid-shaped curve we obtained by titration. This fit is useful for 
determining the concentration of half-response (x0), in our case the 
concentration of Maze that will allow an inhibition of 50% of the 
MazF activity. a1 represents the maximal activity value, a2 the min-
imal activity value
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The mathematical fit indicates that 1.09 µl of pre-expressed Maze are 
necessary for inhibiting 50% of the MazF produced in the reaction. 
This experiment should be reproduced in order to access a quantita-
tive description of the system. however, results indicate validate the 
strong potential of using Maze to inhibit MazF activity in vitro. re-
sults also suggest that the dissociation constant of the complex Maze-
MazF is low, as 1% of the Maze produced in vitro is enough to inhibit 
50% of the MazF activity generated in situ.
In order to estimate the time at which the increase in MazF activity 
was observable, we calculated the first partial derivative of the egFp 
fluorescence curves obtained with titration by Maze. The derivatives 
are presented in Figure 5.12c. The first derivatives show that the fluo-
rescence from prSet-egfp coupled to t7-mazF started to slow after 
35 minutes. The addition of 0.5, 1, 1.5, 2 and 5 µl of Maze extract led 
to a deceleration after 35, 40, 70 and 60 min respectively. The refer-
ence reaction started to slow after 70 min. These results show that the 
in situ expression of MazF does not only decrease the egFp produc-
tion level but also shortens the span of egFp production. The effect of 
MazF activity can be reversed by titration with Maze, which leads to 
a partial recovery of both expression level and time before expression 
decelerates. 
Next, we implemented the Maze titration into the model. an estima-
tion of the MazF-Maze Kd(‹10-7 M) was given by li et al. by monitor-
ing exchange rates by nuclear magnetic resonance (NMr) spectros-
copy  [16]. In a more recent publication, Zorzini et al. determined (by 
isothermal titration calorimetry (ItC)) that the affinity between Maze 
region of interaction (residues 50-82) and the primary binding site of 
MazF dimer was 11 ±3 nM [17]. Note that the possibility of a second 
binding event on a different binding site and involving negative coop-
erativity mechanism was described by both groups, but the affinity is 
low enough (Kd = 59 µM) to be neglected in our model. both values 
came from important contributors in the field of MazF proteins re-
search. although the Kd values were not contradicting, we thought it 
would be important not to overestimate the affinity of Maze for MazF 
dimers. We decided to set the association kon at 1 /(nM.min) and the 
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koff at 50 /min, which would lead to a dissociation constant of 50 nM 
at the equilibrium. Mathematical simulations are presented in figure 
5.13. results indicate that the Maze concentration strongly influences 
the time at which MazF activity can be observed. The mrNa degrada-
tion was delayed for up to 2 hours with 5 µM of Maze. as observed ex-
perimentally in batch reactions, even a high Maze concentration such 
as 5 µM could not completely rescue the egFp expression.
5.2.5 Oscillations observed by mathematical 
simulations
Finally, we used our mathematical model in order to determine 
whether the MazF-Maze ta system could generate oscillations. 
unfortunately, oscillations were observed only by using very high 
MazF-Maze association rate value (kon=100 nM/min; koff=0.1 /min) 
(Fig.  5.14). Maze concentration was set to 500 nM, and mazF (+) 
Figure 5.13: Simulations of MazE titration in flow 
experiment using T7-mazF (no ACA) (0.8 nM)
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template to 5 nM. at such conditions, every specie in the system os-
cillated, with a period of about 100 min and an amplitude of 50 nM 
for gFp, Maze dimers and Maze-MazF complex. although encour-
aging, such behaviour was obtained by using a very unrealistic asso-
ciation rate that makes free MazF virtually inexistent when free Maze 
is available. Such association, which would lead to a dissociation con-
stant in the picomolar range at the equilibrium, was only observed 
with a very few biomolecular associations, such as streptavidin-biotin 
binding (Kd~0.1-1 pM) and never with heterodimer complexes.
5.3 Conclusion and outlook
In this chapter, we presented a partial in vitro reconstitution of the 
MazF-Maze toxin-antitoxin system. We could show that wild-type 
e. coli MazF expressed in vitro shows self-regulation by cleavage of 
its own mrNa. We observed that the removal of aCa sites from the 
Figure 5.14: Mathematical simulations of oscillatory behaviour using the MazF-MazE system 
in flow.
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mazF mrNa leads to an arrest of protein expression, which is equiv-
alent to a non-viable modification of mazF mrNa observed in vivo. 
This observation was validated by using a computational model to 
describe the behaviour of our system in flow. 
We also proposed a method to rapidly produce the Maze antitoxin. 
We used the antitoxin to buffer the MazF activity. This allowed us 
to decrease the MazF activity up to 60% and shift the effect of MazF 
from 35 minutes in absence of Maze to about 70 minutes by addi-
tion of 2 µl of Maze antitoxin. This corresponds to the time at which 
the Ivtt reaction producing egFp slows down in absence of other 
template influencing the reaction. Computational simulations also 
indicated that Maze titration could be used to delay the apparition of 
MazF activity in flow. however, this delay was not enough to enter an 
oscillating regime, as the association between MazF and Maze dimers 
was kinetically limiting. only a very high association rate could allow 
MazF-Maze complex to generate oscillations.
our experiments clearly establish that the MazF-Maze toxin-an-
titoxin enzymatic regulation system could be reconstituted in vitro. 
MazF-Maze system could be useful for in vitro synthetic biology as 
a molecular model and as a regulating module in complex molecular 
networks. however, the thorough quantitation of the effect of Maze 
on the negative feedback is required in order to use the ta system for 
regulation purposes. MazF-Maze complex acts as a transcriptional 
factor, which could be used in future research for implementing more 
complex regulatory system.
5.4 Material and methods
5.4.1 Cell-free gene expressions 
linear templates were synthesised by IDt DNa and amplified by 
pCr. pCr products were purified using Qiagen pCr purification kit. 
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plasmid templates were cloned into e. coli Xl1-blue strains and col-
lected following Qiagen miniprep kit protocol.
Cloning of mazF (+aCa)-ssra gene into prSet-5d plasmid was per-
formed by Maaruthy Yelleswarapu, using NcoI and ecorI digestions.
elutions of genetic material were done using MilliQ. Concentrations 
of all templates were determined using Nanodrop spectrophotometer.
batch expressions were performed as described in chapter 2. In-
cubation at 30 degC and fluorescence measurements were done 
in a 96-wells Nunclon flat black plate by using a berthold tristar 
plate-reader. excitation filter was 488 nm +/- 15 nm, emission filter 
was 530 nm +/-15 nm.
5.4.2 Expression of MazE
I performed the expression of Maze by supplementing the linear tem-
plate t7-maze to an Ivtt mixture at a final concentration of 3 nM. 
The reaction was performed in 2X100 μl in a Nunclon flat-black 
microplate. another sample, containing prSet-egfp 1 nM only, was 
used to estimate the time at which the protein production would 
plateau.  after about 180  min, the mixtures containing Maze were 
pooled together, aliquoted and flash-frozen using liquid nitrogen.
5.4.3 Flow expressions
Flow expressions were performed as described in chapter 4. replen-
ishment rate was set at 100% per hour. Fluorescence measurements 
were performed using olympus IX81 inverted fluorescence micro-
scope, coupled to a mercury lamp illumination (100% power, FItC 
filters) and to an eM CCD camera (iXon andor). Sampling was per-
formed every 5  min. reactions were performed at 30°C. although 
temperature was not controlled, it was regularly monitored using an 
infrared thermometer.
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5.4.4 Data analysis
Microscopy pictures were analysed using ImageJ (reF ImageJ) and 
MIpav (reF MIpav). Data was plotted using origin. boltzmann 
sigmoid fit and first derivative calculations were performed with 
origin.
5.4.5 MazF system model
Model was implemented in collaboration with Dr. evan Spruijt, who 
wrote the equations code and the user’s interface.  equations and dif-
ferential equations solvers used are presented here.
function mazf_gfp_flowreactor(inic) 
% 
% Deterministic/interactive model of T7/MazF/GFP system 
% Call: mazf_gfp_flowreactor([]); 
% 
% Evan Spruijt, Emilien Dubuc 
% Date 05-03-2016 
  
global t y 
  
%% I/O  
% INPUT: initial_concentrations (inic) 
% GLOBAL VARIABLES: t, y 
%   t:      vector of time in min 
%   y:      vector of all concentrations in nM:  
%           [   (1) pm = plasmid of MazF 
%               (2) pg = plasmid of GFP 
%               (3) mrnamazf = mRNA of MazF 
%               (4) mrnagfp = mRNA of GFP 
%               (5) mazfu = unfolded MazF 
%               (6) mazf = MazF monomer 
%               (7) mazf2 = MazF dimer 
%               (8) gfpu = unfolded GFP 
%               (9) gfp = folded (tagged) GFP 
%               (10) maze = MazE monomer 
%               (11) maze2 = MazE dimer 
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%               (12) maze2f2 = MazF/MazE complex 
%           ] 
% OUTPUT: uicontrolled figure, parameters, concentrations 
  
%% TIME RANGE 
timespan = (0:5:1000); % default time range for solution 
in minutes 
  
%% KINETIC AND VARIABLE PARAMETERS 
p.tstart = timespan(1); 
p.tstep = timespan(2)-timespan(1); 
p.end = timespan(end); 
p.k_tx_mazf = 0.06; %1.8 % [1/min] 
p.k_tx_gfp = 0.06; % [1/min]  
p.k_tl_mazf = 1; % [1/min] 
p.k_tl_gfp = 1; % [1/min] 
p.k_mat_mazf = 0.0617; % [1/min] 
p.k_mat_gfp = 0.0617; % [1/min] 
p.kf_mazf2 = 1; %[1/nM*min] 
p.kr_mazf2 = 1; % [1/min] 
p.kf_maze2 = 1; %[1/nM*min] 
p.kr_maze2 = 1; %[1/min] 
p.kf_maze2f2 = 1; %[1/nM*min] 
p.kr_maze2f2 = 50; %[1/min] 
p.k_deg = 0.02; %[1/nM*min] 
p.flowrate = 100; %[%/hour] (100 = dilution factor of (dc/
dt)/c = 1 per hour, 50 = dilution factor of (dc/dt)/c = 
0.5 per hour)  
p.mazetot = 0; %[nM] 
%K’ = kr/kf = m^2/d = x^2/(c-x)/2 ->  2*x^2 + K’x - K’c = 
0 
MazF_ACA = 1; 
  
%% INITIAL CONCENTRATIONS  
% (all in nM) 
if isempty(inic) 
    conc.pm = 0.8; %1 
    conc.pg = 1; %2 
    conc.mrnamazf = 0; %3 
    conc.mrnagfp = 0; %4 
    conc.mazfu = 0; %5 
    conc.mazf = 0; %6 
    conc.mazf2 = 0; %7 
    conc.gfpu = 0; %8 
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    conc.gfp = 0; %9 
    conc.maze = (1/4)*(-(p.kr_maze2/p.kf_maze2)+sqrt((p.
kr_maze2/p.kf_maze2)^2+8*p.kr_maze2/p.kf_maze2*p.maze-
tot)); 
    conc.maze2 = (p.mazetot-conc.maze)/2; 
    conc.maze2f2 = 0; %12 
end 
  
%% PDE FUNCTIONS 
function dy_dt = diffeq(~,y) 
    % No spaces between terms! 
    dy_dt = [   0; % plasmid MazF 
                0; % plasmid GFP 
                +p.k_tx_mazf*y(1)-MazF_ACA*p.k_de-
g*y(3)*y(7)-(p.flowrate/100/60)*y(3); % mRNA MazF 
                +p.k_tx_gfp*y(2)-p.k_deg*y(4)*y(7)-(p.
flowrate/100/60)*y(4); % mRNA GFP 
                +p.k_tl_mazf*y(3)-p.k_mat_mazf*y(5)-(p.
flowrate/100/60)*y(5); % unfolded MazF 
                +p.k_mat_mazf*y(5)-2*p.kf_
mazf2*y(6)^2+2*p.kr_mazf2*y(7)-(p.flowrate/100/60)*y(6); % 
MazF monomer 
                +p.kf_mazf2*y(6)^2-p.kr_mazf2*y(7)-p.
kf_maze2f2*y(7)*y(11)+p.kr_maze2f2*y(12)-(p.flow-
rate/100/60)*y(7); % MazF dimer 
                +p.k_tl_gfp*y(4)-p.k_mat_gfp*y(8)-(p.flow-
rate/100/60)*y(8); % unfolded GFP 
                +p.k_mat_gfp*y(8)-(p.flow-
rate/100/60)*y(9); % maturated GFP 
                +conc.maze*(p.flowrate/100/60)-2*p.
kf_maze2*y(10)^2+2*p.kr_maze2*y(11)-(p.flow-
rate/100/60)*y(10); % MazE monomer 
                +conc.maze2*(p.flowrate/100/60)+p.kf_
maze2*y(10)^2-p.kr_maze2*y(11)-p.kf_maze2f2*y(7)*y(11)+p.
kr_maze2f2*y(12)-(p.flowrate/100/60)*y(11); % MazE dimer 
                +p.kf_maze2f2*y(7)*y(11)-p.kr_maze-
2f2*y(12)-(p.flowrate/100/60)*y(12)]; % MazE/F complex of 
dimers 
end 
function solve_pde 
    SNames = fieldnames(conc);  
    y0 = zeros(size(SNames,1),1); 
    for loopIndex = 1:numel(SNames), y0(loopIndex) = 
conc.(SNames{loopIndex}); end 
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    OPTIONS = odeset(‘RelTol’,5e-4,’AbsTol’,1e-6,’Max-
Step’,0.1*mean(diff(timespan)),’NonNegative’,(1:1:12)); 
     
    % Moderately stiff ode’s, trapezoidal rule 
    [t,y] = ode23t(@diffeq,timespan,y0,OPTIONS); % time-
span = [0:0.1:10], 1.4 s 
     
    % Stiff ode’s, low order method 
    %[t,y] = ode23tb(@diffeq,timespan,y0,OPTIONS); % 
timespan = [0:0.1:10], 1.4 s 
  
    % Non-stiff ode’s, variational order method 
    %[t,y] = ode113(@diffeq,timespan,y0,OPTIONS); % time-
span = [0:0.1:10], 12.4 s 
end
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Chapter 6
Conclusions and 
perspectives
Cell-free synthetic biology is a rapidly expanding field, with the po-
tential to provide unprecedented insight into the inner working of 
cells [1-3], and new routes for rapid testing and forward engineer-
ing of new genetic circuits [4-6]. Moreover, cell-free protein synthesis 
systems offer unique working environments for the development of 
synthetic or minimal lifeforms [7-11]. 
In this thesis, we described our efforts to design and implement in 
vitro synthetic gene oscillators. Although the ultimate goal was not 
reached, the methodology developed and the knowledge acquired 
during this project will be useful for our future research. Firstly, the 
productive, tuneable, and reproducible IVTT system we produced will 
allow further designs of new synthetic gene networks. It is noteworthy 
that our group has recently expanded my work to establish an IVTT 
system capable of producing proteins using the endogenous transcrip-
tion system. This crucial improvement allows us to reconsider the de-
sign of circuits by making use of the full transcriptional diversity of 
E. coli, which was one of our initial objectives. Secondly, our current 
understanding of protein and mRNA degradation machinery, and the 
methods established in order to rapidly modify degradation rates, will 
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provide an interesting framework for testing new circuits both in batch 
and in flow reactors. Finally, the results indicate that more diverse ge-
netic networks could be implemented by using regulatory networks 
other than transcription factor-based feedback loops. Toxin-antitoxin 
systems, MazF-Maze in particular, display non-linear binding proper-
ties that could be exploited for generating enzymatic feedbacks. 
however, it is important to have a closer look at the reasons that could 
explain, at least partially, the failure to reach the initial goals of the proj-
ect. This could help us, and other people working in our field, to avoid 
time-consuming experiments yielding disappointing or limited results. 
Firstly, developing the homemade IVTT platform was an unexpect-
edly time-consuming task. We estimate that it required the equivalent 
of two years phD-student time to fully harness the system. Although 
using a commercially available IVTT kit would have saved a consid-
erable amount of time, a deep understanding of the complex system 
will ultimately allow researchers to make much better informed deci-
sions when optimizing cell free expression of genetic networks.
Secondly, and perhaps crucially, moving beyond batch reactions 
should have been done at an earlier stage. The use of flow reactors 
similar to those used by Maerkl and co-workers [4, 6] would have 
constituted a fundamental improvement for testing our designs. Not 
only flow reactors allow a more rapid testing and/or a strong statistical 
characterisation of individual modules and systems, it is also crucial 
to test networks under steady state conditions where the balance of 
reaction rates will be fully established. In batch, there is a continuous 
change in concentrations, and thus rates of various processes, making 
it too difficult to reach a complete understanding of the system. At 
the time the first microfluidic platform was described, in November 
2013, our project had already reached mid-term. Multilayer microflu-
idics and microvalves seemed like a technology that would require a 
substantial time investment. We reasoned our simple dialysis system 
could be optimised and used instead. We now understand this might 
have been a misapprehension of experimental conditions required for 
the success of the project. For future directions, we strongly consider 
using Maerkl’s open reactors. 
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Finally, the characterisation of our modules relied on indirect read-
out, which was often a coupling to the expression of pRSeT-egfp. This 
method had the main disadvantage to sometimes yield inconclusive 
results, given the complexity of the IVTT reaction. For instance, a 
decrease in fluorescence intensity could be interpreted as a decrease 
in resource availability or as a direct negative regulation of readout 
expression. experiments described in Chapter 4 in particular, lack 
a direct evidence of lacI protein production. Due to its low sensi-
tivity, Coomassie blue staining of polyacrylamide gels often fails in 
proving the presence of a protein produced using lysate-based IVTT 
systems. however, a new method consisting in the incorporation of 
fluorescent lysine allows the labelling of proteins synthesised in IVTT 
[10]. This technique, allowed by the tuneability of IVTT reactions, 
will certainly be of great use for further establishing the qualitative 
production of a protein.
Construction of a minimal lifeform is one of the great challenges of 
cell-free synthetic biology. Such artificial cells will share the same lim-
itations as cells engineered for synthetic biology, i.e. resource burden 
[12, 13]. For this reason, implementing new genetic or metabolic net-
works that would allow a precise and tuneable management of cellu-
lar resources would be beneficial for both fields. In future research, we 
envision that enzymatic systems with increased specificity or orthog-
onality, such as B. subtilis MazF-Maze system [14], or B. subtilis lon 
protease [15], could play an important role for the development of 
new regulatory pathways in E.coli-based IVTT systems. In addition, 
dCas9 protein can be used to virtually prevent the transcription of any 
gene (Fig. 6.1) [16]. For this reason, the increased diversity offered by 
dCas9 in association with single-guide RNA (sgRNA) instructions 
could be used to design a multitude of new genetic networks.
Importantly, interest for E. coli as the synthetic biology workhorse 
might gradually decrease in the following years. In turn, new mi-
croorganisms displaying considerable advantages, i.e. faster growth, 
post-translational modifications, or transcriptional diversity, might 
become the new biological chassis. George Church and co-workers 
suggested, for instance, that Vibrio natriegens, a bacterium with a 
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doubling time of 10 minutes, could replace E. coli in the near future 
[17]. Developing IVTT systems based on these particular organisms 
might therefore become a new priority. 
Freeze-dried IVTT systems are portable and versatile platforms that 
can be used for multiple applications outside the lab. In their “on pa-
per” version, they provide a very efficient tool for diagnosing viral 
infections [1, 3]. In their seminal work, pardee et al. established that 
freeze-dried IVTT systems could also be used to produce a broad 
range of therapeutics, such as vaccines or biosynthetic drugs [18] 
(Fig. 6.2). We envision that, in a close future, freeze-dried IVTT sys-
tems could be used for point-of-care diagnosis and rapid production 
of therapeutics in remote locations. In this perspective, expanding the 
diversity of synthetic circuits available for diagnosis and production 
of associated therapeutics using IVTT systems might soon become of 
great interest.
Figure 6.1: RNA-guided repression using dCas9. dCas9 (blue shape) binds 
double-stranded DNA according to the sequence of the sgRNA (brown line). This 
can be used to prevent transcription initiation by generating steric hindrance 
or, in this case, to prematurely terminate transcription. From [16]
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Another interesting application for cell-free systems is bacteriophage 
engineering. Bacteriophages could be seen as pre-programmed bio-
chemical/genetic systems that can easily be interfaced with live cells. 
engineering bacteriophages for daily-life applications, such as bio-
film treatment or food safety tests [19], will involve an expansion of 
our knowledge and methods in virus design. This might find fur-
ther applications in the field of synthetic cell biology. A landmark 
breakthrough in this respect is the demonstration by Noireaux and 
co-workers of the complete assembly of functional bacteriophages in 
an IVTT reaction [20]. 
In contrast to cell-based production, IVTT systems allow the rapid 
synthesis of recombinant bacteriophages directly from a DNA tem-
Figure 6.2: Therapeutic applications of freeze-dried IVTT systems. From [18]
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plate (Fig. 6.3a) [19]. IVTT systems find applications in the produc-
tion of bacteriophage cocktails for broad-spectrum bacteriophage 
therapy (Fig. 6.3b) or for directing the evolution of bacteriophages in 
order to decrease the clearance by the immune system (Fig. 6.3c) [21].
Bacteriophages could also be used in a semi-bottom-up approach as a 
starting point for building up an artificial system with additional bio-
logical functions. At present, the most minimalistic genome known is 
based on 473 genes (JCV-syn3.0, 531000 base pairs), but the function 
of about 150 genes is still unknown [22]. As its genome is based on a 
Figure 6.3: Production of recombinant bacteriophages using IVTT systems. 
Recombinant bacteriophages can be rapidly synthesised from DNA templates 
(a). This allows the production of a cocktail of bacteriophages for broad-
spectrum bacteriophage therapy (b) or directed evolution of recombinant 
viruses (c). (a) from [19]. (b) and (c) from [21].
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DNA molecule, T7 bacteriophage is an ideal chassis for genetic engi-
neering [23]. Chan et al. demonstrated that T7 bacteriophage could 
be refactored – i.e. the original code could be restructured without 
changing the functionality of the phage [24]. New genes could there-
fore be added to the viral genome in order to explore unknown bio-
logical functions. Such exploration could for example focus on un-
known functions of JCV-syn3.0 genes. 
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Summary
The development of novel regulatory gene networks that are less con-
text dependent and more easily transferable between host organisms 
is an important challenge for the advancement of synthetic biology. 
The testing of individual genetic modules and their integration with-
in a network is often time consuming, due in part to the multiple 
molecular cloning steps required. Moreover, obtaining the condi-
tions that allow a network to perform as desired in vivo can also be 
challenging, as the external control over biochemical concentrations 
and reaction rates is extremely limited. Therefore, the use of in vitro 
transcription-translation (IVTT) platforms could aid in the forward 
engineering of new regulatory gene networks.
Chapter 1 of this thesis provides an overview of the field of synthetic 
biology from a microbiology perspective, as well as highlighting the 
contribution of the in vitro approach within the field.
In Chapter 2, the methods for the preparation of a reaction system 
that synthesises proteins from DNA templates in vitro are described. 
I also discuss the use of a molecular beacon for the monitoring of 
mRNA concentrations. The results show that the concentrations of 
various (bio)chemical components, such as salts, DNA templates, or 
T7 RNA polymerase, can be tuned in order to influence the produc-
tivity of the system. However, in batch this system displays a short 
reaction lifetime, in the order of 4 to 5 hours. This is due to the limited 
substrate supply in a batch reaction and the accumulation of toxic 
by-products. This limited lifetime is one of the reasons motivating the 
development of open or semi-open reactors that extend the reaction 
duration. Results also show that the use of molecular beacons for the 
detection of mRNA lacks robustness. One molecular beacon in par-
ticular, designed for the detection of lacI mRNA, displays unreliable 
responses and does not match the requirements for further use in the 
project.
Chapter 3 explores methods by which IVTT reactions can be main-
tained in a steady state.  Firstly, two methods that focus on the targeted 
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degradation of i) mRNAs and ii) proteins using bacterial enzymes are 
presented. The enzyme in charge of mRNA degradation, MazF, was ei-
ther purified in an active form or produced inside the reaction mixture 
from a genetic template. Results indicate that the rate of in vitro pro-
tein production can be tuned by altering mRNA lifetime using MazF. 
The in situ production of MazF gave particularly good results, showing 
complete inhibition of the deGFP production. Targeted protein degra-
dation was achieved using the ClpXP complex. ClpXP proteins were 
first purified but the active complex could not be obtained through 
overexpression and purification procedures.  In situ production of the 
ClpXP complex from DNA template was successful, yielding complete 
degradation of the deGFP target protein. Secondly, the use of a micro-
dialysis platform for extending the reaction lifetime by maintaining 
substrate concentrations and removing toxic by-products is described. 
This platform sustains the reaction for up to 40 hours. However, it also 
induces variability in protein production, which impacts the reliabil-
ity of such a platform.  Finally, I detail the use of a flow reactor for 
maintaining constant IVTT reagent concentrations whilst diluting 
other species, such as mRNA and proteins produced in the reactor. 
Results show that an open reactor is suitable for the implementation 
of dynamic IVTT reactions, although decay in the protein production 
rate can be observed over time, limiting the observation of dynamic 
behaviours to a period of approximately 10 to 12 hours.
Chapter 4 discusses attempts to build a genetic oscillator based on a 
negative feedback originating from the delayed production of a LacI 
repressor protein. This system also included a positive feedback 
loop, designed to increase the robustness of the oscillations. Results 
show that the positive feedback loop worked poorly, with a limited 
positive impact on the production of eGFP readout. Moreover, the 
indirect method utilised to characterise the negative feedback did 
not yield clear insights into the function of negative feedback. For 
this reason, the existence of the negative feedback generated by 
LacI proteins was not established. I decided to continue the project 
with another, better-characterised system, based on a negative feed-
back generated by the MazF protein.
The aim of Chapter 5 is to show the implementation of a self-regulat-
ing genetic module based on the production of the MazF ribonucle-
ase. The system was designed to allow the MazF enzyme to degrade its 
own mRNA; a regulatory strategy found in bacteria. Results obtained 
using the flow reactor described in Chapter 3 show that MazF can be 
used to generate negative feedback. This feedback is dependant of the 
presence of the ribonuclease recognition sequence. Results also show 
that the antitoxin MazE can be used in order to buffer MazF activity 
using molecular titration, which could be used to create non-linear 
responses from MazF.
Chapter 6 concludes this thesis by discussing the limitations of this 
project as well as by suggesting potential methodological improve-
ments for further research. In addition, an overview of possible new 
directions for synthetic biology that utilise the in vitro approach as a 
starting point is given.
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Samenvatting
De ontwikkeling van nieuwe genregulatienetwerken die minder con-
textafhankelijk zijn en gemakkelijker uit te wisselen zijn tussen gasth-
eerorganismen is een belangrijke uitdaging voor de voortgang van de 
synthetische biologie. Het testen van individuele genetische modulen 
en hun integratie in een netwerk is vaak een tijdrovende bezigheid, 
deels vanwege de veelvoudige moleculaire kloneringsstappen die 
nodig zijn. Het verkrijgen van de omstandigheden die het mogelijk 
maken voor een netwerk om te functioneren zoals gewenst in vivo 
kan bovendien een uitdaging zijn, omdat de externe controle over 
biochemische concentraties en reactiesnelheden uiterst beperkt is. 
Daarom zou het gebruik van in vitro transcriptie-translatie (IVTT) 
platformen kunnen helpen in het forward engineering van nieuwe 
genregulatienetwerken.  
Hoofdstuk 1 van deze thesis geeft een overzicht van het veld van de 
synthetische biologie vanuit een microbiologisch perspectief. Daar-
naast wordt de bijdrage van de in vitro benadering in het veld belicht. 
In hoofdstuk 2 worden de methoden beschreven voor het maken van 
een reactiesysteem dat eiwitten vanuit DNA patronen in vitro syntheti-
seert. Ook bespreek ik het gebruik van een moleculair lichtbaken voor 
het monitoren van mRNA concentraties. De resultaten laten zien dat de 
concentraties van diverse (bio)chemische componenten – zoals zouten, 
DNA patronen, of T7 RNA polymerase – afgesteld kunnen worden om 
de productiviteit van het systeem te beïnvloeden. In bulk vertoont dit 
systeem echter een korte levensduur, van ongeveer 4 tot 5 uur. Dit komt 
door de beperkte voorraad substraat in een bulkreactie en de ophop-
ing van giftige bijproducten. Deze gelimiteerde levensduur is één van 
de motivaties voor de ontwikkeling van open of gedeeltelijk-open reac-
toren die de levensduur van reacties verlengen. De resultaten laten ook 
zien dat het gebruik van moleculaire lichtbakens voor de detectie van 
mRNA robuustheid mist. Eén moleculair baken in het bijzonder, ont-
worpen voor het detecteren van lacI mRNA, toont onbetrouwbare reac-
ties en voldoet niet aan de vereisten voor verder gebruik in het project.
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Hoofdstuk 3 onderzoekt methoden waarbij IVTT reacties in een 
steady state kunnen worden gehouden. Ten eerste worden twee 
methoden gepresenteerd die focussen op de beoogde afbraak van 
i) mRNAs en ii) eiwitten, gebruikmakend van bacteriële enzymen. 
Het enzym MazF, verantwoordelijk voor mRNA afbraak, was ofwel 
gezuiverd in een actieve vorm, ofwel geproduceerd in de reactiemix 
vanuit een genetisch patroon (in situ). 
De resultaten indiceren dat de snelheid van in vitro eiwitproductie 
kan worden aangepast door het afstemmen van de mRNA levensd-
uur, gebruikmakend van MazF. De in situ productie van MazF gaf 
bijzonder goede resultaten, die complete remming lieten zien van 
de deGFP productie. De beoogde eiwitafbraak werd bereikt gebrui-
kmakend van het ClpXP complex. ClpXP eiwitten waren eerst ge-
zuiverd, maar het actieve complex kon echter niet verkregen worden 
door een combinatie van overexpressie en zuiveringsprocedures. 
De in situ productie van het ClpXP complex was wel succesvol en 
leverde complete afbraak op van het deGFP doeleiwit. Ten tweede 
wordt het gebruik van een microdialyseplatform voor het verlengen 
van de reactielevensduur door het behouden van substraatconcen-
traties en het verwijderen van giftige bijproducten beschreven. Dit 
platform ondersteunt de reactie, zodat deze tot wel 40 uur in stand 
kan worden gehouden. Het veroorzaakt echter ook variabiliteit in ei-
witproductie, wat de betrouwbaarheid van zo’n platform beïnvloedt. 
Ten slotte specificeer ik het gebruik van een stroomreactor voor het 
behouden van constante IVTT reagentia concentraties, samen met 
het verdunnen van andere stoffen, zoals mRNA en eiwitten die in de 
reactor geproduceerd worden. De resultaten tonen aan dat een open 
reactor geschikt is voor de implementatie van dynamische IVTT re-
acties, hoewel een continue achteruitgang in de eiwitproductiesnel-
heid waargenomen kan worden, die het observeren van dynamisch 
gedrag beperkt tot een periode van ongeveer 10 tot 12 uur. 
Hoofdstuk 4 beschrijft de pogingen tot het bouwen van een ge-
netische oscillator gebaseerd op negatieve terugkoppeling afkomstig 
van de uitgestelde productie van een LacI repressoreiwit. Dit systeem 
bevatte ook een positieve terugkoppelingslus, ontworpen voor het 
vergroten van de robuustheid van de oscillaties. De resultaten tonen 
aan dat de positieve terugkoppelingslus slecht werkte, met een bep-
erkte positieve impact op de deGFP productie. De indirecte methode, 
die werd gehanteerd om de negatieve terugkoppeling te kenmerken, 
gaf bovendien geen helder inzicht in de functie van de negatieve ter-
ugkoppeling. Hierdoor kon het bestaan van negatieve terugkoppe-
ling gegenereerd door LacI eiwitten niet worden vastgesteld. Ik heb 
besloten het project voort te zetten met een ander, beter gekarakteri-
seerd systeem, gebaseerd op een negatieve terugkoppeling die wordt 
gegenereerd door het MazF eiwit.
Het doel van hoofdstuk 5 is het tonen van de implementatie van een 
zelfregulerende genetische module, gebaseerd op de productie van 
de MazF ribonuclease. Het systeem was ontworpen om het mogelijk 
te maken voor het MazF enzym om zijn eigen mRNA te verteren; 
een regulerende strategie die ook wordt aangetroffen in bacteriën. De 
resultaten verkregen door het gebruik van de stroomreactor, die is 
beschreven in hoofdstuk 3, tonen aan dat MazF gebruikt kan worden 
om negatieve terugkoppeling te genereren. Deze terugkoppeling is 
afhankelijk van de aanwezigheid van de ribonuclease-herkenningsse-
quentie in het mRNA. De resultaten laten ook zien dat het antitoxine 
MazE benut kan worden om MazF activiteit te bufferen, gebruikmak-
end van moleculaire titratie. Dit zou gebruikt kunnen worden voor 
het creëren van niet-lineair gedrag van MazF.
Hoofdstuk 6 concludeert dit proefschrift door de beperkingen van 
dit project te beschrijven en ook potentiële methodologische ver-
beteringen te suggereren voor verder onderzoek. Daarnaast wordt 
een overzicht gegeven van mogelijke nieuwe onderzoeksrichtingen 
voor de synthetische biologie, die de in vitro benadering als startpunt 
gebruiken. 
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